Sharp Advantage (HMO) 2016 Formulary
Transcription
Sharp Advantage (HMO) 2016 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN Sharp Advantage 2016 Part D Formulary Effective 07/01/2016 Formulary ID: 16490.000, Version: 15 This formulary was updated on 06/27/2016. For more recent information or other questions, please contact Sharp Advantage Customer Care at 1-855-820-2112 or visit www.sharphealthplan.com/sharpadvantage for additional information. (TTY users should call 711.) Hours are 8:00 a.m. to 6:00 p.m. Pacific Time, Monday to Friday. Note to existing members: This formulary has changed since last year. Please review this document to make sure that it still contains the drugs you take. When this drug list (formulary) refers to “we,” “us”, or “our,” it means Sharp Health Plan. When it refers to “plan” or “our plan,” it means Sharp Advantage. This document includes the list of the drugs (formulary) for our plan which is current as of July 1, 2016. For an updated formulary, please contact us. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. You must generally use network pharmacies to use your prescription drug benefit. The Formulary may change at any time. You will receive notice when necessary. Benefits may change on January 1 of each year. H5386_SA COMP FORMULARY i What is the Sharp Advantage Formulary? A formulary is a list of covered drugs selected by Sharp Advantage in consultation with a team of health care providers, which represents the prescription therapies believed to be a necessary part of a quality treatment program. Sharp Advantage will generally cover the drugs listed in our formulary as long as the drug is medically necessary, the prescription is filled at a Sharp Advantage network pharmacy, and other plan rules are followed. For more information on how to fill your prescriptions, please review your Evidence of Coverage. Can the Formulary (drug list) change? Generally, if you are taking a drug on our 2016 formulary that was covered at the beginning of the year, we will not discontinue or reduce coverage of the drug during the 2016 coverage year except when a new, less expensive generic drug becomes available or when new adverse information about the safety or effectiveness of a drug is released. Other types of formulary changes, such as removing a drug from our formulary, will not affect members who are currently taking the drug. It will remain available at the same cost-sharing for those members taking it for the remainder of the coverage year. We feel it is important that you have continued access for the remainder of the coverage year to the formulary drugs that were available when you chose our plan, except for cases in which you can save additional money or we can ensure your safety. If we remove drugs from our formulary, add prior authorization, quantity limits and/or step therapy restrictions on a drug or move a drug to a higher cost-sharing tier, we must notify affected members of the change at least 60 days before the change becomes effective, or at the time the member requests a refill of the drug, at which time the member will receive a 60-day supply of the drug. If the Food and Drug Administration deems a drug on our formulary to be unsafe or the drug’s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary and provide notice to members who take the drug. The enclosed formulary is current as of July 1, 2016. To get updated information about the drugs covered by Sharp Advantage, please contact us. Our contact information appears on the front and back cover pages. In the event of mid-year non-maintenance formulary changes, we will notify in writing so that you have the changes. We will post an updated version of the Sharp Advantage formulary on our website at www.sharphealthplan.com/sharpadvantage. If you would like a printed version of the corrections, we will mail it to you upon request. ii How do I use the Formulary? There are two ways to find your drug within the formulary: Medical Condition The formulary begins on page 1. The drugs in this formulary are grouped into categories depending on the type of medical conditions that they are used to treat. For example, drugs used to treat a heart condition are listed under the category, “Cardiovascular Agents”. If you know what your drug is used for, look for the category name in the list that begins on page number 1. Then look under the category name for your drug. Alphabetical Listing If you are not sure what category to look under, you should look for your drug in the Index that begins on page I-1. The Index provides an alphabetical list of all of the drugs included in this document. Both brand name drugs and generic drugs are listed in the Index. Look in the Index and find your drug. Next to your drug, you will see the page number where you can find coverage information. Turn to the page listed in the Index and find the name of your drug in the first column of the list. What are generic drugs? Sharp Advantage covers both brand name drugs and generic drugs. A generic drug is approved by the FDA as having the same active ingredient as the brand name drug. Generally, generic drugs cost less than brand name drugs. Are there any restrictions on my coverage? Some covered drugs may have additional requirements or limits on coverage. These requirements and limits may include: • Prior Authorization: Sharp Advantage requires you or your physician to get prior authorization for certain drugs. This means that you will need to get approval from Sharp Advantage before you fill your prescriptions. If you don’t get approval, Sharp Advantage may not cover the drug. • Quantity Limits: For certain drugs, Sharp Advantage limits the amount of the drug that Sharp Advantage will cover. For example, Sharp Advantage provides 30 tablets for 30 days per prescription for simvastatin. This may be in addition to a standard one-month or three-month supply. • Step Therapy: In some cases, Sharp Advantage requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition. For example, if Drug A and Drug B both treat your medical condition, Sharp Advantage may not cover Drug B unless you try Drug A first. If Drug A does not work for you, Sharp Advantage will then cover Drug B. You can find out if your drug has any additional requirements or limits by looking in the formulary that begins on page 1. You can also get more information about the restrictions applied to specific covered drugs by visiting our Web site. We have posted on line a document that explain our prior authorization and step therapy restrictions. You may also ask us to send you a copy. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. iii You can ask Sharp Advantage to make an exception to these restrictions or limits or for a list of other, similar drugs that may treat your health condition. See the section, “How do I request an exception to the Sharp Advantage formulary?” on page iv for information about how to request an exception. What if my drug is not on the Formulary? If your drug is not included in this formulary (list of covered drugs), you should first contact Member Services and ask if your drug is covered. If you learn that Sharp Advantage does not cover your drug, you have two options: • You can ask Member Services for a list of similar drugs that are covered by Sharp Advantage. When you receive the list, show it to your doctor and ask him or her to prescribe a similar drug that is covered by Sharp Advantage. • You can ask Sharp Advantage to make an exception and cover your drug. See below for information about how to request an exception. How do I request an exception to the Sharp Advantage Formulary? You can ask Sharp Advantage to make an exception to our coverage rules. There are several types of exceptions that you can ask us to make. • • • You can ask us to cover a drug even if it is not on our formulary. If approved, this drug will be covered at a pre-determined cost-sharing level, and you would not be able to ask us to provide the drug at a lower cost-sharing level. You can ask us to cover a formulary drug at a lower cost-sharing level if this drug is not on the specialty tier. If approved this would lower the amount you must pay for your drug. You can ask us to waive coverage restrictions or limits on your drug. For example, for certain drugs, Sharp Advantage limits the amount of the drug that we will cover. If your drug has a quantity limit, you can ask us to waive the limit and cover a greater amount. Generally, Sharp Advantage will only approve your request for an exception if the alternative drugs included on the plan’s formulary, the lower cost-sharing drug or additional utilization restrictions would not be as effective in treating your condition and/or would cause you to have adverse medical effects. You should contact us to ask us for an initial coverage decision for a formulary, tiering or utilization restriction exception. When you request a formulary, tiering or utilization restriction exception you should submit a statement from your prescriber or physician supporting your request. Generally, we must make our decision within 72 hours of getting your prescriber’s supporting statement. You can request an expedited (fast) exception if you or your doctor believe that your health could be seriously harmed by waiting up to 72 hours for a decision. If your request to expedite is granted, we must give you a decision no later than 24 hours after we get a supporting statement from your doctor or other prescriber. What do I do before I can talk to my doctor about changing my drugs or requesting an exception? As a new or continuing member in our plan you may be taking drugs that are not on our formulary. Or, you may be taking a drug that is on our formulary but your ability to get it is limited. For example, you may need a prior authorization from us before you can fill your prescription. You should talk to your doctor to decide iv if you should switch to an appropriate drug that we cover or request a formulary exception so that we will cover the drug you take. While you talk to your doctor to determine the right course of action for you, we may cover your drug in certain cases during the first 90 days you are a member of our plan. For each of your drugs that is not on our formulary or if your ability to get your drugs is limited, we will cover a temporary 30-day supply (unless you have a prescription written for fewer days) when you go to a network pharmacy. After your first 30-day supply, we will not pay for these drugs, even if you have been a member of the plan less than 90 days. If you are a resident of a long-term care facility, we will allow you to refill your prescription until we have provided you with 98-day transition supply, consistent with dispensing increment, (unless you have a prescription written for fewer days). We will cover more than one refill of these drugs for the first 90 days you are a member of our plan. If you need a drug that is not on our formulary or if your ability to get your drugs is limited, but you are past the first 90 days of membership in our plan, we will cover a 31-day emergency supply of that drug (unless you have a prescription for fewer days) while you pursue a formulary exception. If you are a member entering a long-term care (LTC) facility from other care settings and have a level of care change, we will cover one 31-day supply of a particular drug, or less if your prescription is written for fewer days. For more information For more detailed information about your Sharp Advantage prescription drug coverage, please review your Evidence of Coverage and other plan materials. If you have questions about Sharp Advantage, please contact us. Our contact information, along with the date we last updated the formulary, appears on the front and back cover pages. If you have general questions about Medicare prescription drug coverage, please call Medicare at 1-800MEDICARE (1-800-633-4227) 24 hours a day/7 days a week. TTY users should call 1-877-486-2048. Or, visit http://www.medicare.gov. Sharp Advantage’s Formulary The formulary that begins on page 1 provides coverage information about the drugs covered by Sharp Advantage. If you have trouble finding your drug in the list, turn to the Index that begins on page I-1. The first column of the chart lists the drug name. Brand name drugs are capitalized (e.g., CRESTOR) and generic drugs are listed in lower-case italics (e.g., lisinopril). The information in the Requirements/Limits column tells you if Sharp Advantage has any special requirements for coverage of your drug. v The following abbreviations may be found within the body of this document COVERAGE NOTES ABBREVIATIONS ABBREVIATION DESCRIPTION PA Prior Authorization Restriction PA BvD Prior Authorization Restriction for Part B vs Part D Determination EXPLANATION You (or your provider) are required to get prior authorization from Sharp Advantage before you fill your prescription for this drug. Without prior approval, we may not cover this drug. This drug may be eligible for payment under Medicare Part B or Part D. You (or your provider) are required to get authorization from us to determine that this drug is covered under Medicare Part D before you fill your prescription for this drug. Without prior approval, we may not cover this drug. PA-HRM Prior Authorization If you are 65 years or older, you (or your provider) are Restrictions for members required to get prior authorization from us before you fill your 65 years and older prescription for this drug. Without prior authorization, we may not cover this drug. PA NSO Prior Authorization If you are a new member or you have not taken this drug Restriction for New Starts previously, you (or your provider) are required to get prior Only authorization from us before you fill your prescription for this drug. Without prior approval, we may not cover this drug. QL Quantity Limit Restrictions ST Step Therapy Restriction Before we will provide coverage for this drug, you must first try another drug(s) to treat your medical condition. This drug may only be covered if the other drug(s) does not work for you. LA Limited Access Drugs This prescription may be available only at certain pharmacies. For more information consult your Pharmacy Directory or call Member Services at 1-855-820-2112 (TTY 711) 8:00 a.m. to 6:00 p.m. Pacific Time, Monday-Friday. NM No Mail Order This drug is not available through mail order. We limit the amount of this drug that is covered per prescription, or within a specific time frame. vi Table of Contents Contents of Table Analgesics ........................................................................................................................................................................................................................................................................................................ 3 Anesthetics ................................................................................................................................................................................................................................................................................................. 10 Anti-Addiction/Substance Abuse Treatment Agents ................................................................................................................................................................... 11 Antianxiety Agents ........................................................................................................................................................................................................................................................................ 12 Antibacterials ......................................................................................................................................................................................................................................................................................... 13 Anticancer Agents ........................................................................................................................................................................................................................................................................... 23 Anticholinergic Agents ............................................................................................................................................................................................................................................................. 33 Anticonvulsants .................................................................................................................................................................................................................................................................................. 34 Antidementia Agents .................................................................................................................................................................................................................................................................. 38 Antidepressants ................................................................................................................................................................................................................................................................................... 39 Antidiabetic Agents ...................................................................................................................................................................................................................................................................... 42 Antifungals ................................................................................................................................................................................................................................................................................................ 47 Antihistamines ...................................................................................................................................................................................................................................................................................... 50 Anti-Infectives (Skin And Mucous Membrane) .................................................................................................................................................................................. 50 Antimigraine Agents ................................................................................................................................................................................................................................................................... 50 Antimycobacterials ........................................................................................................................................................................................................................................................................ 51 Antinausea Agents ......................................................................................................................................................................................................................................................................... 52 Antiparasite Agents ...................................................................................................................................................................................................................................................................... 53 Antiparkinsonian Agents ...................................................................................................................................................................................................................................................... 54 Antipsychotic Agents ................................................................................................................................................................................................................................................................. 55 Antivirals (Systemic) ................................................................................................................................................................................................................................................................... 59 Blood Products/Modifiers/Volume Expanders ..................................................................................................................................................................................... 65 Caloric Agents ...................................................................................................................................................................................................................................................................................... 69 Cardiovascular Agents ............................................................................................................................................................................................................................................................. 73 Central Nervous System Agents ................................................................................................................................................................................................................................. 86 Contraceptives ...................................................................................................................................................................................................................................................................................... 88 Dental And Oral Agents ........................................................................................................................................................................................................................................................ 95 Dermatological Agents ............................................................................................................................................................................................................................................................ 95 Devices ......................................................................................................................................................................................................................................................................................................... 101 Enzyme Replacement/Modifiers ............................................................................................................................................................................................................................ 102 Eye, Ear, Nose, Throat Agents ................................................................................................................................................................................................................................. 104 Gastrointestinal Agents ....................................................................................................................................................................................................................................................... 109 Genitourinary Agents ............................................................................................................................................................................................................................................................. 113 Heavy Metal Antagonists ................................................................................................................................................................................................................................................. 114 Hormonal Agents, Stimulant/Replacement/Modifying ....................................................................................................................................................... 114 Immunological Agents .......................................................................................................................................................................................................................................................... 121 Inflammatory Bowel Disease Agents ............................................................................................................................................................................................................... 129 Irrigating Solutions .................................................................................................................................................................................................................................................................... 129 Metabolic Bone Disease Agents .............................................................................................................................................................................................................................. 130 Miscellaneous Therapeutic Agents ..................................................................................................................................................................................................................... 132 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 1 Effective: July 01, 2016 Contents of Table Ophthalmic Agents .................................................................................................................................................................................................................................................................... 137 Replacement Preparations .............................................................................................................................................................................................................................................. 138 Respiratory Tract Agents ................................................................................................................................................................................................................................................. 143 Skeletal Muscle Relaxants ............................................................................................................................................................................................................................................... 147 Sleep Disorder Agents ........................................................................................................................................................................................................................................................... 147 Vasodilating Agents .................................................................................................................................................................................................................................................................. 148 Vitamins And Minerals ....................................................................................................................................................................................................................................................... 149 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 2 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits Analgesics Analgesics, Miscellaneous acetaminophen-codeine 120 mg-12 mg/5 ml solution 120-12 mg/5 ml acetaminophen-codeine oral solution 300 mg-30 mg /12.5 ml acetaminophen-codeine oral tablet 300-15 mg, 300-30 mg acetaminophen-codeine oral tablet 300-60 mg ALLZITAL ORAL TABLET 25-325 MG ascomp with codeine oral capsule 30-50-325-40 mg BELBUCA BUCCAL FILM 150 MCG, 300 MCG, 450 MCG, 600 MCG, 75 MCG, 750 MCG, 900 MCG buprenorphine hcl injection syringe 0.3 mg/ml butalbital compound w/codeine oral capsule 30-50-325-40 mg butalbital-acetaminop-caf-cod oral capsule 50-300-40-30 mg, 50-325-40-30 mg butalbital-acetaminophen oral tablet 50-325 mg butalbital-acetaminophen-caff oral capsule 50-325-40 mg butalbital-acetaminophen-caff oral tablet 50-325-40 mg butalbital-aspirin-caffeine oral capsule 50-325-40 mg butorphanol tartrate nasal spray,non-aerosol 10 mg/ml (Acetaminophen with Codeine) (Acetaminophen with Codeine) (Tylenol-Codeine No.3) (Tylenol-Codeine No.3) 2 QL (2700 per 30 days) 2 QL (2700 per 30 days) 2 QL (360 per 30 days) 2 QL (180 per 30 days) 2 (Fiorinal with Codeine #3) 2 QL (180 per 30 days) 4 ST; QL (60 per 30 days) (Buprenorphine HCl) 2 (Fiorinal with Codeine #3) (Fioricet with Codeine) 2 QL (180 per 30 days) 2 QL (180 per 30 days) (Tencon) 2 QL (180 per 30 days) (Esgic) 2 QL (180 per 30 days) (Esgic) 2 QL (180 per 30 days) (Fiorinal) 2 QL (180 per 30 days) (Butorphanol Tartrate) 2 QL (5 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 3 Effective: July 01, 2016 Drug Name Drug Tier BUTRANS TRANSDERMAL PATCH WEEKLY 10 MCG/HOUR, 15 MCG/HOUR, 20 MCG/HOUR, 5 MCG/HOUR, 7.5 MCG/HOUR capacet oral capsule 50-325-40 mg codeine sulfate oral tablet 15 mg, 30 mg, 60 mg EMBEDA ORAL CAPSULE,ORAL ONLY,EXT.REL PELL 100-4 MG, 20-0.8 MG, 30-1.2 MG, 50-2 MG, 60-2.4 MG, 80-3.2 MG endocet oral tablet 10-325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg endodan oral tablet 4.8355-325 mg fentanyl citrate buccal lozenge on a handle 1,200 mcg, 1,600 mcg, 200 mcg, 400 mcg, 600 mcg, 800 mcg fentanyl transdermal patch 72 hour 100 mcg/hr, 12 mcg/hr, 25 mcg/hr, 37.5 mcg/hour, 50 mcg/hr, 62.5 mcg/hour, 75 mcg/hr, 87.5 mcg/hour hydrocodone-acetaminophen oral solution 10-325 mg/15 ml(15 ml), 2.5-167 mg/5 ml, 7.5-325 mg/15 ml hydrocodone-acetaminophen oral tablet 10-300 mg, 5-300 mg, 7.5-300 mg 3 QL (4 per 28 days) 2 2 QL (180 per 30 days) QL (180 per 30 days) 4 QL (60 per 30 days) (Xolox) 2 QL (360 per 30 days) (Percodan) (Actiq) 2 5 QL (360 per 30 days) PA; QL (120 per 30 days) (Duragesic) 2 QL (10 per 30 days) (Hycet) 2 QL (2700 per 30 days) (Norco) 2 (Norco) 2 (includes Vicodin, Vicodin ES and Vicodin HP); QL (390 per 30 days) QL (360 per 30 days) (Ibudone) 2 QL (150 per 30 days) (Dilaudid-HP) 2 (Dilaudid) 2 hydrocodone-acetaminophen oral tablet 10-325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg hydrocodone-ibuprofen oral tablet 10-200 mg, 2.5-200 mg, 5-200 mg, 7.5-200 mg hydromorphone (pf) injection solution 10 mg/ml hydromorphone (pf) injection solution 4 mg/ml (Esgic) (Codeine Sulfate) Requirements/Limits You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 4 Effective: July 01, 2016 Drug Name hydromorphone injection solution 2 mg/ml hydromorphone injection syringe 2 mg/ml hydromorphone oral liquid 1 mg/ml hydromorphone oral tablet 2 mg, 4 mg hydromorphone oral tablet 8 mg HYSINGLA ER ORAL TABLET,ORAL ONLY,EXT.REL.24 HR 100 MG, 120 MG, 20 MG, 30 MG, 40 MG, 60 MG, 80 MG LAZANDA NASAL SPRAY,NON-AEROSOL 100 MCG/SPRAY, 400 MCG/SPRAY lorcet (hydrocodone) oral tablet 5-325 mg lorcet hd oral tablet 10-325 mg lorcet plus oral tablet 7.5-325 mg margesic oral capsule 50-325-40 mg methadone injection solution 10 mg/ml methadone oral solution 10 mg/5 ml, 5 mg/5 ml methadone oral tablet 10 mg, 5 mg methadose oral tablet,soluble 40 mg morphine (pf) in 0.9 % nacl intravenous pt controlled analgesia syring 50 mg/25 ml (2 mg/ml) morphine 10 mg/ml carpuject 10 mg/ml morphine 2 mg/ml carpuject 2 mg/ml morphine 4 mg/ml carpuject 4 mg/ml morphine 8 mg/ml syringe 8 mg/ml morphine concentrate oral solution 100 mg/5 ml (20 mg/ml) morphine concentrate oral syringe 20 mg/ml Drug Tier (Hydromorphone HCl) 2 (Hydromorphone HCl) (Dilaudid) (Dilaudid) (Dilaudid) 2 2 2 2 3 Requirements/Limits QL (1200 per 30 days) QL (180 per 30 days) QL (240 per 30 days) QL (30 per 30 days) 5 PA; QL (30 per 30 days) (Norco) 2 QL (360 per 30 days) (Norco) (Norco) (Esgic) (Methadone HCl) (Methadone HCl) 2 2 2 2 2 QL (360 per 30 days) QL (360 per 30 days) QL (180 per 30 days) (Diskets) (Diskets) (Morphine Sulfate/0.9% Nacl/PF) 2 2 2 QL (360 per 30 days) QL (90 per 30 days) (Morphine Sulfate) (Morphine Sulfate) (Morphine Sulfate) (Morphine Sulfate) (Morphine Sulfate) 2 2 2 2 2 (Morphine Sulfate) 2 QL (1800 per 30 days) QL (200 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 5 Effective: July 01, 2016 Drug Name morphine in dextrose 5 % injection pt controlled analgesia syring 100 mg/50 ml (2 mg/ml), 50 mg/25 ml (2 mg/ml) morphine injection solution 15 mg/ml, 8 mg/ml morphine injection syringe 10 mg/ml morphine intramuscular pen injector 10 mg/0.7 ml morphine intravenous cartridge 15 mg/ml morphine intravenous solution 25 mg/ml, 50 mg/ml morphine intravenous syringe 10 mg/ml, 2 mg/ml, 4 mg/ml, 8 mg/ml morphine oral solution 10 mg/5 ml morphine oral solution 20 mg/5 ml (4 mg/ml) MORPHINE ORAL TABLET 15 MG, 30 MG morphine oral tablet extended release 100 mg, 30 mg, 60 mg morphine oral tablet extended release 15 mg, 200 mg morphine rectal suppository 10 mg, 20 mg, 30 mg, 5 mg NUCYNTA ER ORAL TABLET EXTENDED RELEASE 12 HR 100 MG, 150 MG, 200 MG, 250 MG, 50 MG NUCYNTA ORAL TABLET 100 MG, 50 MG, 75 MG oxycodone oral capsule 5 mg oxycodone oral concentrate 20 mg/ml oxycodone oral solution 5 mg/5 ml oxycodone oral tablet 10 mg, 15 mg, 20 mg, 30 mg, 5 mg Drug Tier Requirements/Limits (Morphine Sulfate/D5W) 2 (Morphine Sulfate) 2 (Morphine Sulfate) (Morphine Sulfate) 2 2 (Morphine Sulfate) (Morphine Sulfate) 2 2 (Morphine Sulfate) 2 (Morphine Sulfate) (Morphine Sulfate) 2 2 QL (700 per 30 days) QL (300 per 30 days) 4 QL (180 per 30 days) (MS Contin) 2 QL (120 per 30 days) (MS Contin) 2 QL (180 per 30 days) (Morphine Sulfate) 2 (Oxycodone HCl) (Oxycodone HCl) (Oxycodone HCl) (Roxicodone) 3 QL (60 per 30 days) 3 QL (181 per 30 days) 2 2 2 2 QL (180 per 30 days) QL (180 per 30 days) QL (1300 per 30 days) QL (180 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 6 Effective: July 01, 2016 Drug Name oxycodone oral tablet,oral only,ext.rel.12 hr 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg oxycodone oral tablet,oral only,ext.rel.12 hr 80 mg oxycodone-acetaminophen oral tablet 10-325 mg, 2.5-325 mg, 5-325 mg, 7.5-325 mg oxycodone-acetaminophen oral tablet 10-650 mg oxycodone-acetaminophen oral tablet 7.5-500 mg oxycodone-aspirin oral tablet 4.8355-325 mg OXYCONTIN ORAL TABLET,ORAL ONLY,EXT.REL.12 HR 10 MG, 15 MG, 20 MG, 30 MG, 40 MG, 60 MG OXYCONTIN ORAL TABLET,ORAL ONLY,EXT.REL.12 HR 80 MG oxymorphone oral tablet 10 mg, 5 mg oxymorphone oral tablet extended release 12 hr 10 mg, 15 mg, 20 mg, 5 mg, 7.5 mg oxymorphone oral tablet extended release 12 hr 30 mg, 40 mg reprexain oral tablet 10-200 mg, 2.5-200 mg, 5-200 mg roxicet oral solution 5-325 mg/5 ml tencon oral tablet 50-325 mg tramadol oral tablet 50 mg tramadol-acetaminophen oral tablet 37.5-325 mg Drug Tier Requirements/Limits (Oxycontin) 2 QL (60 per 30 days) (Oxycontin) 5 QL (120 per 30 days) (Xolox) 2 QL (360 per 30 days) (Xolox) 2 QL (180 per 30 days) (Xolox) 2 QL (240 per 30 days) (Percodan) 2 QL (360 per 30 days) 3 QL (60 per 30 days) 3 QL (120 per 30 days) (Opana) (Opana ER) 2 2 QL (180 per 30 days) QL (60 per 30 days) (Opana ER) 2 QL (120 per 30 days) (Ibudone) 2 QL (150 per 30 days) (Oxycodone HCl/Acetaminophen) (Tencon) (Ultram) (Ultracet) 2 QL (1800 per 30 days) 2 2 2 QL (180 per 30 days) QL (240 per 30 days) QL (240 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 7 Effective: July 01, 2016 Drug Name Drug Tier vicodin es oral tablet 7.5-300 mg (Norco) 2 vicodin hp oral tablet 10-300 mg (Norco) 2 vicodin oral tablet 5-300 mg (Norco) 2 XARTEMIS XR ORAL TAB,ORAL ONLY,IR - ER, BIPHASE 7.5-325 MG xylon 10 oral tablet 10-200 mg zebutal oral capsule 50-325-40 mg ZOHYDRO ER ORAL CAPSULE, ORAL ONLY, ER 12HR 10 MG, 15 MG, 20 MG, 30 MG, 40 MG, 50 MG Nonsteroidal Anti-Inflammatory Agents CALDOLOR INTRAVENOUS RECON SOLN 400 MG/4 ML (100 MG/ML) celecoxib oral capsule 100 mg, 200 mg, 400 mg, 50 mg choline,magnesium salicylate oral liquid 500 mg/5 ml diclofenac potassium oral tablet 50 mg diclofenac sodium oral tablet extended release 24 hr 100 mg diclofenac sodium oral tablet,delayed release (dr/ec) 25 mg, 50 mg, 75 mg diclofenac sodium topical gel 3 % diclofenac-misoprostol oral tablet,ir,delayed rel,biphasic 50-200 mg-mcg, 75-200 mg-mcg (Ibudone) (Esgic) Requirements/Limits 3 (includes Vicodin, Vicodin ES and Vicodin HP); QL (390 per 30 days) (includes Vicodin, Vicodin ES and Vicodin HP); QL (390 per 30 days) (includes Vicodin, Vicodin ES and Vicodin HP); QL (390 per 30 days) QL (360 per 30 days) 2 2 4 QL (150 per 30 days) QL (180 per 30 days) QL (60 per 30 days) 4 (Celebrex) 2 (Choline Sal/Mag Salicylate) (Diclofenac Potassium) (Voltaren-XR) 2 (Diclofenac Sodium) 2 (Voltaren) (Arthrotec 50) 5 2 QL (60 per 30 days) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 8 Effective: July 01, 2016 Drug Name diflunisal oral tablet 500 mg etodolac oral capsule 200 mg, 300 mg etodolac oral tablet 400 mg, 500 mg etodolac oral tablet extended release 24 hr 400 mg, 500 mg, 600 mg fenoprofen oral tablet 600 mg FLECTOR TRANSDERMAL PATCH 12 HOUR 1.3 % flurbiprofen oral tablet 100 mg, 50 mg ibuprofen oral suspension 100 mg/5 ml ibuprofen oral tablet 400 mg, 600 mg, 800 mg indomethacin oral capsule 25 mg indomethacin oral capsule 50 mg indomethacin oral capsule, extended release 75 mg indomethacin sodium intravenous recon soln 1 mg ketoprofen oral capsule 50 mg, 75 mg ketoprofen oral capsule,ext rel. pellets 24 hr 200 mg ketorolac 30 mg/ml carpuject luer lock, 10's,l/f 30 mg/ml ketorolac injection cartridge 15 mg/ml Drug Tier (Diflunisal) (Etodolac) (Etodolac) (Etodolac) 2 2 2 2 (Fenoprofen Calcium) 2 3 (Flurbiprofen) (Ibuprofen) (Ibuprofen) 2 2 1 (Indomethacin) (Indomethacin) (Indomethacin) 2 2 2 (Indomethacin Sodium) (Ketoprofen) (Ketoprofen) 2 (Ketorolac Tromethamine) (Ketorolac Tromethamine) ketorolac injection cartridge 30 mg/ml (Ketorolac Tromethamine) ketorolac injection solution 15 mg/ml (Ketorolac Tromethamine) ketorolac injection solution 30 mg/ml (1 (Ketorolac ml) Tromethamine) ketorolac intramuscular solution 60 mg/2 (Ketorolac ml Tromethamine) ketorolac oral tablet 10 mg (Ketorolac Tromethamine) mefenamic acid oral capsule 250 mg (Ponstel) Requirements/Limits PA QL (240 per 30 days) QL (120 per 30 days) QL (60 per 30 days) 2 2 2 2 QL (40 per 30 days) 2 QL (20 per 30 days) 2 QL (40 per 30 days) 2 QL (20 per 30 days) 2 QL (20 per 30 days) 2 QL (20 per 30 days) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 9 Effective: July 01, 2016 Drug Name meloxicam oral suspension 7.5 mg/5 ml meloxicam oral tablet 15 mg, 7.5 mg nabumetone oral tablet 500 mg, 750 mg naproxen oral suspension 125 mg/5 ml naproxen oral tablet 250 mg, 375 mg, 500 mg naproxen oral tablet,delayed release (dr/ec) 375 mg, 500 mg naproxen sodium oral tablet 275 mg, 550 mg piroxicam oral capsule 10 mg, 20 mg sulindac oral tablet 150 mg, 200 mg tolmetin oral capsule 400 mg tolmetin oral tablet 200 mg, 600 mg VOLTAREN TOPICAL GEL 1 % Drug Tier (Mobic) (Mobic) (Nabumetone) (Naprosyn) (Naprosyn) 2 1 2 2 1 (Ec-Naprosyn) 2 (Anaprox) 1 (Feldene) (Sulindac) (Tolmetin Sodium) (Tolmetin Sodium) 2 2 2 2 2 (Lidocaine HCl) 2 (Xylocaine-MPF) 2 (Lidocaine HCl/PF) 2 (Xylocaine) (Xylocaine) 2 2 (Xylocaine) 2 (Lidocaine HCl) (Lidocaine HCl) 2 2 (Xylocaine) 2 (Lidocaine HCl) 2 Requirements/Limits Anesthetics Local Anesthetics glydo mucous membrane jelly in applicator 2 % lidocaine (pf) injection solution 15 mg/ml (1.5 %), 40 mg/ml (4 %), 5 mg/ml (0.5 %) lidocaine (pf) intravenous syringe 100 mg/5 ml (2 %) lidocaine 2% viscous soln 2 % lidocaine hcl injection solution 10 mg/ml (1 %), 20 mg/ml (2 %) lidocaine hcl laryngotracheal solution 4 % lidocaine hcl mucous membrane gel 2 % lidocaine hcl mucous membrane jelly in applicator 2 % lidocaine hcl mucous membrane solution 2 %, 4 % (40 mg/ml) lidocaine hcl urethral gel 2 % You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 10 Effective: July 01, 2016 Drug Name Drug Tier lidocaine topical adhesive (Lidoderm) patch,medicated 5 % lidocaine topical ointment 5 % (Lidocaine) lidocaine-prilocaine topical cream 2.5-2.5 (EMLA) % 2 Requirements/Limits PA 2 2 Anti-Addiction/Substance Abuse Treatment Agents Anti-Addiction/Substance Abuse Treatment Agents acamprosate oral tablet,delayed release (dr/ec) 333 mg buprenorphine hcl sublingual tablet 2 mg, 8 mg buprenorphine-naloxone sublingual tablet 2-0.5 mg, 8-2 mg bupropion hcl sr 150 mg tablet f/c 150 mg CHANTIX CONTINUING MONTH BOX ORAL TABLET 1 MG CHANTIX ORAL TABLET 0.5 MG, 1 MG CHANTIX STARTING MONTH BOX ORAL TABLETS,DOSE PACK 0.5 MG (11)- 1 MG (42) disulfiram oral tablet 250 mg, 500 mg naloxone injection solution 0.4 mg/ml naloxone injection syringe 0.4 mg/ml, 1 mg/ml naltrexone oral tablet 50 mg NARCAN NASAL SPRAY,NON-AEROSOL 4 MG/ACTUATION NICOTROL INHALATION CARTRIDGE 10 MG ZUBSOLV SUBLINGUAL TABLET 1.4-0.36 MG, 11.4-2.9 MG, 2.9-0.71 MG, 5.7-1.4 MG, 8.6-2.1 MG (Acamprosate Calcium) (Buprenorphine HCl) 2 (Buprenorphine HCl/Naloxone HCl) (Zyban) 2 2 PA; QL (90 per 30 days) PA; QL (90 per 30 days) 2 3 QL (168 per 84 days) 3 QL (168 per 84 days) 3 QL (53 per 28 days) (Antabuse) (Naloxone HCl) (Naloxone HCl) 2 2 2 (Revia) 2 4 QL (4 per 30 days) 4 QL (1008 per 90 days) 3 PA; QL (90 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 11 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits Antianxiety Agents Benzodiazepines alprazolam oral tablet 0.25 mg, 0.5 mg, 1 mg, 2 mg alprazolam oral tablet extended release 24 hr 0.5 mg, 1 mg, 2 mg alprazolam oral tablet extended release 24 hr 3 mg chlordiazepoxide hcl oral capsule 10 mg, 25 mg, 5 mg clonazepam oral tablet 0.5 mg, 1 mg clonazepam oral tablet 2 mg clonazepam oral tablet,disintegrating 0.125 mg, 0.25 mg, 0.5 mg, 1 mg clonazepam oral tablet,disintegrating 2 mg clorazepate dipotassium oral tablet 15 mg clorazepate dipotassium oral tablet 3.75 mg, 7.5 mg diazepam injection syringe 5 mg/ml diazepam intensol oral concentrate 5 mg/ml diazepam oral solution 5 mg/5 ml (1 mg/ml) diazepam oral tablet 10 mg, 2 mg, 5 mg diazepam rectal kit 12.5-15-17.5-20 mg, 2.5 mg, 5-7.5-10 mg estazolam oral tablet 1 mg estazolam oral tablet 2 mg flurazepam oral capsule 15 mg flurazepam oral capsule 30 mg lorazepam intensol oral concentrate 2 mg/ml lorazepam oral tablet 0.5 mg, 1 mg, 2 mg midazolam oral syrup 2 mg/ml (Xanax) 2 QL (120 per 30 days) (Xanax XR) 2 QL (120 per 30 days) (Xanax XR) 2 QL (90 per 30 days) (Chlordiazepoxide HCl) (Klonopin) (Klonopin) (Clonazepam) 2 QL (120 per 30 days) 2 2 2 QL (90 per 30 days) QL (300 per 30 days) QL (90 per 30 days) (Clonazepam) 2 QL (300 per 30 days) (Tranxene T-Tab) (Tranxene T-Tab) 2 2 QL (120 per 30 days) QL (60 per 30 days) (Diazepam) (Diazepam) 2 2 QL (10 per 28 days) QL (1200 per 30 days) (Diazepam) 2 QL (1200 per 30 days) (Valium) (Diastat) 2 2 QL (120 per 30 days) (Estazolam) (Estazolam) (Flurazepam HCl) (Flurazepam HCl) (Ativan) 2 2 2 2 2 QL (60 per 30 days) QL (30 per 30 days) QL (60 per 30 days) QL (30 per 30 days) QL (150 per 30 days) (Ativan) (Midazolam HCl) 2 2 QL (90 per 30 days) QL (10 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 12 Effective: July 01, 2016 Drug Name Drug Tier ONFI ORAL SUSPENSION 2.5 MG/ML temazepam oral capsule 15 mg, 22.5 mg, 30 mg temazepam oral capsule 7.5 mg triazolam oral tablet 0.125 mg triazolam oral tablet 0.25 mg 4 Requirements/Limits (Restoril) 2 PA NSO; QL (480 per 30 days) QL (30 per 30 days) (Restoril) (Halcion) (Halcion) 2 2 2 QL (120 per 30 days) QL (120 per 30 days) QL (60 per 30 days) 5 PA BvD Antibacterials Aminoglycosides BETHKIS INHALATION SOLUTION FOR NEBULIZATION 300 MG/4 ML gentamicin in nacl (iso-osm) intravenous piggyback 100 mg/100 ml, 100 mg/50 ml, 60 mg/50 ml, 70 mg/50 ml, 80 mg/100 ml, 80 mg/50 ml, 90 mg/100 ml gentamicin injection solution 40 mg/ml gentamicin ped 20 mg/2 ml vial 25's,pedi,latex-free 20 mg/2 ml gentamicin sulfate (pf) intravenous solution 80 mg/8 ml neomycin oral tablet 500 mg streptomycin intramuscular recon soln 1 gram TOBI PODHALER INHALATION CAPSULE, W/INHALATION DEVICE 28 MG tobramycin in 0.225 % nacl inhalation solution for nebulization 300 mg/5 ml tobramycin in 0.9 % nacl intravenous piggyback 60 mg/50 ml, 80 mg/100 ml tobramycin sulfate injection solution 10 mg/ml, 40 mg/ml Antibacterials, Miscellaneous baciim intramuscular recon soln 50,000 unit (Gentamicin In Nacl, Iso-Osm) 2 (Gentamicin Sulfate) (Gentamicin Sulfate/PF) (Gentamicin Sulfate/PF) (Neomycin Sulfate) (Streptomycin Sulfate) 2 2 2 2 2 5 QL (224 per 28 days) (Tobi) 5 PA BvD (Tobramycin/Sodium Chloride) (Tobramycin Sulfate) 2 (Bacitracin) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 13 Effective: July 01, 2016 Drug Name bacitracin intramuscular recon soln 50,000 unit chloramphenicol sod succinate intravenous recon soln 1 gram clindamycin 75 mg/5 ml soln 75 mg/5 ml clindamycin hcl oral capsule 150 mg, 300 mg, 75 mg clindamycin in 5 % dextrose intravenous piggyback 300 mg/50 ml, 600 mg/50 ml, 900 mg/50 ml clindamycin pediatric oral recon soln 75 mg/5 ml clindamycin phosphate injection solution 150 mg/ml clindamycin phosphate intravenous solution 600 mg/4 ml colistin (colistimethate na) injection recon soln 150 mg CUBICIN INTRAVENOUS RECON SOLN 500 MG linezolid intravenous parenteral solution 600 mg/300 ml linezolid oral suspension for reconstitution 100 mg/5 ml linezolid oral tablet 600 mg methenamine hippurate oral tablet 1 gram metronidazole in nacl (iso-os) intravenous piggyback 500 mg/100 ml metronidazole oral capsule 375 mg metronidazole oral tablet 250 mg, 500 mg nitrofurantoin macrocrystal oral capsule 100 mg, 25 mg, 50 mg nitrofurantoin monohyd/m-cryst oral capsule 100 mg Drug Tier (Bacitracin) 2 (Chloramphenicol Sod Succ) (Cleocin Palmitate) (Cleocin HCl) 2 (Cleocin Phosphate In D5w) 2 (Cleocin Palmitate) 2 (Cleocin Phosphate) 2 (Cleocin Phosphate) 2 (Coly-Mycin M Parenteral) 5 Requirements/Limits 2 2 5 (Zyvox) 5 (Zyvox) 5 (Zyvox) (Hiprex) 5 2 (Metronidazole/Sodiu m Chloride) (Flagyl) (Flagyl) (Macrodantin/Macrobi d) (Macrobid) 2 2 2 2 QL (120 per 30 days) 2 QL (120 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 14 Effective: July 01, 2016 Drug Name nitrofurantoin monohyd/m-cryst oral capsule 100 mg (75/25) nitrofurantoin oral suspension 25 mg/5 ml polymyxin b sulfate injection recon soln 500,000 unit SYNERCID INTRAVENOUS RECON SOLN 500 MG trimethoprim oral tablet 100 mg vancomycin hcl 1g/200 ml bag 1 gram/200 ml vancomycin intravenous recon soln 1,000 mg, 10 gram, 750 mg vancomycin intravenous recon soln 500 mg vancomycin oral capsule 125 mg, 250 mg XIFAXAN ORAL TABLET 200 MG XIFAXAN ORAL TABLET 550 MG ZYVOX ORAL SUSPENSION FOR RECONSTITUTION 100 MG/5 ML Cephalosporins cefaclor oral capsule 250 mg, 500 mg cefaclor oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml, 375 mg/5 ml cefaclor oral tablet extended release 12 hr 500 mg cefadroxil oral capsule 500 mg cefadroxil oral suspension for reconstitution 250 mg/5 ml, 500 mg/5 ml cefadroxil oral tablet 1 gram CEFAZOLIN IN DEXTROSE (ISO-OS) INTRAVENOUS PIGGYBACK 1 GRAM/50 ML cefazolin in dextrose (iso-os) intravenous piggyback 2 gram/50 ml cefazolin injection recon soln 1 gram, 10 gram, 500 mg Drug Tier Requirements/Limits (Macrobid) 2 QL (120 per 30 days) (Furadantin) (Polymyxin B Sulfate) 2 2 QL (2400 per 30 days) 5 (Trimethoprim) (Vancomycin HCl/D5W) (Vancomycin HCl) 2 2 (Vancomycin HCl/D5W) (Vancocin HCl) 2 2 5 5 5 5 (Cefaclor) (Cefaclor) 2 2 (Cefaclor) 2 (Cefadroxil) (Cefadroxil) 2 2 (Cefadroxil) 2 2 (Cefazolin Sodium/Dextrose, Iso) (Cefazolin Sodium) 2 PA; QL (9 per 30 days) PA 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 15 Effective: July 01, 2016 Drug Name cefdinir oral capsule 300 mg cefdinir oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml cefditoren pivoxil oral tablet 200 mg, 400 mg CEFEPIME 2 GM INJECTION 2 GRAM/100 ML CEFEPIME IN DEXTROSE 5 % INTRAVENOUS PIGGYBACK 1 GRAM/50 ML, 2 GRAM/50 ML cefepime injection recon soln 1 gram, 2 gram cefixime oral suspension for reconstitution 100 mg/5 ml, 200 mg/5 ml cefotaxime injection recon soln 1 gram, 10 gram, 2 gram, 500 mg cefoxitin in dextrose, iso-osm intravenous piggyback 2 gram/50 ml cefoxitin intravenous recon soln 1 gram, 10 gram, 2 gram cefpodoxime oral suspension for reconstitution 100 mg/5 ml, 50 mg/5 ml cefpodoxime oral tablet 100 mg, 200 mg cefprozil oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml cefprozil oral tablet 250 mg, 500 mg ceftazidime injection recon soln 2 gram, 6 gram ceftibuten oral capsule 400 mg ceftibuten oral suspension for reconstitution 180 mg/5 ml ceftriaxone 1 gm piggyback 50ml galaxycontainer 1 gram/50 ml ceftriaxone 1 gm vial 10's, fliptop,l/f 1 gram Drug Tier (Cefdinir) (Cefdinir) 2 2 (Spectracef) 2 Requirements/Limits 4 4 (Maxipime) 2 (Suprax) 2 (Claforan) 2 (Cefoxitin Sodium/Dextrose, Iso) (Cefoxitin Sodium) 2 (Cefpodoxime Proxetil) 2 (Cefpodoxime Proxetil) (Cefprozil) 2 2 (Cefprozil) (Fortaz) 2 2 (Cedax) (Cedax) 2 2 (Ceftriaxone Na/Dextrose, Iso) (Rocephin) 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 16 Effective: July 01, 2016 Drug Name ceftriaxone 2 gm piggyback 50ml galaxycontainer 2 gram/50 ml ceftriaxone injection recon soln 10 gram, 250 mg, 500 mg ceftriaxone intravenous recon soln 1 gram, 2 gram cefuroxime axetil oral tablet 250 mg, 500 mg cefuroxime sodium injection recon soln 1.5 gram, 750 mg cefuroxime sodium intravenous recon soln 7.5 gram cephalexin oral capsule 250 mg, 500 mg, 750 mg cephalexin oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml cephalexin oral tablet 250 mg, 500 mg MEFOXIN IN DEXTROSE (ISO-OSM) INTRAVENOUS PIGGYBACK 1 GRAM/50 ML, 2 GRAM/50 ML SUPRAX ORAL SUSPENSION FOR RECONSTITUTION 500 MG/5 ML SUPRAX ORAL TABLET,CHEWABLE 100 MG, 200 MG tazicef injection recon soln 2 gram, 6 gram TEFLARO INTRAVENOUS RECON SOLN 400 MG, 600 MG Macrolides azithromycin intravenous recon soln 500 mg azithromycin oral packet 1 gram azithromycin oral suspension for reconstitution 100 mg/5 ml, 200 mg/5 ml Drug Tier (Ceftriaxone Na/Dextrose, Iso) (Rocephin) 2 (Ceftriaxone Na/Dextrose, Iso) (Ceftin) 2 (Zinacef) 2 (Zinacef) 2 (Keflex) 1 (Cephalexin) 1 (Cephalexin) 1 4 Requirements/Limits 2 2 4 4 (Fortaz) 2 4 (Zithromax) 2 (Zithromax) (Zithromax) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 17 Effective: July 01, 2016 Drug Name azithromycin oral tablet 250 mg, 250 mg (6 pack), 600 mg azithromycin oral tablet 500 mg clarithromycin oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml clarithromycin oral tablet 250 mg, 500 mg clarithromycin oral tablet extended release 24 hr 500 mg DIFICID ORAL TABLET 200 MG e.e.s. 400 oral tablet 400 mg e.e.s. granules oral suspension for reconstitution 200 mg/5 ml ery-tab oral tablet,delayed release (dr/ec) 250 mg, 500 mg ERY-TAB ORAL TABLET,DELAYED RELEASE (DR/EC) 333 MG erythrocin (as stearate) oral tablet 250 mg ERYTHROCIN INTRAVENOUS RECON SOLN 1,000 MG, 500 MG erythromycin ethylsuccinate oral tablet 400 mg erythromycin oral capsule,delayed release(dr/ec) 250 mg erythromycin oral tablet 250 mg, 500 mg Miscellaneous B-Lactam Antibiotics aztreonam injection recon soln 1 gram CAYSTON INHALATION SOLUTION FOR NEBULIZATION 75 MG/ML imipenem-cilastatin intravenous recon soln 250 mg, 500 mg Drug Tier (Zithromax) 2 (Zithromax) (Biaxin) 2 2 (Biaxin) 2 (Clarithromycin) 2 (Erythromycin Ethylsuccinate) (Eryped 200) (Erythromycin Base) 5 2 Requirements/Limits QL (20 per 10 days) 2 2 4 (Erythromycin Stearate) 2 4 (Erythromycin Ethylsuccinate) (Erythromycin Base) 2 (Erythromycin Base) 2 (Azactam) 2 5 (Primaxin) 2 LA 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 18 Effective: July 01, 2016 Drug Name Drug Tier INVANZ INJECTION RECON SOLN 1 GRAM meropenem intravenous recon soln 500 mg meropenem iv 1 gm vial outer, latex-free 1 gram Penicillins amoxicillin oral capsule 250 mg, 500 mg amoxicillin oral suspension for reconstitution 125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, 400 mg/5 ml amoxicillin oral tablet 500 mg, 875 mg amoxicillin oral tablet,chewable 125 mg, 250 mg amoxicillin-pot clavulanate oral suspension for reconstitution 200-28.5 mg/5 ml, 250-62.5 mg/5 ml, 400-57 mg/5 ml, 600-42.9 mg/5 ml amoxicillin-pot clavulanate oral tablet 250-125 mg, 500-125 mg, 875-125 mg amoxicillin-pot clavulanate oral tablet extended release 12 hr 1,000-62.5 mg amoxicillin-pot clavulanate oral tablet,chewable 200-28.5 mg, 400-57 mg ampicillin 2 gm vial 10's, latex-free 2 gram ampicillin oral capsule 250 mg, 500 mg ampicillin oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml ampicillin sodium injection recon soln 1 gram, 10 gram, 125 mg ampicillin sodium intravenous recon soln 2 gram ampicillin-sulbactam 1.5 gm vl p/f, latex-free 1.5 gram ampicillin-sulbactam injection recon soln 15 gram, 3 gram 4 (Merrem) 2 (Merrem) 2 (Amoxicillin) (Amoxicillin) 1 1 (Amoxicillin) (Amoxicillin) 1 1 (Augmentin) 2 (Augmentin) 2 (Augmentin XR) 2 (Amoxicillin/Potassium Clav) (Ampicillin Sodium) 2 (Ampicillin Trihydrate) (Ampicillin Trihydrate) 1 1 (Ampicillin Sodium) 2 (Ampicillin Sodium) 2 (Unasyn) 2 (Unasyn) 2 Requirements/Limits 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 19 Effective: July 01, 2016 Drug Name ampicillin-sulbactam intravenous recon soln 1.5 gram BICILLIN C-R INTRAMUSCULAR SYRINGE 1,200,000 UNIT/ 2 ML(600K/600K), 1,200,000 UNIT/ 2 ML(900K/300K) BICILLIN L-A INTRAMUSCULAR SYRINGE 1,200,000 UNIT/2 ML, 2,400,000 UNIT/4 ML, 600,000 UNIT/ML dicloxacillin oral capsule 250 mg, 500 mg nafcillin 2 gm vial sterile, latex-free 2 gram nafcillin injection recon soln 1 gram, 10 gram nafcillin intravenous recon soln 2 gram oxacillin 1 gm add-vantage vl add-vantage, inner 1 gram oxacillin in dextrose(iso-osm) intravenous piggyback 1 gram/50 ml, 2 gram/50 ml oxacillin injection recon soln 10 gram oxacillin intravenous recon soln 2 gram penicillin g pot in dextrose intravenous piggyback 1 million unit/50 ml, 2 million unit/50 ml, 3 million unit/50 ml penicillin g potassium injection recon soln 5 million unit penicillin g procaine intramuscular syringe 1.2 million unit/2 ml, 600,000 unit/ml penicillin gk 20 million unit 20 million unit penicillin v potassium oral recon soln 125 mg/5 ml, 250 mg/5 ml penicillin v potassium oral tablet 250 mg, 500 mg Drug Tier (Unasyn) Requirements/Limits 2 4 4 (Dicloxacillin Sodium) (Nafcillin Sodium) 2 2 (Nafcillin Sodium) 2 (Nafcillin Sodium) (Oxacillin Sodium) 2 2 (Oxacillin Sodium/Dextrose, Iso) 2 (Oxacillin Sodium) (Oxacillin Sodium) (Pen G Pot/Dextrose-Water) 2 2 2 (Penicillin G Potassium) (Penicillin G Procaine) 2 (Penicillin G Potassium) (Penicillin V Potassium) (Penicillin V Potassium) 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 20 Effective: July 01, 2016 Drug Name pfizerpen-g injection recon soln 20 million unit piperacillin-tazobactam intravenous recon soln 2.25 gram, 3.375 gram, 4.5 gram piperacil-tazobact 40.5 gram p/f, pharmacy bulk 40.5 gram Quinolones ciprofloxacin (mixture) oral tablet, er multiphase 24 hr 1,000 mg, 500 mg ciprofloxacin 200 mg/20 ml vl sdv,latex-free 200 mg/20 ml ciprofloxacin hcl oral tablet 100 mg, 250 mg, 500 mg, 750 mg ciprofloxacin in 5 % dextrose intravenous piggyback 200 mg/100 ml ciprofloxacin lactate intravenous solution 400 mg/40 ml ciprofloxacin oral suspension,microcapsule recon 250 mg/5 ml, 500 mg/5 ml ciprofloxacn-d5w 400 mg/200 ml p/f,latex/f, in d5w 400 mg/200 ml levofloxacin in d5w intravenous piggyback 500 mg/100 ml, 750 mg/150 ml levofloxacin intravenous solution 25 mg/ml levofloxacin oral solution 250 mg/10 ml levofloxacin oral tablet 250 mg, 500 mg, 750 mg moxifloxacin oral tablet 400 mg ofloxacin oral tablet 400 mg Sulfonamides sulfadiazine oral tablet 500 mg sulfamethoxazole-trimethoprim intravenous solution 400-80 mg/5 ml Drug Tier (Penicillin G Potassium) (Zosyn) 2 (Zosyn) 2 (Cipro XR) 2 (Ciprofloxacin Lactate) 2 (Cipro) 1 (Cipro I.V.) 2 (Ciprofloxacin Lactate) 2 (Cipro) 2 (Cipro I.V.) 2 (Levaquin) 2 (Levofloxacin) 2 (Levaquin) (Levaquin) 2 1 (Avelox) (Ofloxacin) 2 2 (Sulfadiazine) (Sulfamethoxazole/Tri methoprim) 2 2 Requirements/Limits 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 21 Effective: July 01, 2016 Drug Name sulfamethoxazole-trimethoprim oral suspension 200-40 mg/5 ml sulfamethoxazole-trimethoprim oral tablet 400-80 mg, 800-160 mg sulfasalazine oral tablet 500 mg sulfasalazine oral tablet,delayed release (dr/ec) 500 mg sulfatrim oral suspension 200-40 mg/5 ml Tetracyclines demeclocycline oral tablet 150 mg, 300 mg doxy 100 vial 10's, p/f 100 mg doxycycline hyclate 100 mg cap 100 mg doxycycline hyclate 100 mg tab f/c 100 mg doxycycline hyclate intravenous recon soln 100 mg doxycycline hyclate oral capsule 100 mg doxycycline hyclate oral capsule 50 mg doxycycline hyclate oral tablet 100 mg, 50 mg doxycycline hyclate oral tablet 20 mg doxycycline hyclate oral tablet,delayed release (dr/ec) 100 mg, 150 mg, 75 mg doxycycline mono 100 mg cap 100 mg doxycycline mono 100 mg tablet f/c 100 mg doxycycline mono 50 mg tablet 50 mg doxycycline monohydrate oral capsule 150 mg, 50 mg, 75 mg doxycycline monohydrate oral suspension for reconstitution 25 mg/5 ml doxycycline monohydrate oral tablet 150 mg, 75 mg Drug Tier (Sulfamethoxazole/Tri methoprim) (Bactrim) 2 (Azulfidine) (Azulfidine) 2 2 (Sulfamethoxazole/Tri methoprim) 2 (Demeclocycline HCl) 2 (Doxycycline Hyclate) (Morgidox) (Doryx) 2 2 2 (Doxycycline Hyclate) 2 (Adoxa) (Morgidox) (Avidoxy) 2 2 2 (Doryx) (Doryx) 2 2 (Adoxa) (Avidoxy) 2 2 (Avidoxy) (Adoxa) 2 2 (Vibramycin) 2 (Avidoxy) 2 Requirements/Limits 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 22 Effective: July 01, 2016 Drug Name Drug Tier MINOCIN INTRAVENOUS RECON SOLN 100 MG minocycline oral capsule 100 mg, 50 mg, 75 mg minocycline oral tablet 100 mg, 50 mg, 75 mg minocycline oral tablet extended release 24 hr 135 mg, 45 mg, 90 mg tetracycline oral capsule 250 mg, 500 mg TYGACIL INTRAVENOUS RECON SOLN 50 MG 5 (Minocin) 2 (Minocycline HCl) 2 (Minocycline HCl) 2 (Tetracycline HCl) 2 5 Requirements/Limits Anticancer Agents Anticancer Agents ABRAXANE INTRAVENOUS SUSPENSION FOR RECONSTITUTION 100 MG ADCETRIS INTRAVENOUS RECON SOLN 50 MG adriamycin intravenous recon soln 10 mg, 20 mg, 50 mg adriamycin intravenous solution 10 mg/5 ml adrucil 2,500 mg/50 ml vial outer, latex-free 2.5 gram/50 ml adrucil intravenous solution 500 mg/10 ml AFINITOR DISPERZ ORAL TABLET FOR SUSPENSION 2 MG, 3 MG, 5 MG AFINITOR ORAL TABLET 10 MG 5 5 (Doxorubicin HCl) 2 PA NSO; QL (4 per 21 days) PA BvD (Doxorubicin HCl) 2 PA BvD (Fluorouracil) 2 PA BvD (Fluorouracil) 2 5 PA BvD PA NSO; QL (112 per 28 days) 5 PA NSO; QL (56 per 28 days) PA NSO; QL (28 per 28 days) PA NSO; QL (240 per 30 days) AFINITOR ORAL TABLET 2.5 MG, 5 MG, 7.5 MG ALECENSA ORAL CAPSULE 150 MG ALIMTA INTRAVENOUS RECON SOLN 500 MG 5 5 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 23 Effective: July 01, 2016 Drug Name Drug Tier anastrozole oral tablet 1 mg AVASTIN INTRAVENOUS SOLUTION 25 MG/ML, 25 MG/ML (16 ML) azacitidine injection recon soln 100 mg BELEODAQ INTRAVENOUS RECON SOLN 500 MG BENDEKA INTRAVENOUS SOLUTION 25 MG/ML bexarotene oral capsule 75 mg (Arimidex) bicalutamide oral tablet 50 mg bleomycin injection recon soln 30 unit bleomycin sulfate 15 unit vial latex-free 15 unit BLINCYTO INTRAVENOUS KIT 35 MCG BOSULIF ORAL TABLET 100 MG 2 5 PA NSO 5 5 PA NSO 5 PA NSO (Targretin) 5 PA NSO; QL (420 per 30 days) (Casodex) (Bleomycin Sulfate) (Bleomycin Sulfate) 2 2 2 (Vidaza) 5 5 BOSULIF ORAL TABLET 500 MG 5 CABOMETYX ORAL TABLET 20 MG, 60 MG CABOMETYX ORAL TABLET 40 MG CAPRELSA ORAL TABLET 100 MG 5 CAPRELSA ORAL TABLET 300 MG 5 carboplatin intravenous solution 10 mg/ml cladribine intravenous solution 10 mg/10 ml COMETRIQ ORAL CAPSULE 100 MG/DAY(80 MG[1]-20 MG[1]), 140 MG/DAY(80 MG[1]-20 MG[3]), 60 MG/DAY (20 MG [3]/DAY) Requirements/Limits 5 5 PA BvD PA BvD PA NSO; QL (140 per 365 days) PA NSO; QL (120 per 30 days) PA NSO; QL (30 per 30 days) PA NSO; QL (30 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (30 per 30 days) (Carboplatin) 2 (Cladribine) 2 PA BvD 5 PA NSO; QL (112 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 24 Effective: July 01, 2016 Drug Name Drug Tier COTELLIC ORAL TABLET 20 MG cyclophosphamide intravenous recon soln 1 gram, 2 gram, 500 mg CYCLOPHOSPHAMIDE ORAL CAPSULE 25 MG, 50 MG cyclophosphamide oral tablet 25 mg, 50 mg CYRAMZA INTRAVENOUS SOLUTION 10 MG/ML, 10 MG/ML (50 ML) dactinomycin intravenous recon soln 0.5 mg DARZALEX INTRAVENOUS SOLUTION 20 MG/ML DAUNOXOME INTRAVENOUS SOLUTION 2 MG/ML decitabine intravenous recon soln 50 mg docetaxel 160 mg/16 ml vial mdv 160 mg/16 ml (10 mg/ml) docetaxel intravenous solution 20 mg/2 ml (final), 80 mg/4 ml (20 mg/ml), 80 mg/8 ml (10 mg/ml) doxorubicin, peg-liposomal intravenous suspension 2 mg/ml DROXIA ORAL CAPSULE 200 MG, 300 MG, 400 MG ELIGARD SUBCUTANEOUS SYRINGE 22.5 MG (3 MONTH) ELIGARD SUBCUTANEOUS SYRINGE 30 MG (4 MONTH) ELIGARD SUBCUTANEOUS SYRINGE 45 MG (6 MONTH) ELIGARD SUBCUTANEOUS SYRINGE 7.5 MG (1 MONTH) EMCYT ORAL CAPSULE 140 MG 5 (Cyclophosphamide) (Cyclophosphamide) (Dactinomycin) Requirements/Limits 2 PA NSO; LA; QL (63 per 28 days) PA BvD 4 PA BvD; ST 2 PA BvD; ST 5 PA NSO 2 5 PA NSO; LA 3 (Dacogen) (Taxotere) 5 5 (Taxotere) 5 (Doxil) 5 PA BvD 3 4 QL (1 per 84 days) 4 QL (1 per 112 days) 4 QL (1 per 168 days) 4 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 25 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits EMPLICITI INTRAVENOUS RECON SOLN 300 MG, 400 MG ERIVEDGE ORAL CAPSULE 150 MG ETOPOPHOS INTRAVENOUS RECON SOLN 100 MG etoposide intravenous solution 20 mg/ml exemestane oral tablet 25 mg FARESTON ORAL TABLET 60 MG FARYDAK ORAL CAPSULE 10 MG, 15 MG, 20 MG FASLODEX INTRAMUSCULAR SYRINGE 250 MG/5 ML floxuridine injection recon soln 0.5 gram fluorouracil 5,000 mg/100 ml latex-free 5 gram/100 ml fluorouracil intravenous solution 2.5 gram/50 ml flutamide oral capsule 125 mg GAZYVA INTRAVENOUS SOLUTION 1,000 MG/40 ML gemcitabine intravenous recon soln 1 gram GILOTRIF ORAL TABLET 20 MG, 30 MG, 40 MG GLEEVEC ORAL TABLET 100 MG 5 PA NSO 5 PA NSO; QL (30 per 30 days) 4 (Etoposide) (Aromasin) 2 2 5 5 PA NSO 5 (Floxuridine) (Fluorouracil) 2 2 PA BvD PA BvD (Fluorouracil) 2 PA BvD (Flutamide) 2 5 PA NSO (Gemzar) 5 5 5 GLEEVEC ORAL TABLET 400 MG 5 GLEOSTINE ORAL CAPSULE 10 MG, 100 MG, 40 MG HERCEPTIN INTRAVENOUS RECON SOLN 440 MG HEXALEN ORAL CAPSULE 50 MG hydroxyurea oral capsule 500 mg 4 5 PA NSO; QL (30 per 30 days) PA NSO; QL (90 per 30 days) PA NSO; QL (60 per 30 days) PA NSO 5 2 (Hydrea) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 26 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits IBRANCE ORAL CAPSULE 100 MG, 125 MG, 75 MG ICLUSIG ORAL TABLET 15 MG 5 ICLUSIG ORAL TABLET 45 MG 5 ifosfamide 1 gm/20 ml vial sd polymer vial 1 gram/20 ml ifosfamide intravenous recon soln 1 gram ifosfamide-mesna intravenous kit 1-1 gram, 3,000-1,000 mg IMBRUVICA ORAL CAPSULE 140 MG IMLYGIC INJECTION SUSPENSION 10EXP6 (1 MILLION) PFU/ML IMLYGIC INJECTION SUSPENSION 10EXP8 (100 MILLION) PFU/ML INLYTA ORAL TABLET 1 MG (Ifex) 2 PA NSO; QL (21 per 28 days) PA NSO; QL (60 per 30 days) PA NSO; QL (30 per 30 days) PA BvD (Ifex) (Ifosfamide/Mesna) 2 5 PA BvD PA BvD 5 PA NSO 5 PA NSO; QL (4 per 365 days) 5 PA NSO; QL (8 per 28 days) 5 PA NSO; QL (180 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (60 per 30 days) 5 INLYTA ORAL TABLET 5 MG 5 IRESSA ORAL TABLET 250 MG 5 irinotecan intravenous solution 100 mg/5 (Camptosar) ml, 500 mg/25 ml IXEMPRA 15 MG KIT WITH DILUENT 15 MG IXEMPRA INTRAVENOUS RECON SOLN 45 MG JAKAFI ORAL TABLET 10 MG, 15 MG, 20 MG, 25 MG, 5 MG KEYTRUDA INTRAVENOUS RECON SOLN 50 MG 2 5 5 5 5 PA NSO; QL (60 per 30 days) PA NSO You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 27 Effective: July 01, 2016 Drug Name Drug Tier KEYTRUDA INTRAVENOUS SOLUTION 100 MG/4 ML (25 MG/ML) KYPROLIS INTRAVENOUS RECON SOLN 60 MG LENVIMA ORAL CAPSULE 10 MG/DAY (10 MG X 1/DAY), 14 MG/DAY(10 MG X 1-4 MG X 1), 20 MG/DAY (10 MG X 2), 24 MG/DAY(10 MG X 2-4 MG X 1) letrozole oral tablet 2.5 mg LEUKERAN ORAL TABLET 2 MG leuprolide subcutaneous kit 1 mg/0.2 ml lipodox intravenous suspension 2 mg/ml lomustine oral capsule 10 mg, 100 mg, 40 mg LONSURF ORAL TABLET 15-6.14 MG LONSURF ORAL TABLET 20-8.19 MG LUPRON DEPOT (3 MONTH) INTRAMUSCULAR SYRINGE KIT 11.25 MG, 22.5 MG LUPRON DEPOT (4 MONTH) INTRAMUSCULAR SYRINGE KIT 30 MG LUPRON DEPOT (6 MONTH) INTRAMUSCULAR SYRINGE KIT 45 MG LUPRON DEPOT INTRAMUSCULAR SYRINGE KIT 3.75 MG, 7.5 MG LYNPARZA ORAL CAPSULE 50 MG LYSODREN ORAL TABLET 500 MG MARQIBO INTRAVENOUS KIT 5 MG/31 ML(0.16 MG/ML) FINAL 5 PA NSO 5 PA NSO; QL (6 per 28 days) PA NSO 5 (Femara) (Leuprolide Acetate) (Doxil) (Lomustine) 2 4 2 5 2 5 Requirements/Limits PA BvD 5 PA NSO; QL (100 per 28 days) PA NSO; QL (80 per 28 days) QL (1 per 84 days) 5 QL (1 per 84 days) 5 QL (1 per 168 days) 5 5 5 3 5 PA NSO; QL (480 per 30 days) PA NSO; QL (4 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 28 Effective: July 01, 2016 Drug Name MATULANE ORAL CAPSULE 50 MG megestrol oral tablet 20 mg, 40 mg MEKINIST ORAL TABLET 0.5 MG Drug Tier 5 (Megestrol Acetate) MEKINIST ORAL TABLET 2 MG melphalan hcl intravenous recon soln 50 mg mercaptopurine oral tablet 50 mg methotrexate 50 mg/2 ml vial latex-free, 5's, mdv 25 mg/ml methotrexate sodium (pf) injection recon soln 1 gram methotrexate sodium (pf) injection solution 25 mg/ml methotrexate sodium oral tablet 2.5 mg mitoxantrone intravenous concentrate 2 mg/ml NEXAVAR ORAL TABLET 200 MG Requirements/Limits 2 5 5 PA NSO; QL (90 per 30 days) PA NSO; QL (30 per 30 days) (Alkeran) 5 (Mercaptopurine) (Methotrexate Sodium) 2 2 PA BvD (Methotrexate Sodium/PF) (Methotrexate Sodium) 2 PA BvD 2 PA BvD (Methotrexate Sodium) (Mitoxantrone HCl) 2 2 PA BvD; ST 5 PA NSO; QL (120 per 30 days) NILANDRON ORAL TABLET 150 MG NINLARO ORAL CAPSULE 2.3 MG, 3 MG, 4 MG ODOMZO ORAL CAPSULE 200 MG ONCASPAR INJECTION SOLUTION 750 UNIT/ML onxol intravenous concentrate 6 mg/ml (Paclitaxel) OPDIVO INTRAVENOUS SOLUTION 40 MG/4 ML oxaliplatin intravenous solution 100 (Eloxatin) mg/20 ml paclitaxel intravenous concentrate 6 (Paclitaxel) mg/ml 3 5 5 5 PA NSO; QL (3 per 28 days) PA NSO; LA PA NSO 2 5 PA NSO 5 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 29 Effective: July 01, 2016 Drug Name Drug Tier PERJETA INTRAVENOUS SOLUTION 420 MG/14 ML (30 MG/ML) POMALYST ORAL CAPSULE 1 MG, 2 MG, 3 MG, 4 MG PORTRAZZA INTRAVENOUS SOLUTION 800 MG/50 ML (16 MG/ML) PROLEUKIN INTRAVENOUS RECON SOLN 22 MILLION UNIT PURIXAN ORAL SUSPENSION 20 MG/ML REVLIMID ORAL CAPSULE 10 MG, 15 MG, 2.5 MG, 20 MG, 25 MG, 5 MG RITUXAN INTRAVENOUS CONCENTRATE 10 MG/ML SOLTAMOX ORAL SOLUTION 10 MG/5 ML SPRYCEL ORAL TABLET 100 MG, 140 MG, 50 MG, 70 MG, 80 MG SPRYCEL ORAL TABLET 20 MG 5 PA NSO 5 PA NSO; QL (21 per 28 days) PA NSO; QL (100 per 21 days) STIVARGA ORAL TABLET 40 MG 5 SUTENT ORAL CAPSULE 12.5 MG, 25 MG, 37.5 MG, 50 MG SYLVANT INTRAVENOUS RECON SOLN 100 MG, 400 MG SYNRIBO SUBCUTANEOUS RECON SOLN 3.5 MG TABLOID ORAL TABLET 40 MG TAFINLAR ORAL CAPSULE 50 MG, 75 MG TAGRISSO ORAL TABLET 40 MG, 80 MG tamoxifen oral tablet 10 mg, 20 mg (Tamoxifen Citrate) 5 5 Requirements/Limits 5 5 5 PA NSO; LA 5 PA NSO 4 5 5 5 5 3 5 5 PA NSO; QL (30 per 30 days) PA NSO; QL (60 per 30 days) PA NSO; QL (84 per 28 days) PA NSO; QL (30 per 30 days) PA NSO PA NSO; QL (28 per 28 days) PA NSO; QL (120 per 30 days) PA NSO; LA; QL (30 per 30 days) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 30 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits TARCEVA ORAL TABLET 100 MG, 25 MG TARCEVA ORAL TABLET 150 MG 5 TARGRETIN ORAL CAPSULE 75 MG TARGRETIN TOPICAL GEL 1 % 5 TASIGNA ORAL CAPSULE 150 MG, 200 MG TECENTRIQ INTRAVENOUS SOLUTION 1,200 MG/20 ML (60 MG/ML) TEMODAR INTRAVENOUS RECON SOLN 100 MG teniposide intravenous solution 50 mg/5 ml thiotepa injection recon soln 15 mg toposar intravenous solution 20 mg/ml topotecan hcl 4 mg/4 ml vial suv,latex-free 4 mg/4 ml (1 mg/ml) topotecan intravenous recon soln 4 mg TORISEL INTRAVENOUS RECON SOLN 30 MG/3 ML (10 MG/ML) (FIRST) TREANDA 25 MG VIAL 25 MG TREANDA INTRAVENOUS RECON SOLN 100 MG TREANDA INTRAVENOUS SOLUTION 180 MG/2 ML, 45 MG/0.5 ML TRELSTAR 22.5 MG SYRINGE WITH MIXJECT 22.5 MG/2 ML TRELSTAR INTRAMUSCULAR SUSPENSION FOR RECONSTITUTION 22.5 MG 5 PA NSO; QL (60 per 30 days) PA NSO; QL (90 per 30 days) PA NSO; QL (420 per 30 days) PA NSO; QL (60 per 28 days) PA NSO; QL (112 per 28 days) PA NSO; QL (20 per 21 days) 5 5 5 5 (Teniposide) 5 (Thiotepa) (Etoposide) (Hycamtin) 5 2 5 (Hycamtin) 5 5 PA NSO; (vial only) PA BvD; QL (4 per 28 days) 5 5 5 5 QL (1 per 168 days) 5 QL (1 per 168 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 31 Effective: July 01, 2016 Drug Name Drug Tier TRELSTAR INTRAMUSCULAR SYRINGE 11.25 MG/2 ML TRELSTAR INTRAMUSCULAR SYRINGE 3.75 MG/2 ML tretinoin (chemotherapy) oral capsule 10 mg TREXALL ORAL TABLET 10 MG, 15 MG, 5 MG, 7.5 MG TYKERB ORAL TABLET 250 MG UNITUXIN INTRAVENOUS SOLUTION 3.5 MG/ML VALSTAR INTRAVESICAL SOLUTION 40 MG/ML VECTIBIX INTRAVENOUS SOLUTION 100 MG/5 ML (20 MG/ML) VELCADE INJECTION RECON SOLN 3.5 MG VENCLEXTA ORAL TABLET 10 MG, 50 MG VENCLEXTA ORAL TABLET 100 MG VENCLEXTA STARTING PACK ORAL TABLETS,DOSE PACK 10 MG-50 MG- 100 MG vinblastine intravenous solution 1 mg/ml vincasar pfs 2 mg/2 ml vial 2 mg/2 ml vincasar pfs intravenous solution 1 mg/ml vincristine 2 mg/2 ml vial p/f, sdv 2 mg/2 ml vincristine intravenous solution 1 mg/ml vinorelbine intravenous solution 50 mg/5 ml VOTRIENT ORAL TABLET 200 MG 5 Requirements/Limits QL (1 per 84 days) 5 (Tretinoin) 5 (capsule: 10mg) 4 PA BvD; ST 5 5 PA NSO 5 5 PA NSO 5 PA NSO 4 PA NSO; LA 5 PA NSO; LA 5 PA NSO; LA (Vinblastine Sulfate) (Vincristine Sulfate) (Vincristine Sulfate) (Vincristine Sulfate) 2 2 2 2 PA BvD PA BvD PA BvD PA BvD (Vincristine Sulfate) (Navelbine) 2 2 PA BvD 5 PA NSO; QL (120 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 32 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits XALKORI ORAL CAPSULE 200 MG, 250 MG XTANDI ORAL CAPSULE 40 MG 5 YERVOY INTRAVENOUS SOLUTION 50 MG/10 ML (5 MG/ML) YONDELIS INTRAVENOUS RECON SOLN 1 MG ZALTRAP INTRAVENOUS SOLUTION 100 MG/4 ML (25 MG/ML) ZELBORAF ORAL TABLET 240 MG 5 PA NSO; QL (60 per 30 days) PA NSO; QL (120 per 30 days) PA NSO 5 PA NSO 5 PA NSO 5 ZOLADEX SUBCUTANEOUS IMPLANT 10.8 MG ZOLADEX SUBCUTANEOUS IMPLANT 3.6 MG ZOLINZA ORAL CAPSULE 100 MG ZYDELIG ORAL TABLET 100 MG, 150 MG ZYKADIA ORAL CAPSULE 150 MG 4 PA NSO; QL (240 per 30 days) QL (1 per 84 days) 4 QL (1 per 28 days) ZYTIGA ORAL TABLET 250 MG 5 5 5 5 5 PA NSO; QL (60 per 30 days) PA NSO; QL (140 per 28 days) PA NSO; QL (120 per 30 days) Anticholinergic Agents Antimuscarinics/Antispasmodics atropine injection solution 0.4 mg/ml, 1 (Atropine Sulfate) mg/ml atropine injection syringe 0.05 mg/ml, 0.1 (Atropine Sulfate) mg/ml propantheline oral tablet 15 mg (Propantheline Bromide) STIOLTO RESPIMAT INHALATION MIST 2.5-2.5 MCG/ACTUATION 2 2 2 3 QL (4 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 33 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits Anticonvulsants Anticonvulsants APTIOM ORAL TABLET 200 MG, 400 MG, 600 MG, 800 MG BANZEL ORAL SUSPENSION 40 MG/ML BANZEL ORAL TABLET 200 MG, 400 MG BRIVIACT INTRAVENOUS SOLUTION 50 MG/5 ML BRIVIACT ORAL SOLUTION 10 MG/ML BRIVIACT ORAL TABLET 10 MG, 100 MG, 25 MG, 50 MG, 75 MG carbamazepine oral capsule, er multiphase 12 hr 100 mg, 200 mg, 300 mg carbamazepine oral suspension 100 mg/5 ml carbamazepine oral tablet 200 mg carbamazepine oral tablet extended release 12 hr 100 mg, 200 mg, 400 mg carbamazepine oral tablet,chewable 100 mg CELONTIN ORAL CAPSULE 300 MG DILANTIN ORAL CAPSULE 30 MG divalproex oral capsule, sprinkle 125 mg divalproex oral tablet extended release 24 hr 250 mg, 500 mg divalproex oral tablet,delayed release (dr/ec) 125 mg, 250 mg, 500 mg epitol oral tablet 200 mg ethosuximide oral capsule 250 mg ethosuximide oral solution 250 mg/5 ml felbamate oral suspension 600 mg/5 ml felbamate oral tablet 400 mg, 600 mg 4 4 4 4 4 5 (Carbatrol) 2 (Tegretol) 2 (Tegretol) (Tegretol XR) 2 2 (Carbamazepine) 2 PA NSO; QL (80 per 30 days) PA NSO; QL (600 per 30 days) PA NSO; QL (60 per 30 days) 3 (Depakote Sprinkle) (Depakote ER) 2 2 2 (Depakote) 2 (Tegretol) (Zarontin) (Zarontin) (Felbatol) (Felbatol) 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 34 Effective: July 01, 2016 Drug Name fosphenytoin 500 mg pe/10 ml 10's,sdv,latex-free 500 mg pe/10 ml fosphenytoin injection solution 100 mg pe/2 ml FYCOMPA ORAL TABLET 10 MG, 12 MG, 2 MG, 4 MG, 6 MG, 8 MG gabapentin oral capsule 100 mg, 300 mg, 400 mg gabapentin oral solution 250 mg/5 ml gabapentin oral tablet 600 mg, 800 mg GABITRIL ORAL TABLET 12 MG, 16 MG GRALISE 30-DAY STARTER PACK ORAL TABLET EXTENDED RELEASE 24 HR 300 MG (9)- 600 MG (69) GRALISE ORAL TABLET EXTENDED RELEASE 24 HR 300 MG, 600 MG LAMICTAL ODT STARTER (BLUE) ORAL TABLET DISINTEGRATING, DOSE PK 25 MG (21) -50 MG (7) LAMICTAL ODT STARTER (GREEN) ORAL TABLET DISINTEGRATING, DOSE PK 50 MG (42) -100 MG (14) LAMICTAL ODT STARTER (ORANGE) ORAL TABLET DISINTEGRATING, DOSE PK 25 MG(14)-50 MG (14)-100 MG (7) LAMICTAL ORAL TABLET, CHEWABLE DISPERSIBLE 2 MG lamotrigine oral tablet 100 mg, 150 mg, 200 mg, 25 mg Drug Tier (Cerebyx) 2 (Cerebyx) 2 Requirements/Limits 4 (Neurontin) 2 (Neurontin) (Neurontin) 2 2 3 4 ST; QL (78 per 30 days) 4 ST; QL (90 per 30 days) 4 4 4 4 (Lamictal) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 35 Effective: July 01, 2016 Drug Name lamotrigine oral tablet disintegrating, dose pk 25 mg (21) -50 mg (7), 25 mg(14)-50 mg (14)-100 mg (7), 50 mg (42) -100 mg (14) lamotrigine oral tablet extended release 24hr 100 mg, 200 mg, 25 mg, 250 mg, 300 mg, 50 mg lamotrigine oral tablet, chewable dispersible 25 mg, 5 mg lamotrigine oral tablet,disintegrating 100 mg, 200 mg, 25 mg, 50 mg lamotrigine oral tablets,dose pack 25 mg (35) levetiracetam in nacl (iso-os) intravenous piggyback 1,000 mg/100 ml, 1,500 mg/100 ml, 500 mg/100 ml levetiracetam intravenous solution 500 mg/5 ml levetiracetam oral solution 100 mg/ml levetiracetam oral tablet 1,000 mg, 250 mg, 500 mg, 750 mg levetiracetam oral tablet extended release 24 hr 500 mg, 750 mg LYRICA ORAL CAPSULE 100 MG, 150 MG, 200 MG, 225 MG, 25 MG, 300 MG, 50 MG, 75 MG LYRICA ORAL SOLUTION 20 MG/ML oxcarbazepine oral suspension 300 mg/5 ml oxcarbazepine oral tablet 150 mg, 300 mg, 600 mg OXTELLAR XR ORAL TABLET EXTENDED RELEASE 24 HR 150 MG, 300 MG, 600 MG PEGANONE ORAL TABLET 250 MG Drug Tier (Lamictal Odt (Blue)) 2 (Lamictal XR) 2 (Lamictal) 2 (Lamictal Odt) 2 (Lamictal (Blue)) 2 (Levetiracetam In Nacl (Iso-Os)) 2 (Keppra) 2 (Keppra) (Keppra) 2 2 (Keppra XR) 2 Requirements/Limits 3 QL (90 per 30 days) 3 QL (900 per 30 days) (Trileptal) 2 (Trileptal) 2 4 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 36 Effective: July 01, 2016 Drug Name phenobarbital oral elixir 20 mg/5 ml (4 mg/ml) phenobarbital oral tablet 100 mg, 15 mg, 16.2 mg, 32.4 mg, 60 mg, 64.8 mg, 97.2 mg phenobarbital oral tablet 30 mg phenobarbital sodium injection solution 130 mg/ml, 65 mg/ml phenytoin oral suspension 125 mg/5 ml phenytoin oral tablet,chewable 50 mg phenytoin sodium extended oral capsule 100 mg, 200 mg, 300 mg phenytoin sodium intravenous solution 50 mg/ml phenytoin sodium intravenous syringe 50 mg/ml POTIGA ORAL TABLET 200 MG, 300 MG, 400 MG POTIGA ORAL TABLET 50 MG primidone oral tablet 250 mg, 50 mg SABRIL ORAL POWDER IN PACKET 500 MG SABRIL ORAL TABLET 500 MG SPRITAM ORAL TABLET FOR SUSPENSION 1,000 MG SPRITAM ORAL TABLET FOR SUSPENSION 250 MG, 500 MG, 750 MG TEGRETOL XR ORAL TABLET EXTENDED RELEASE 12 HR 100 MG tiagabine oral tablet 2 mg, 4 mg topiragen oral tablet 100 mg, 200 mg, 25 mg, 50 mg topiramate oral capsule, sprinkle 15 mg, 25 mg Drug Tier Requirements/Limits (Phenobarbital) 2 QL (1500 per 30 days) (Phenobarbital) 2 QL (90 per 30 days) (Phenobarbital) (Phenobarbital Sodium) (Dilantin-125) (Dilantin) (Dilantin) 2 2 QL (200 per 30 days) QL (2 per 30 days) (Phenytoin Sodium) 2 (Phenytoin Sodium) 2 (Mysoline) 2 2 2 4 QL (90 per 30 days) 4 2 5 QL (270 per 30 days) 5 4 4 ST ; QL (60 per 30 days) ST ; QL (120 per 30 days) 3 (Gabitril) (Topamax) 2 2 (Topamax) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 37 Effective: July 01, 2016 Drug Name topiramate oral capsule,sprinkle,er 24hr 100 mg, 150 mg, 200 mg, 25 mg, 50 mg topiramate oral tablet 100 mg, 200 mg, 25 mg, 50 mg TROKENDI XR ORAL CAPSULE,EXTENDED RELEASE 24HR 100 MG, 200 MG, 25 MG, 50 MG valproate sodium intravenous solution 500 mg/5 ml (100 mg/ml) valproic acid (as sodium salt) oral solution 250 mg/5 ml valproic acid oral capsule 250 mg VIMPAT INTRAVENOUS SOLUTION 200 MG/20 ML VIMPAT ORAL SOLUTION 10 MG/ML VIMPAT ORAL TABLET 100 MG, 150 MG, 200 MG, 50 MG zonisamide oral capsule 100 mg, 25 mg, 50 mg Drug Tier (Qudexy XR) 2 (Topamax) 2 Requirements/Limits 4 (Depacon) 2 (Depakene) 2 (Depakene) 2 4 QL (200 per 5 days) 4 QL (1200 per 30 days) 4 QL (60 per 30 days) (Zonegran) 2 (Aricept) (Donepezil HCl) 2 2 QL (30 per 30 days) QL (30 per 30 days) (Razadyne ER) 2 QL (30 per 30 days) (Galantamine Hbr) (Razadyne) 2 2 QL (200 per 30 days) QL (60 per 30 days) (Namenda) (Namenda) (Namenda) 2 2 2 QL (360 per 30 days) QL (60 per 30 days) QL (49 per 28 days) Antidementia Agents Antidementia Agents donepezil oral tablet 10 mg, 23 mg, 5 mg donepezil oral tablet,disintegrating 10 mg, 5 mg galantamine oral capsule,ext rel. pellets 24 hr 16 mg, 24 mg, 8 mg galantamine oral solution 4 mg/ml galantamine oral tablet 12 mg, 4 mg, 8 mg memantine oral solution 2 mg/ml memantine oral tablet 10 mg, 5 mg memantine oral tablets,dose pack 5-10 mg You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 38 Effective: July 01, 2016 Drug Name Drug Tier NAMENDA XR ORAL CAP,SPRINKLE,ER 24HR DOSE PACK 7-14-21-28 MG NAMENDA XR ORAL CAPSULE,SPRINKLE,ER 24HR 14 MG, 21 MG, 28 MG, 7 MG NAMZARIC ORAL CAPSULE,SPRINKLE,ER 24HR 14-10 MG, 28-10 MG rivastigmine tartrate oral capsule 1.5 mg, (Exelon) 3 mg, 4.5 mg, 6 mg rivastigmine transdermal patch 24 hour (Exelon) 13.3 mg/24 hour, 4.6 mg/24 hr, 9.5 mg/24 hr Requirements/Limits 3 QL (28 per 28 days) 3 QL (30 per 30 days) 3 2 QL (60 per 30 days) 2 QL (30 per 30 days) Antidepressants Antidepressants amitriptyline oral tablet 10 mg, 100 mg, 150 mg, 25 mg, 50 mg, 75 mg amoxapine oral tablet 100 mg, 150 mg, 25 mg, 50 mg BRINTELLIX ORAL TABLET 10 MG, 20 MG, 5 MG buproban oral tablet extended release 150 mg bupropion hcl oral tablet 100 mg, 75 mg bupropion hcl oral tablet extended release 100 mg, 150 mg, 200 mg bupropion hcl oral tablet extended release 24 hr 150 mg, 300 mg citalopram oral solution 10 mg/5 ml citalopram oral tablet 10 mg, 20 mg, 40 mg clomipramine oral capsule 25 mg, 50 mg, 75 mg desipramine oral tablet 10 mg, 100 mg, 150 mg, 25 mg, 50 mg, 75 mg (Amitriptyline HCl) 2 (Amoxapine) 2 4 (Wellbutrin SR) 2 (Wellbutrin) (Wellbutrin SR) 2 2 (Wellbutrin XL) 2 (Citalopram Hydrobromide) (Celexa) 2 (Anafranil) 2 (Norpramin) 2 1 QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 39 Effective: July 01, 2016 Drug Name Drug Tier DESVENLAFAXINE FUMARATE ORAL TABLET EXTENDED RELEASE 24HR 100 MG, 50 MG doxepin oral capsule 10 mg, 100 mg, 150 mg, 25 mg, 50 mg, 75 mg doxepin oral concentrate 10 mg/ml duloxetine oral capsule,delayed release(dr/ec) 20 mg, 60 mg duloxetine oral capsule,delayed release(dr/ec) 30 mg duloxetine oral capsule,delayed release(dr/ec) 40 mg EMSAM TRANSDERMAL PATCH 24 HOUR 12 MG/24 HR, 6 MG/24 HR, 9 MG/24 HR escitalopram oxalate oral solution 5 mg/5 ml escitalopram oxalate oral tablet 10 mg, 20 mg, 5 mg FETZIMA ORAL CAPSULE,EXT REL 24HR DOSE PACK 20 MG (2)40 MG (26) FETZIMA ORAL CAPSULE,EXTENDED RELEASE 24 HR 120 MG, 20 MG, 40 MG, 80 MG fluoxetine oral capsule 10 mg, 20 mg, 40 mg fluoxetine oral capsule,delayed release(dr/ec) 90 mg fluoxetine oral solution 20 mg/5 ml (4 mg/ml) fluoxetine oral tablet 10 mg, 20 mg FLUOXETINE ORAL TABLET 60 MG fluvoxamine oral capsule,extended release 24hr 100 mg, 150 mg 3 (Doxepin HCl) 2 (Doxepin HCl) (Duloxetine) 2 2 (Duloxetine) 2 (Duloxetine) 2 4 (Lexapro) 2 (Lexapro) 2 Requirements/Limits QL (30 per 30 days) (Cymbalta); QL (60 per 30 days) (Cymbalta); QL (30 per 30 days) (Irenka); QL (30 per 30 days) QL (30 per 30 days) 4 4 (Prozac) 1 (Prozac Weekly) 2 (Fluoxetine HCl) 2 (Fluoxetine HCl) 2 4 (Fluvoxamine Maleate) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 40 Effective: July 01, 2016 Drug Name fluvoxamine oral tablet 100 mg, 25 mg, 50 mg imipramine hcl oral tablet 10 mg, 25 mg, 50 mg imipramine pamoate oral capsule 100 mg, 125 mg, 150 mg, 75 mg maprotiline oral tablet 25 mg, 50 mg, 75 mg MARPLAN ORAL TABLET 10 MG mirtazapine oral tablet 15 mg, 30 mg, 45 mg, 7.5 mg mirtazapine oral tablet,disintegrating 15 mg, 30 mg, 45 mg nefazodone oral tablet 100 mg, 150 mg, 200 mg, 250 mg, 50 mg nortriptyline oral capsule 10 mg, 25 mg, 50 mg, 75 mg nortriptyline oral solution 10 mg/5 ml olanzapine-fluoxetine oral capsule 12-25 mg, 12-50 mg, 3-25 mg, 6-25 mg, 6-50 mg paroxetine hcl oral tablet 10 mg, 20 mg, 30 mg, 40 mg paroxetine hcl oral tablet extended release 24 hr 12.5 mg, 25 mg, 37.5 mg PAXIL ORAL SUSPENSION 10 MG/5 ML perphenazine-amitriptyline oral tablet 2-10 mg, 2-25 mg, 4-10 mg, 4-25 mg, 4-50 mg phenelzine oral tablet 15 mg PRISTIQ ORAL TABLET EXTENDED RELEASE 24 HR 100 MG, 25 MG, 50 MG protriptyline oral tablet 10 mg, 5 mg sertraline oral concentrate 20 mg/ml Drug Tier (Fluvoxamine Maleate) 2 (Tofranil) 2 (Tofranil-Pm) 2 (Maprotiline HCl) 2 (Remeron) 4 2 (Remeron) 2 (Nefazodone HCl) 2 (Pamelor) 2 (Nortriptyline HCl) (Symbyax) 2 2 (Paxil) 2 (Paxil CR) 2 Requirements/Limits 4 (Perphenazine/Amitript yline HCl) 2 (Nardil) 2 4 (Protriptyline HCl) (Zoloft) QL (30 per 30 days) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 41 Effective: July 01, 2016 Drug Name sertraline oral tablet 100 mg, 25 mg, 50 mg SILENOR ORAL TABLET 3 MG, 6 MG SURMONTIL ORAL CAPSULE 100 MG, 25 MG, 50 MG tranylcypromine oral tablet 10 mg trazodone oral tablet 100 mg, 150 mg, 300 mg, 50 mg trimipramine oral capsule 100 mg, 25 mg, 50 mg TRINTELLIX ORAL TABLET 10 MG, 20 MG, 5 MG venlafaxine oral capsule,extended release 24hr 150 mg, 37.5 mg, 75 mg venlafaxine oral tablet 100 mg, 25 mg, 37.5 mg, 50 mg, 75 mg venlafaxine oral tablet extended release 24hr 150 mg, 37.5 mg, 75 mg venlafaxine oral tablet extended release 24hr 225 mg VIIBRYD ORAL TABLET 10 MG, 20 MG, 40 MG VIIBRYD ORAL TABLETS,DOSE PACK 10 MG (7)- 20 MG (23), 10 MG (7)-20 MG (7)-40 MG (16) Drug Tier (Zoloft) Requirements/Limits 1 3 QL (30 per 30 days) 4 (Parnate) (Trazodone HCl) 2 1 (Trimipramine Maleate) 2 4 (Effexor XR) 2 (Venlafaxine HCl) 2 (Venlafaxine HCl) 2 (Venlafaxine HCl) 3 4 4 Antidiabetic Agents Antidiabetic Agents, Miscellaneous acarbose oral tablet 100 mg, 25 mg, 50 mg ACTOPLUS MET XR ORAL TABLET, ER MULTIPHASE 24 HR 15-1,000 MG, 30-1,000 MG alogliptin oral tablet 12.5 mg, 25 mg, 6.25 mg (Precose) (Nesina) 2 QL (90 per 30 days) 3 QL (60 per 30 days) 4 QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 42 Effective: July 01, 2016 Drug Name Drug Tier alogliptin-metformin oral tablet (Kazano) 12.5-1,000 mg, 12.5-500 mg alogliptin-pioglitazone oral tablet 12.5-15 (Oseni) mg, 12.5-30 mg, 12.5-45 mg, 25-15 mg, 25-30 mg, 25-45 mg CYCLOSET ORAL TABLET 0.8 MG GLYSET ORAL TABLET 100 MG, 25 MG, 50 MG GLYXAMBI ORAL TABLET 10-5 MG, 25-5 MG INVOKAMET ORAL TABLET 150-1,000 MG, 150-500 MG, 50-1,000 MG, 50-500 MG INVOKANA ORAL TABLET 100 MG, 300 MG JANUMET ORAL TABLET 50-1,000 MG, 50-500 MG JANUMET XR ORAL TABLET, ER MULTIPHASE 24 HR 100-1,000 MG, 50-1,000 MG, 50-500 MG JANUVIA ORAL TABLET 100 MG, 25 MG, 50 MG JARDIANCE ORAL TABLET 10 MG, 25 MG JENTADUETO ORAL TABLET 2.5-1,000 MG, 2.5-500 MG, 2.5-850 MG KAZANO ORAL TABLET 12.5-1,000 MG, 12.5-500 MG KORLYM ORAL TABLET 300 MG metformin oral tablet 1,000 mg metformin oral tablet 500 mg metformin oral tablet 850 mg metformin oral tablet extended release 24 hr 500 mg (Glucophage) (Glucophage) (Glucophage) (Glucophage XR) Requirements/Limits 4 QL (60 per 30 days) 4 QL (30 per 30 days) 4 3 QL (180 per 30 days) QL (90 per 30 days) 3 ST 3 ST 3 ST 3 3 3 3 ST 3 4 QL (60 per 30 days) 5 PA; QL (112 per 28 days) QL (75 per 30 days) QL (150 per 30 days) QL (90 per 30 days) QL (120 per 30 days) 1 1 1 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 43 Effective: July 01, 2016 Drug Name metformin oral tablet extended release 24 hr 750 mg metformin oral tablet extended release 24hr 1,000 mg metformin oral tablet extended release 24hr 500 mg miglitol oral tablet 100 mg, 25 mg, 50 mg nateglinide oral tablet 120 mg, 60 mg NESINA ORAL TABLET 12.5 MG, 25 MG, 6.25 MG OSENI ORAL TABLET 12.5-15 MG, 12.5-30 MG, 12.5-45 MG, 25-15 MG, 25-30 MG, 25-45 MG pioglitazone oral tablet 15 mg, 30 mg, 45 mg pioglitazone-glimepiride oral tablet 30-2 mg, 30-4 mg pioglitazone-metformin oral tablet 15-500 mg, 15-850 mg repaglinide oral tablet 0.5 mg, 1 mg, 2 mg repaglinide-metformin oral tablet 1-500 mg, 2-500 mg SYMLINPEN 120 SUBCUTANEOUS PEN INJECTOR 2,700 MCG/2.7 ML SYMLINPEN 60 SUBCUTANEOUS PEN INJECTOR 1,500 MCG/1.5 ML SYNJARDY ORAL TABLET 12.5-1,000 MG, 12.5-500 MG, 5-1,000 MG, 5-500 MG TRADJENTA ORAL TABLET 5 MG TRULICITY SUBCUTANEOUS PEN INJECTOR 0.75 MG/0.5 ML, 1.5 MG/0.5 ML VICTOZA 3-PAK SUBCUTANEOUS PEN INJECTOR 0.6 MG/0.1 ML (18 MG/3 ML) Drug Tier Requirements/Limits (Glucophage XR) 2 QL (90 per 30 days) (Fortamet) 2 QL (60 per 30 days) (Fortamet) 2 QL (150 per 30 days) (Glyset) (Starlix) 2 2 4 QL (90 per 30 days) QL (90 per 30 days) QL (30 per 30 days) 4 QL (30 per 30 days) (Actos) 2 QL (30 per 30 days) (Duetact) 2 QL (30 per 30 days) (Actoplus Met) 2 QL (90 per 30 days) (Prandin) (Prandimet) 2 2 QL (240 per 30 days) QL (150 per 30 days) 4 QL (10.8 per 28 days) 4 QL (6 per 28 days) 3 ST 3 3 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 44 Effective: July 01, 2016 Drug Name Drug Tier Insulins HUMALOG 100 UNITS/ML CARTRIDGE 5'S, OUTER 100 UNIT/ML HUMALOG KWIKPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML HUMALOG KWIKPEN SUBCUTANEOUS INSULIN PEN 200 UNIT/ML (3 ML) HUMALOG MIX 50-50 KWIKPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML (50-50) HUMALOG MIX 50-50 SUBCUTANEOUS SUSPENSION 100 UNIT/ML (50-50) HUMALOG MIX 75-25 KWIKPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML (75-25) HUMALOG MIX 75-25 SUBCUTANEOUS SUSPENSION 100 UNIT/ML (75-25) HUMALOG SUBCUTANEOUS SOLUTION 100 UNIT/ML HUMALOG SUBCUTANEOUS SOLUTION 100 UNIT/ML (PREFILLED SYRINGE) HUMULIN 70/30 KWIKPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML (70-30) HUMULIN 70/30 SUBCUTANEOUS SUSPENSION 100 UNIT/ML (70-30) HUMULIN N KWIKPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML (3 ML) HUMULIN N SUBCUTANEOUS SUSPENSION 100 UNIT/ML Requirements/Limits 3 QL (30 per 28 days) 3 QL (30 per 28 days) 3 QL (12 per 28 days) 3 QL (30 per 28 days) 3 QL (40 per 28 days) 3 QL (30 per 28 days) 3 QL (40 per 28 days) 3 QL (40 per 28 days) 3 QL (30 per 28 days) 3 QL (30 per 28 days) 3 QL (40 per 28 days) 3 QL (30 per 28 days) 3 QL (40 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 45 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits HUMULIN R INJECTION SOLUTION 100 UNIT/ML HUMULIN R U-500 (CONC) KWIKPEN SUBCUTANEOUS INSULIN PEN 500 UNIT/ML (3 ML) HUMULIN R U-500 (CONCENTRATED) SUBCUTANEOUS SOLUTION 500 UNIT/ML LANTUS SOLOSTAR SUBCUTANEOUS INSULIN PEN 100 UNIT/ML (3 ML) LANTUS SUBCUTANEOUS SOLUTION 100 UNIT/ML NOVOLIN 70/30 SUBCUTANEOUS SUSPENSION 100 UNIT/ML (70-30) NOVOLIN N SUBCUTANEOUS SUSPENSION 100 UNIT/ML NOVOLIN R INJECTION SOLUTION 100 UNIT/ML NOVOLOG FLEXPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML NOVOLOG MIX 70-30 FLEXPEN SUBCUTANEOUS INSULIN PEN 100 UNIT/ML (70-30) NOVOLOG MIX 70-30 SUBCUTANEOUS SOLUTION 100 UNIT/ML (70-30) NOVOLOG PENFILL SUBCUTANEOUS CARTRIDGE 100 UNIT/ML NOVOLOG SUBCUTANEOUS SOLUTION 100 UNIT/ML TOUJEO SOLOSTAR SUBCUTANEOUS INSULIN PEN 300 UNIT/ML (1.5 ML) 3 QL (40 per 28 days) 3 QL (24 per 28 days) 3 QL (40 per 28 days) 3 3 3 QL (40 per 28 days) 3 QL (40 per 28 days) 3 QL (40 per 28 days) 3 QL (30 per 28 days) 3 QL (30 per 28 days) 3 QL (40 per 28 days) 3 QL (30 per 28 days) 3 QL (40 per 28 days) 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 46 Effective: July 01, 2016 Drug Name Sulfonylureas glimepiride oral tablet 1 mg, 2 mg glimepiride oral tablet 4 mg glipizide oral tablet 10 mg glipizide oral tablet 5 mg glipizide oral tablet extended release 24hr 10 mg glipizide oral tablet extended release 24hr 2.5 mg glipizide oral tablet extended release 24hr 5 mg glipizide-metformin oral tablet 2.5-250 mg glipizide-metformin oral tablet 2.5-500 mg, 5-500 mg glyburide micronized oral tablet 1.5 mg glyburide micronized oral tablet 3 mg glyburide micronized oral tablet 6 mg glyburide oral tablet 1.25 mg glyburide oral tablet 2.5 mg glyburide oral tablet 5 mg glyburide-metformin oral tablet 1.25-250 mg glyburide-metformin oral tablet 2.5-500 mg, 5-500 mg tolazamide oral tablet 250 mg tolazamide oral tablet 500 mg tolbutamide oral tablet 500 mg Drug Tier (Amaryl) (Amaryl) (Glucotrol) (Glucotrol) (Glucotrol XL) Requirements/Limits 1 1 1 1 2 QL (30 per 30 days) QL (60 per 30 days) QL (120 per 30 days) QL (60 per 30 days) QL (60 per 30 days) 2 QL (30 per 30 days) (Glucotrol XL) 2 QL (30 per 30 days) (Glipizide/Metformin HCl) (Glipizide/Metformin HCl) (Glynase) (Glynase) (Glynase) (Glyburide) (Glyburide) (Glyburide) (Glucovance) 2 QL (240 per 30 days) 2 QL (120 per 30 days) 2 2 2 2 2 2 2 QL (400 per 30 days) QL (180 per 30 days) QL (120 per 30 days) QL (280 per 30 days) QL (240 per 30 days) QL (120 per 30 days) QL (240 per 30 days) (Glucovance) 2 QL (120 per 30 days) (Tolazamide) (Tolazamide) (Tolbutamide) 2 2 2 QL (120 per 30 days) QL (60 per 30 days) QL (180 per 30 days) 5 PA BvD 5 PA BvD 2 PA BvD Antifungals Antifungals ABELCET INTRAVENOUS SUSPENSION 5 MG/ML AMBISOME INTRAVENOUS SUSPENSION FOR RECONSTITUTION 50 MG amphotericin b injection recon soln 50 mg (Amphotericin B) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 47 Effective: July 01, 2016 Drug Name Drug Tier CANCIDAS INTRAVENOUS RECON SOLN 50 MG, 70 MG ciclopirox topical cream 0.77 % ciclopirox topical gel 0.77 % ciclopirox topical shampoo 1 % ciclopirox topical solution 8 % ciclopirox topical suspension 0.77 % ciclopirox-ure-camph-menth-euc topical solution 8 % clotrimazole mucous membrane troche 10 mg clotrimazole topical cream 1 % clotrimazole topical solution 1 % clotrimazole-betamethasone topical cream 1-0.05 % clotrimazole-betamethasone topical lotion 1-0.05 % econazole topical cream 1 % EXELDERM TOPICAL CREAM 1 % EXELDERM TOPICAL SOLUTION 1% fluconazole in dextrose(iso-o) intravenous piggyback 400 mg/200 ml fluconazole in nacl (iso-osm) intravenous piggyback 100 mg/50 ml, 200 mg/100 ml fluconazole oral suspension for reconstitution 10 mg/ml, 40 mg/ml fluconazole oral tablet 100 mg, 150 mg, 200 mg, 50 mg fluconazole-nacl 400 mg/200 ml 10's,latex-free, p/f 400 mg/200 ml flucytosine oral capsule 250 mg, 500 mg griseofulvin microsize oral suspension 125 mg/5 ml griseofulvin microsize oral tablet 500 mg 5 (Ciclodan) (Loprox) (Loprox) (Penlac) (Ciclopirox Olamine) (Ciclodan) 2 2 2 2 2 2 (Clotrimazole) 2 (Clotrimazole) (Clotrimazole) (Lotrisone) 2 2 2 (Clotrimazole/Betamet hasone Dip) (Econazole Nitrate) 2 (Fluconazole In Nacl,Iso-Osm) (Fluconazole In Nacl,Iso-Osm) (Diflucan) 2 (Diflucan) 2 (Fluconazole In Nacl,Iso-Osm) (Ancobon) (Griseofulvin, Microsize) (Grifulvin V) 2 Requirements/Limits 2 4 4 2 2 5 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 48 Effective: July 01, 2016 Drug Name griseofulvin ultramicrosize oral tablet 125 mg, 250 mg itraconazole oral capsule 100 mg ketoconazole oral tablet 200 mg ketoconazole topical cream 2 % ketoconazole topical shampoo 2 % miconazole-3 vaginal suppository 200 mg NOXAFIL INTRAVENOUS SOLUTION 300 MG/16.7 ML NOXAFIL ORAL SUSPENSION 200 MG/5 ML (40 MG/ML) NOXAFIL ORAL TABLET,DELAYED RELEASE (DR/EC) 100 MG nyamyc topical powder 100,000 unit/gram nystatin oral suspension 100,000 unit/ml nystatin oral tablet 500,000 unit nystatin topical cream 100,000 unit/gram nystatin topical ointment 100,000 unit/gram nystatin topical powder 100,000 unit/gram nystatin-triamcinolone topical cream 100,000-0.1 unit/g-% nystatin-triamcinolone topical ointment 100,000-0.1 unit/gram-% nystop topical powder 100,000 unit/gram SPORANOX ORAL SOLUTION 10 MG/ML terbinafine hcl oral tablet 250 mg voriconazole intravenous solution 200 mg voriconazole oral suspension for reconstitution 200 mg/5 ml (40 mg/ml) voriconazole oral tablet 200 mg, 50 mg Drug Tier (Gris-Peg) 2 (Sporanox) (Ketoconazole) (Ketoconazole) (Nizoral) (Miconazole Nitrate) 2 2 2 2 2 5 Requirements/Limits 5 5 (Nystatin) 2 (Nystatin) (Nystatin) (Nystatin) (Nystatin) 2 2 2 2 (Nystatin) 2 (Nystatin/Triamcin) 2 (Nystatin/Triamcin) 2 (Nystatin) 2 4 (Lamisil) (Vfend IV) (Vfend) 2 2 5 (Vfend) 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 49 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits Antihistamines Antihistamines carbinoxamine maleate oral liquid 4 mg/5 (Carbinoxamine ml Maleate) carbinoxamine maleate oral tablet 4 mg (Carbinoxamine Maleate) clemastine oral tablet 2.68 mg (Clemastine Fumarate) cyproheptadine oral syrup 2 mg/5 ml (Cyproheptadine HCl) cyproheptadine oral tablet 4 mg (Cyproheptadine HCl) diphenhydramine hcl injection solution 50 (Diphenhydramine mg/ml HCl) diphenhydramine hcl injection syringe 50 (Diphenhydramine mg/ml HCl) levocetirizine oral solution 2.5 mg/5 ml (Xyzal) levocetirizine oral tablet 5 mg (Xyzal) promethazine oral syrup 6.25 mg/5 ml (Promethazine HCl) 2 2 2 2 2 2 2 2 2 2 Anti-Infectives (Skin And Mucous Membrane) Anti-Infectives (Skin And Mucous Membrane) AVC VAGINAL VAGINAL CREAM 15 % clindamycin phosphate vaginal cream 2 % metronidazole vaginal gel 0.75 % terconazole vaginal cream 0.4 %, 0.8 % terconazole vaginal suppository 80 mg 3 (Cleocin) (Metrogel-Vaginal) (Terazol 7) (Terconazole) 2 2 2 2 (Axert) 2 QL (12 per 28 days) (D.H.E.45) 2 QL (30 per 28 days) (Migranal) 2 QL (8 per 28 days) Antimigraine Agents Antimigraine Agents almotriptan malate oral tablet 12.5 mg, 6.25 mg dihydroergotamine injection solution 1 mg/ml dihydroergotamine nasal spray,non-aerosol 0.5 mg/pump act. (4 mg/ml) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 50 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits ERGOMAR SUBLINGUAL TABLET 2 MG naratriptan oral tablet 1 mg, 2.5 mg rizatriptan oral tablet 10 mg, 5 mg rizatriptan oral tablet,disintegrating 10 mg, 5 mg sumatriptan 6 mg/0.5 ml syrng p/f,dehp/f,pvc/f 6 mg/0.5 ml sumatriptan nasal spray,non-aerosol 20 mg/actuation, 5 mg/actuation sumatriptan succinate oral tablet 100 mg, 25 mg, 50 mg sumatriptan succinate subcutaneous cartridge 4 mg/0.5 ml sumatriptan succinate subcutaneous cartridge 6 mg/0.5 ml sumatriptan succinate subcutaneous pen injector 4 mg/0.5 ml sumatriptan succinate subcutaneous pen injector 6 mg/0.5 ml, 6 mg/0.5 ml (auto-injector) sumatriptan succinate subcutaneous solution 6 mg/0.5 ml zolmitriptan oral tablet 2.5 mg, 5 mg zolmitriptan oral tablet,disintegrating 2.5 mg, 5 mg 4 QL (40 per 28 days) (Amerge) (Maxalt) (Maxalt Mlt) 2 2 2 QL (18 per 28 days) QL (18 per 28 days) QL (18 per 28 days) (Sumatriptan Succinate) (Imitrex) 2 QL (4 per 28 days) 2 QL (12 per 28 days) (Imitrex) 2 QL (18 per 28 days) (Sumatriptan Succinate) (Imitrex) 2 QL (4 per 28 days) 2 QL (4 per 28 days) (Sumatriptan Succinate) (Sumatriptan Succinate) 2 QL (4 per 28 days) 2 QL (4 per 28 days) (Imitrex) 2 QL (4 per 28 days) (Zomig) (Zomig Zmt) 2 2 QL (12 per 28 days) QL (12 per 28 days) Antimycobacterials Antimycobacterials CAPASTAT INJECTION RECON SOLN 1 GRAM dapsone oral tablet 100 mg, 25 mg ethambutol oral tablet 100 mg, 400 mg isoniazid oral solution 50 mg/5 ml isoniazid oral tablet 100 mg, 300 mg PASER ORAL GRANULES DR FOR SUSP IN PACKET 4 GRAM 4 (Dapsone) (Myambutol) (Isoniazid) (Isoniazid) 2 2 2 1 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 51 Effective: July 01, 2016 Drug Name Drug Tier PRIFTIN ORAL TABLET 150 MG pyrazinamide oral tablet 500 mg rifabutin oral capsule 150 mg rifampin intravenous recon soln 600 mg rifampin oral capsule 150 mg, 300 mg RIFATER ORAL TABLET 50-120-300 MG SIRTURO ORAL TABLET 100 MG 4 2 2 2 2 4 (Pyrazinamide) (Mycobutin) (Rifadin) (Rifadin) 5 TRECATOR ORAL TABLET 250 MG Requirements/Limits PA; QL (188 per 168 days) 4 Antinausea Agents Antinausea Agents AKYNZEO ORAL CAPSULE 300-0.5 MG compro rectal suppository 25 mg dimenhydrinate injection solution 50 mg/ml dronabinol oral capsule 10 mg, 2.5 mg, 5 mg EMEND INTRAVENOUS RECON SOLN 115 MG, 150 MG EMEND ORAL CAPSULE 125 MG, 80 MG EMEND ORAL CAPSULE 40 MG EMEND ORAL CAPSULE,DOSE PACK 125 MG (1)- 80 MG (2) granisetron (pf) intravenous solution 100 mcg/ml granisetron hcl intravenous solution 1 mg/ml (1 ml) granisetron hcl oral tablet 1 mg granisol oral solution 1 mg/5 ml meclizine oral tablet 12.5 mg, 25 mg ondansetron hcl (pf) injection solution 4 mg/2 ml 3 (Compazine) (Dimenhydrinate) 2 2 (Marinol) 2 PA BvD 4 QL (2 per 28 days) 4 PA BvD 4 4 PA BvD (Granisetron HCl/PF) 2 (Granisetron HCl) 2 (Granisetron HCl) (Granisetron HCl) (Antivert) (Ondansetron HCl/PF) 2 2 2 2 PA BvD PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 52 Effective: July 01, 2016 Drug Name ondansetron hcl (pf) injection syringe 4 mg/2 ml ondansetron hcl oral solution 4 mg/5 ml ondansetron hcl oral tablet 24 mg, 4 mg, 8 mg ondansetron oral tablet,disintegrating 4 mg, 8 mg phenadoz rectal suppository 12.5 mg, 25 mg prochlorperazine edisylate injection solution 10 mg/2 ml (5 mg/ml) prochlorperazine maleate oral tablet 10 mg, 5 mg prochlorperazine rectal suppository 25 mg promethazine oral tablet 12.5 mg, 25 mg, 50 mg promethazine rectal suppository 12.5 mg, 25 mg, 50 mg promethegan rectal suppository 12.5 mg, 25 mg, 50 mg TRANSDERM-SCOP TRANSDERMAL PATCH 3 DAY 1.5 MG (1 MG OVER 3 DAYS) Drug Tier Requirements/Limits (Ondansetron HCl/PF) 2 (Zofran) (Zofran) 2 2 PA BvD PA BvD (Zofran Odt) 2 PA BvD (Phenergan) 2 (Prochlorperazine Edisylate) (Compazine) 2 (Compazine) 2 (Promethazine HCl) 2 (Phenergan) 2 (Phenergan) 2 1 4 QL (10 per 30 days) Antiparasite Agents Antiparasite Agents ALBENZA ORAL TABLET 200 MG ALINIA ORAL SUSPENSION FOR RECONSTITUTION 100 MG/5 ML ALINIA ORAL TABLET 500 MG atovaquone oral suspension 750 mg/5 ml atovaquone-proguanil oral tablet 250-100 mg, 62.5-25 mg chloroquine phosphate oral tablet 250 mg, 500 mg 4 4 (Mepron) (Malarone) (Chloroquine Phosphate) 4 5 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 53 Effective: July 01, 2016 Drug Name Drug Tier COARTEM ORAL TABLET 20-120 MG DARAPRIM ORAL TABLET 25 MG EMVERM ORAL TABLET,CHEWABLE 100 MG hydroxychloroquine oral tablet 200 mg ivermectin oral tablet 3 mg mefloquine oral tablet 250 mg NEBUPENT INHALATION RECON SOLN 300 MG paromomycin oral capsule 250 mg PENTAM INJECTION RECON SOLN 300 MG PRIMAQUINE ORAL TABLET 26.3 MG quinine sulfate oral capsule 324 mg tinidazole oral tablet 250 mg, 500 mg 4 (Plaquenil) (Stromectol) (Mefloquine HCl) (Paromomycin Sulfate) Requirements/Limits 4 2 QL (6 per 21 days) 2 2 2 4 PA BvD 2 4 4 QL (90 per 30 days) (Qualaquin) (Tindamax) 2 2 PA; QL (42 per 7 days) (Amantadine HCl) (Amantadine HCl) (Amantadine HCl) 2 2 2 5 Antiparkinsonian Agents Antiparkinsonian Agents amantadine hcl oral capsule 100 mg amantadine hcl oral solution 50 mg/5 ml amantadine hcl oral tablet 100 mg APOKYN SUBCUTANEOUS CARTRIDGE 10 MG/ML AZILECT ORAL TABLET 0.5 MG, 1 MG benztropine injection solution 2 mg/2 ml benztropine oral tablet 0.5 mg, 1 mg, 2 mg bromocriptine oral capsule 5 mg bromocriptine oral tablet 2.5 mg cabergoline oral tablet 0.5 mg carbidopa oral tablet 25 mg carbidopa-levodopa oral tablet 10-100 mg, 25-100 mg, 25-250 mg QL (60 per 30 days) 3 (Cogentin) (Benztropine Mesylate) 2 2 (Parlodel) (Parlodel) (Cabergoline) (Lodosyn) (Sinemet CR) 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 54 Effective: July 01, 2016 Drug Name carbidopa-levodopa oral tablet extended release 25-100 mg, 50-200 mg carbidopa-levodopa oral tablet,disintegrating 10-100 mg, 25-100 mg, 25-250 mg carbidopa-levodopa-entacapone oral tablet 12.5-50-200 mg, 18.75-75-200 mg, 25-100-200 mg, 31.25-125-200 mg, 37.5-150-200 mg, 50-200-200 mg entacapone oral tablet 200 mg NEUPRO TRANSDERMAL PATCH 24 HOUR 1 MG/24 HOUR, 2 MG/24 HOUR, 3 MG/24 HOUR, 4 MG/24 HOUR, 6 MG/24 HOUR, 8 MG/24 HOUR pramipexole oral tablet 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg ropinirole oral tablet 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg ropinirole oral tablet extended release 24 hr 12 mg, 2 mg, 4 mg, 6 mg, 8 mg selegiline hcl oral capsule 5 mg selegiline hcl oral tablet 5 mg trihexyphenidyl oral elixir 0.4 mg/ml trihexyphenidyl oral tablet 2 mg, 5 mg Drug Tier (Sinemet CR) 2 (Carbidopa/Levodopa) 2 (Stalevo 50) 2 (Comtan) 2 3 (Mirapex) 2 (Requip) 2 (Requip XL) 2 (Eldepryl) (Selegiline HCl) (Trihexyphenidyl HCl) (Trihexyphenidyl HCl) 2 2 2 2 Requirements/Limits Antipsychotic Agents Antipsychotic Agents ABILIFY MAINTENA INTRAMUSCULAR SUSPENSION,EXTENDED REL RECON 300 MG ABILIFY MAINTENA INTRAMUSCULAR SUSPENSION,EXTENDED REL RECON 400 MG 5 5 QL (1 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 55 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits ABILIFY MAINTENA INTRAMUSCULAR SUSPENSION,EXTENDED REL SYRING 300 MG, 400 MG aripiprazole oral solution 1 mg/ml aripiprazole oral tablet 10 mg, 15 mg, 20 mg, 30 mg, 5 mg aripiprazole oral tablet 2 mg aripiprazole oral tablet,disintegrating 10 mg aripiprazole oral tablet,disintegrating 15 mg ARISTADA INTRAMUSCULAR SUSPENSION,EXTENDED REL SYRING 441 MG/1.6 ML ARISTADA INTRAMUSCULAR SUSPENSION,EXTENDED REL SYRING 662 MG/2.4 ML ARISTADA INTRAMUSCULAR SUSPENSION,EXTENDED REL SYRING 882 MG/3.2 ML chlorpromazine injection solution 25 mg/ml chlorpromazine oral tablet 10 mg, 100 mg, 200 mg, 25 mg, 50 mg clozapine oral tablet 100 mg clozapine oral tablet 200 mg clozapine oral tablet 25 mg, 50 mg clozapine oral tablet,disintegrating 100 mg, 12.5 mg, 150 mg, 200 mg, 25 mg FANAPT ORAL TABLET 1 MG, 10 MG, 12 MG, 2 MG, 4 MG, 6 MG, 8 MG FANAPT ORAL TABLETS,DOSE PACK 1MG(2)-2MG(2)4MG(2)-6MG(2) 5 QL (1 per 28 days) (Abilify) (Abilify) 2 2 QL (900 per 30 days) QL (30 per 30 days) (Abilify) (Abilify Discmelt) 2 2 QL (60 per 30 days) QL (90 per 30 days) (Abilify Discmelt) 2 QL (60 per 30 days) 5 QL (1.6 per 28 days) 5 QL (2.4 per 28 days) 5 QL (3.2 per 28 days) (Chlorpromazine HCl) 2 (Chlorpromazine HCl) 2 (Clozaril) (Clozaril) (Clozaril) (Fazaclo) 2 2 2 2 QL (270 per 30 days) QL (135 per 30 days) QL (90 per 30 days) ST 4 ST ; QL (60 per 30 days) 4 ST ; QL (8 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 56 Effective: July 01, 2016 Drug Name fluphenazine decanoate injection solution 25 mg/ml fluphenazine hcl injection solution 2.5 mg/ml fluphenazine hcl oral concentrate 5 mg/ml fluphenazine hcl oral elixir 2.5 mg/5 ml fluphenazine hcl oral tablet 1 mg, 10 mg, 2.5 mg, 5 mg GEODON INTRAMUSCULAR RECON SOLN 20 MG/ML (FINAL CONC.) haloperidol decanoate intramuscular solution 100 mg/ml haloperidol decanoate intramuscular solution 50 mg/ml haloperidol lactate injection solution 5 mg/ml haloperidol lactate oral concentrate 2 mg/ml haloperidol oral tablet 0.5 mg, 1 mg, 10 mg, 2 mg, 20 mg, 5 mg INVEGA SUSTENNA INTRAMUSCULAR SYRINGE 117 MG/0.75 ML, 156 MG/ML, 234 MG/1.5 ML INVEGA SUSTENNA INTRAMUSCULAR SYRINGE 39 MG/0.25 ML, 78 MG/0.5 ML INVEGA TRINZA INTRAMUSCULAR SYRINGE 273 MG/0.875 ML, 410 MG/1.315 ML, 546 MG/1.75 ML, 819 MG/2.625 ML LATUDA ORAL TABLET 120 MG, 20 MG, 40 MG, 60 MG, 80 MG loxapine succinate oral capsule 10 mg, 25 mg, 5 mg, 50 mg molindone oral tablet 10 mg Drug Tier (Fluphenazine Decanoate) (Fluphenazine HCl) 2 (Fluphenazine HCl) (Fluphenazine HCl) (Fluphenazine HCl) 2 2 2 Requirements/Limits 2 4 (Haloperidol Decanoate) (Haldol Decanoate 50) 2 (Haloperidol Lactate) 2 (Haloperidol Lactate) 2 (Haloperidol) 2 QL (6 per 28 days) 2 5 3 5 4 (Loxapine Succinate) 2 (Moban) 2 QL (240 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 57 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits molindone oral tablet 25 mg molindone oral tablet 5 mg NUPLAZID ORAL TABLET 17 MG (Moban) (Moban) 2 2 5 olanzapine intramuscular recon soln 10 mg olanzapine oral tablet 10 mg, 15 mg, 2.5 mg, 20 mg, 5 mg, 7.5 mg olanzapine oral tablet,disintegrating 10 mg, 15 mg, 5 mg olanzapine oral tablet,disintegrating 20 mg paliperidone oral tablet extended release 24hr 1.5 mg, 3 mg, 9 mg paliperidone oral tablet extended release 24hr 6 mg perphenazine oral tablet 16 mg, 2 mg, 4 mg, 8 mg pimozide oral tablet 1 mg, 2 mg quetiapine oral tablet 100 mg, 200 mg, 25 mg, 300 mg, 400 mg, 50 mg REXULTI ORAL TABLET 0.25 MG REXULTI ORAL TABLET 0.5 MG REXULTI ORAL TABLET 1 MG, 2 MG, 3 MG, 4 MG RISPERDAL CONSTA INTRAMUSCULAR SYRINGE 12.5 MG/2 ML, 25 MG/2 ML, 37.5 MG/2 ML, 50 MG/2 ML risperidone oral solution 1 mg/ml risperidone oral tablet 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg risperidone oral tablet,disintegrating 0.25 mg, 0.5 mg, 1 mg, 2 mg risperidone oral tablet,disintegrating 3 mg, 4 mg (Zyprexa) 2 QL (270 per 30 days) QL (120 per 30 days) PA NSO; QL (60 per 30 days) QL (30 per 30 days) (Zyprexa) 2 QL (30 per 30 days) (Zyprexa Zydis) 2 QL (30 per 30 days) (Zyprexa Zydis) 2 QL (31 per 30 days) (Invega) 2 QL (30 per 30 days) (Invega) 2 QL (60 per 30 days) (Perphenazine) 2 (Orap) (Seroquel) 2 2 QL (90 per 30 days) 5 5 5 QL (120 per 30 days) QL (60 per 30 days) QL (30 per 30 days) 4 QL (4 per 28 days) (Risperdal) (Risperdal) 2 2 QL (480 per 30 days) QL (60 per 30 days) (Risperdal M-Tab) 2 QL (60 per 30 days) (Risperdal M-Tab) 2 QL (120 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 58 Effective: July 01, 2016 Drug Name Drug Tier SAPHRIS (BLACK CHERRY) SUBLINGUAL TABLET 10 MG, 2.5 MG, 5 MG SEROQUEL XR ORAL TABLET EXTENDED RELEASE 24 HR 150 MG, 300 MG, 400 MG, 50 MG SEROQUEL XR ORAL TABLET EXTENDED RELEASE 24 HR 200 MG thioridazine oral tablet 10 mg, 100 mg, 25 mg, 50 mg thiothixene oral capsule 1 mg, 10 mg, 2 mg, 5 mg trifluoperazine oral tablet 1 mg, 10 mg, 2 mg, 5 mg VERSACLOZ ORAL SUSPENSION 50 MG/ML VRAYLAR ORAL CAPSULE 1.5 MG, 3 MG, 4.5 MG, 6 MG VRAYLAR ORAL CAPSULE,DOSE PACK 1.5 MG (1)- 3 MG (6) ziprasidone hcl oral capsule 20 mg, 40 mg, 60 mg, 80 mg ZYPREXA RELPREVV 405 MG VL KIT W/ DILUENT, OUTER 405 MG ZYPREXA RELPREVV INTRAMUSCULAR SUSPENSION FOR RECONSTITUTION 210 MG 4 ST ; QL (60 per 30 days) 4 ST ; QL (60 per 30 days) 4 ST ; QL (30 per 30 days) (Thioridazine HCl) 2 (Thiothixene) 2 (Trifluoperazine HCl) 2 5 (Geodon) Requirements/Limits 5 ST ; QL (540 per 30 days) QL (30 per 30 days) 4 QL (7 per 30 days) 2 QL (60 per 30 days) 5 5 Antivirals (Systemic) Antiretrovirals abacavir oral tablet 300 mg abacavir-lamivudine-zidovudine oral tablet 300-150-300 mg APTIVUS ORAL CAPSULE 250 MG APTIVUS ORAL SOLUTION 100 MG/ML (Ziagen) (Trizivir) 2 5 5 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 59 Effective: July 01, 2016 Drug Name Drug Tier ATRIPLA ORAL TABLET 600-200-300 MG COMPLERA ORAL TABLET 200-25-300 MG CRIXIVAN ORAL CAPSULE 200 MG, 400 MG DESCOVY ORAL TABLET 200-25 MG didanosine oral capsule,delayed (Videx EC) release(dr/ec) 125 mg, 200 mg, 250 mg, 400 mg EDURANT ORAL TABLET 25 MG EMTRIVA ORAL CAPSULE 200 MG EMTRIVA ORAL SOLUTION 10 MG/ML EPIVIR HBV ORAL SOLUTION 25 MG/5 ML (5 MG/ML) EPZICOM ORAL TABLET 600-300 MG EVOTAZ ORAL TABLET 300-150 MG FUZEON SUBCUTANEOUS RECON SOLN 90 MG GENVOYA ORAL TABLET 150-150-200-10 MG INTELENCE ORAL TABLET 100 MG, 200 MG INTELENCE ORAL TABLET 25 MG INVIRASE ORAL CAPSULE 200 MG INVIRASE ORAL TABLET 500 MG ISENTRESS ORAL POWDER IN PACKET 100 MG ISENTRESS ORAL TABLET 400 MG ISENTRESS ORAL TABLET,CHEWABLE 100 MG, 25 MG Requirements/Limits 5 5 4 5 2 5 3 3 4 5 5 5 5 5 3 5 5 3 5 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 60 Effective: July 01, 2016 Drug Name Drug Tier KALETRA ORAL SOLUTION 400-100 MG/5 ML KALETRA ORAL TABLET 100-25 MG KALETRA ORAL TABLET 200-50 MG lamivudine oral solution 10 mg/ml lamivudine oral tablet 100 mg, 150 mg, 300 mg lamivudine-zidovudine oral tablet 150-300 mg LEXIVA ORAL SUSPENSION 50 MG/ML LEXIVA ORAL TABLET 700 MG nevirapine oral suspension 50 mg/5 ml nevirapine oral tablet 200 mg nevirapine oral tablet extended release 24 hr 100 mg, 400 mg NORVIR ORAL CAPSULE 100 MG NORVIR ORAL SOLUTION 80 MG/ML NORVIR ORAL TABLET 100 MG ODEFSEY ORAL TABLET 200-25-25 MG PREZCOBIX ORAL TABLET 800-150 MG-MG PREZISTA ORAL SUSPENSION 100 MG/ML PREZISTA ORAL TABLET 150 MG, 75 MG PREZISTA ORAL TABLET 400 MG, 600 MG, 800 MG RESCRIPTOR ORAL TABLET 200 MG RESCRIPTOR ORAL TABLET, DISPERSIBLE 100 MG 5 Requirements/Limits 3 5 (Epivir) (Epivir) 2 2 (Combivir) 5 3 (Viramune) (Viramune) (Viramune XR) 5 2 2 2 3 3 3 5 5 4 3 5 4 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 61 Effective: July 01, 2016 Drug Name Drug Tier RETROVIR INTRAVENOUS SOLUTION 10 MG/ML REYATAZ ORAL CAPSULE 150 MG, 200 MG, 300 MG REYATAZ ORAL POWDER IN PACKET 50 MG SELZENTRY ORAL TABLET 150 MG, 300 MG stavudine oral capsule 15 mg, 20 mg, 30 (Zerit) mg, 40 mg stavudine oral recon soln 1 mg/ml (Zerit) STRIBILD ORAL TABLET 150-150-200-300 MG SUSTIVA ORAL CAPSULE 200 MG, 50 MG SUSTIVA ORAL TABLET 600 MG TIVICAY ORAL TABLET 50 MG TRIUMEQ ORAL TABLET 600-50-300 MG TRUVADA ORAL TABLET 100-150 MG, 133-200 MG, 167-250 MG, 200-300 MG VIDEX 2 GRAM PEDIATRIC ORAL RECON SOLN 10 MG/ML (FINAL) VIDEX 4 GM PEDIATRIC SOLN 10 MG/ML (FINAL) VIRACEPT ORAL TABLET 250 MG, 625 MG VIRAMUNE XR ORAL TABLET EXTENDED RELEASE 24 HR 100 MG VIREAD ORAL POWDER 40 MG/SCOOP (40 MG/GRAM) VIREAD ORAL TABLET 150 MG, 200 MG, 250 MG, 300 MG VITEKTA ORAL TABLET 150 MG, 85 MG Requirements/Limits 3 5 5 5 2 2 5 4 4 5 5 5 3 3 4 3 5 5 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 62 Effective: July 01, 2016 Drug Name Drug Tier ZIAGEN ORAL SOLUTION 20 MG/ML zidovudine oral capsule 100 mg zidovudine oral syrup 10 mg/ml zidovudine oral tablet 300 mg Antivirals, Miscellaneous foscarnet intravenous solution 24 mg/ml RELENZA DISKHALER INHALATION BLISTER WITH DEVICE 5 MG/ACTUATION rimantadine oral tablet 100 mg SYNAGIS 100 MG/1 ML VIAL 100 MG/ML SYNAGIS INTRAMUSCULAR SOLUTION 50 MG/0.5 ML TAMIFLU ORAL CAPSULE 30 MG, 45 MG, 75 MG TAMIFLU ORAL SUSPENSION FOR RECONSTITUTION 6 MG/ML Hcv Antivirals DAKLINZA ORAL TABLET 30 MG, 60 MG, 90 MG HARVONI ORAL TABLET 90-400 MG OLYSIO ORAL CAPSULE 150 MG 4 (Retrovir) (Retrovir) (Zidovudine) 2 2 2 (Foscavir) 2 4 (Flumadine) 2 5 Requirements/Limits PA BvD 5 3 3 5 5 5 SOVALDI ORAL TABLET 400 MG 5 TECHNIVIE ORAL TABLET 12.5-75-50 MG VIEKIRA PAK ORAL TABLETS,DOSE PACK 12.5 MG-75 MG -50 MG/250 MG ZEPATIER ORAL TABLET 50-100 MG 5 5 5 PA; QL (28 per 28 days) PA; QL (30 per 30 days) PA; QL (28 per 28 days) PA; QL (28 per 28 days) PA; QL (56 per 28 days) PA; QL (112 per 28 days) PA; QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 63 Effective: July 01, 2016 Drug Name Interferons INTRON A 25 MILLION UNIT/2.5 ML 10 MILLION UNIT/ML INTRON A INJECTION RECON SOLN 10 MILLION UNIT (1 ML) INTRON A INJECTION RECON SOLN 18 MILLION UNIT (1 ML), 50 MILLION UNIT (1 ML) INTRON A INJECTION SOLUTION 6 MILLION UNIT/ML PEGASYS PROCLICK SUBCUTANEOUS PEN INJECTOR 135 MCG/0.5 ML, 180 MCG/0.5 ML PEGASYS SUBCUTANEOUS SOLUTION 180 MCG/ML PEGASYS SUBCUTANEOUS SYRINGE 180 MCG/0.5 ML PEGINTRON SUBCUTANEOUS KIT 120 MCG/0.5 ML, 150 MCG/0.5 ML, 50 MCG/0.5 ML, 80 MCG/0.5 ML SYLATRON SUBCUTANEOUS KIT 200 MCG, 300 MCG, 600 MCG Nucleosides And Nucleotides acyclovir oral capsule 200 mg acyclovir oral suspension 200 mg/5 ml acyclovir oral tablet 400 mg, 800 mg acyclovir sodium intravenous solution 50 mg/ml adefovir oral tablet 10 mg BARACLUDE ORAL SOLUTION 0.05 MG/ML cidofovir intravenous solution 75 mg/ml entecavir oral tablet 0.5 mg, 1 mg famciclovir oral tablet 125 mg, 250 mg, 500 mg Drug Tier Requirements/Limits 4 PA NSO 4 PA NSO 4 PA NSO 4 PA NSO 5 PA 5 PA 5 PA 5 PA 5 PA NSO; QL (4 per 28 days) (Zovirax) (Zovirax) (Zovirax) (Acyclovir Sodium) 2 2 2 2 (Hepsera) 5 4 (Vistide) (Baraclude) (Famvir) 5 5 2 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 64 Effective: July 01, 2016 Drug Name ganciclovir sodium intravenous recon soln 500 mg ribasphere oral capsule 200 mg ribasphere oral tablet 200 mg, 400 mg, 600 mg ribasphere ribapak oral tablets,dose pack 200 mg (7)- 400 mg (7), 400-400 mg (28)-mg (28), 600-400 mg (28)-mg (28) ribavirin oral capsule 200 mg ribavirin oral tablet 200 mg TYZEKA ORAL TABLET 600 MG valacyclovir oral tablet 1 gram, 500 mg VALCYTE ORAL RECON SOLN 50 MG/ML valganciclovir oral tablet 450 mg VIRAZOLE INHALATION RECON SOLN 6 GRAM Drug Tier (Cytovene) 2 (Rebetol) (Copegus) 2 2 (Ribatab) 5 (Rebetol) (Copegus) 2 2 5 2 4 (Valtrex) (Valcyte) 5 5 Requirements/Limits PA BvD PA BvD Blood Products/Modifiers/Volume Expanders Anticoagulants CEPROTIN (BLUE BAR) INTRAVENOUS RECON SOLN 500 UNIT ELIQUIS ORAL TABLET 2.5 MG, 5 MG enoxaparin subcutaneous solution 300 mg/3 ml enoxaparin subcutaneous syringe 100 mg/ml, 120 mg/0.8 ml, 150 mg/ml enoxaparin subcutaneous syringe 30 mg/0.3 ml, 40 mg/0.4 ml, 60 mg/0.6 ml, 80 mg/0.8 ml fondaparinux subcutaneous syringe 10 mg/0.8 ml 5 3 (Lovenox) 2 (Lovenox) 5 (Lovenox) 2 (Arixtra) 2 QL (24 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 65 Effective: July 01, 2016 Drug Name fondaparinux subcutaneous syringe 2.5 mg/0.5 ml fondaparinux subcutaneous syringe 5 mg/0.4 ml fondaparinux subcutaneous syringe 7.5 mg/0.6 ml heparin (porcine) in 5 % dex intravenous parenteral solution 12,500 unit/250 ml, 20,000 unit/500 ml (40 unit/ml), 25,000 unit/500 ml (50 unit/ml) heparin (porcine) in 5 % dex intravenous parenteral solution 25,000 unit/250 ml(100 unit/ml) heparin (porcine) in nacl (pf) intravenous parenteral solution 1,000 unit/500 ml heparin (porcine) injection solution 1,000 unit/ml, 10,000 unit/ml, 20,000 unit/ml, 5,000 unit/ml heparin, porcine (pf) injection solution 5,000 unit/0.5 ml heparin, porcine (pf) injection syringe 5,000 unit/0.5 ml heparin-0.45% nacl 25,000 units/250 ml (100 units/ml) bag latex-free, inner 25,000 unit/250 ml heparin-d5w 25,000 units/250 ml (100 units/ml) bag excel container 25,000 unit/250 ml(100 unit/ml) IPRIVASK SUBCUTANEOUS RECON SOLN 15 MG jantoven oral tablet 1 mg, 10 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg PRADAXA ORAL CAPSULE 110 MG, 150 MG, 75 MG SAVAYSA ORAL TABLET 15 MG, 30 MG, 60 MG Drug Tier Requirements/Limits (Arixtra) 2 QL (15 per 30 days) (Arixtra) 2 QL (12 per 30 days) (Arixtra) 2 QL (18 per 30 days) (Heparin Sodium,Porcine/D5W) 2 (Heparin Sod,Pork In 0.45% NaCl) 2 (Heparin Sodium,Porcine/Ns/PF ) (Heparin Sodium,Porcine) 2 (Heparin Sodium,Porcine/PF) (Monoject Prefill Advanced) (Heparin Sod,Pork In 0.45% NaCl) 2 (Heparin Sodium,Porcine/D5W) 2 2 2 2 5 (Coumadin) PA; QL (24 per 28 days) 1 4 ST; QL (60 per 30 days) 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 66 Effective: July 01, 2016 Drug Name warfarin oral tablet 1 mg, 10 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg XARELTO ORAL TABLET 10 MG, 15 MG, 20 MG XARELTO ORAL TABLETS,DOSE PACK 15 MG (42)- 20 MG (9) Blood Formation Modifiers CINRYZE INTRAVENOUS RECON SOLN 500 UNIT (5 ML) EPOGEN 10,000 UNITS/ML VIAL SDV, P/F, OUTER 10,000 UNIT/ML EPOGEN INJECTION SOLUTION 2,000 UNIT/ML, 20,000 UNIT/2 ML, 20,000 UNIT/ML, 3,000 UNIT/ML, 4,000 UNIT/ML GRANIX SUBCUTANEOUS SYRINGE 300 MCG/0.5 ML, 480 MCG/0.8 ML LEUKINE INJECTION RECON SOLN 250 MCG MIRCERA INJECTION SYRINGE 100 MCG/0.3 ML, 200 MCG/0.3 ML, 50 MCG/0.3 ML, 75 MCG/0.3 ML MOZOBIL SUBCUTANEOUS SOLUTION 24 MG/1.2 ML (20 MG/ML) NEULASTA SUBCUTANEOUS SYRINGE 6 MG/0.6ML NEULASTA SUBCUTANEOUS SYRINGE, W/ WEARABLE INJECTOR 6 MG/0.6 ML NEUMEGA SUBCUTANEOUS RECON SOLN 5 MG NEUPOGEN INJECTION SOLUTION 300 MCG/ML, 480 MCG/1.6 ML Drug Tier (Coumadin) Requirements/Limits 1 3 3 5 PA 3 PA; QL (12 per 28 days) PA; QL (12 per 28 days) 3 5 5 4 PA; QL (0.6 per 28 days) 5 5 5 5 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 67 Effective: July 01, 2016 Drug Name Drug Tier NEUPOGEN INJECTION SYRINGE 300 MCG/0.5 ML, 480 MCG/0.8 ML PROCRIT 10,000 UNITS/ML VIAL 4'S, MDV, OUTER 20,000 UNIT/2 ML PROCRIT INJECTION SOLUTION 10,000 UNIT/ML, 2,000 UNIT/ML, 3,000 UNIT/ML, 4,000 UNIT/ML PROCRIT INJECTION SOLUTION 20,000 UNIT/ML PROCRIT INJECTION SOLUTION 40,000 UNIT/ML PROMACTA ORAL TABLET 12.5 MG, 25 MG, 50 MG, 75 MG ZARXIO INJECTION SYRINGE 300 MCG/0.5 ML, 480 MCG/0.8 ML Hematologic Agents, Miscellaneous aminocaproic acid oral solution 250 mg/ml (25 %) aminocaproic acid oral tablet 1,000 mg, 500 mg anagrelide oral capsule 0.5 mg, 1 mg protamine intravenous solution 10 mg/ml tranexamic acid intravenous solution 1,000 mg/10 ml (100 mg/ml) tranexamic acid oral tablet 650 mg Platelet-Aggregation Inhibitors aspirin-dipyridamole oral capsule, er multiphase 12 hr 25-200 mg BRILINTA ORAL TABLET 60 MG, 90 MG cilostazol oral tablet 100 mg, 50 mg clopidogrel oral tablet 300 mg, 75 mg dipyridamole oral tablet 25 mg, 50 mg, 75 mg 5 3 3 5 5 5 Requirements/Limits PA; QL (12 per 28 days) PA; QL (12 per 28 days) PA; QL (12 per 28 days) PA; QL (6 per 28 days) PA; QL (30 per 30 days) 5 (Aminocaproic Acid) 2 (Aminocaproic Acid) 2 (Agrylin) (Protamine Sulfate) (Tranexamic Acid) 2 2 2 (Lysteda) 2 (Aggrenox) 2 QL (30 per 30 days) 3 (Pletal) (Plavix) (Persantine) 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 68 Effective: July 01, 2016 Drug Name EFFIENT ORAL TABLET 10 MG, 5 MG pentoxifylline oral tablet extended release 400 mg Drug Tier 3 (Pentoxifylline) Requirements/Limits QL (30 per 30 days) 2 Caloric Agents Caloric Agents AMINO ACIDS 15 % INTRAVENOUS PARENTERAL SOLUTION 15 % AMINOSYN 10 % INTRAVENOUS PARENTERAL SOLUTION 10 % AMINOSYN 3.5 % INTRAVENOUS PARENTERAL SOLUTION 3.5 % AMINOSYN 7 % INTRAVENOUS PARENTERAL SOLUTION 7 % AMINOSYN 7 % WITH ELECTROLYTES INTRAVENOUS PARENTERAL SOLUTION 7 % AMINOSYN 8.5 % INTRAVENOUS PARENTERAL SOLUTION 8.5 % AMINOSYN 8.5 %-ELECTROLYTES INTRAVENOUS PARENTERAL SOLUTION 8.5 % AMINOSYN II 10 % INTRAVENOUS PARENTERAL SOLUTION 10 % AMINOSYN II 15 % INTRAVENOUS PARENTERAL SOLUTION 15 % AMINOSYN II 7 % INTRAVENOUS PARENTERAL SOLUTION 7 % AMINOSYN II 8.5 % INTRAVENOUS PARENTERAL SOLUTION 8.5 % 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 69 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits AMINOSYN II 8.5 %-ELECTROLYTES INTRAVENOUS PARENTERAL SOLUTION 8.5 % AMINOSYN M 3.5 % INTRAVENOUS PARENTERAL SOLUTION 3.5 % AMINOSYN-HBC 7% INTRAVENOUS PARENTERAL SOLUTION 7 % AMINOSYN-PF 10 % INTRAVENOUS PARENTERAL SOLUTION 10 % AMINOSYN-PF 7 % (SULFITE-FREE) INTRAVENOUS PARENTERAL SOLUTION 7 % AMINOSYN-RF 5.2 % INTRAVENOUS PARENTERAL SOLUTION 5.2 % CLINIMIX 5%/D15W SULFITE FREE INTRAVENOUS PARENTERAL SOLUTION 5 % CLINIMIX 5%/D25W SULFITE-FREE INTRAVENOUS PARENTERAL SOLUTION 5 % CLINIMIX 2.75%/D5W SULFIT FREE INTRAVENOUS PARENTERAL SOLUTION 2.75 % CLINIMIX 4.25%/D10W SULF FREE INTRAVENOUS PARENTERAL SOLUTION 4.25 % CLINIMIX 4.25%/D5W SULFIT FREE INTRAVENOUS PARENTERAL SOLUTION 4.25 % CLINIMIX 4.25%-D20W SULF-FREE INTRAVENOUS PARENTERAL SOLUTION 4.25 % 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 70 Effective: July 01, 2016 Drug Name Drug Tier CLINIMIX 4.25%-D25W SULF-FREE INTRAVENOUS PARENTERAL SOLUTION 4.25 % CLINIMIX 5%-D20W(SULFITE-FREE) INTRAVENOUS PARENTERAL SOLUTION 5 % CLINIMIX E 2.75%/D10W SUL FREE INTRAVENOUS PARENTERAL SOLUTION 2.75 % CLINIMIX E 2.75%/D5W SULF FREE INTRAVENOUS PARENTERAL SOLUTION 2.75 % CLINIMIX E 4.25%/D10W SUL FREE INTRAVENOUS PARENTERAL SOLUTION 4.25 % CLINIMIX E 4.25%/D25W SUL FREE INTRAVENOUS PARENTERAL SOLUTION 4.25 % CLINIMIX E 4.25%/D5W SULF FREE INTRAVENOUS PARENTERAL SOLUTION 4.25 % CLINIMIX E 5%/D15W SULFIT FREE INTRAVENOUS PARENTERAL SOLUTION 5 % CLINIMIX E 5%/D20W SULFIT FREE INTRAVENOUS PARENTERAL SOLUTION 5 % CLINIMIX E 5%/D25W SULFIT FREE INTRAVENOUS PARENTERAL SOLUTION 5 % CLINISOL SF 15 % INTRAVENOUS PARENTERAL SOLUTION 15 % cysteine (l-cysteine) intravenous solution (Cysteine HCl) 50 mg/ml dextrose 10 % in water (d10w) (Dextrose 10 % in intravenous parenteral solution 10 % Water) Requirements/Limits 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 2 PA BvD 2 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 71 Effective: July 01, 2016 Drug Name dextrose 20 % in water (d20w) intravenous parenteral solution 20 % dextrose 25 % in water (d25w) intravenous syringe dextrose 40 % in water (d40w) intravenous parenteral solution 40 % dextrose 5 % in ringers intravenous parenteral solution 5 % dextrose 5 % in water (d5w) intravenous parenteral solution dextrose 50 % in water (d50w) intravenous parenteral solution dextrose 50 % in water (d50w) intravenous syringe dextrose 70 % in water (d70w) intravenous parenteral solution FREAMINE HBC 6.9 % INTRAVENOUS PARENTERAL SOLUTION 6.9 % FREAMINE III 10 % INTRAVENOUS PARENTERAL SOLUTION 10 % HEPATAMINE 8% INTRAVENOUS PARENTERAL SOLUTION 8 % HEPATASOL 8 % INTRAVENOUS PARENTERAL SOLUTION 8 % INTRALIPID INTRAVENOUS EMULSION 20 %, 30 % KABIVEN INTRAVENOUS EMULSION 3.31-9.8-3.9 % LIPOSYN II INTRAVENOUS EMULSION 20 % LIPOSYN III INTRAVENOUS EMULSION 10 %, 20 %, 30 % NEPHRAMINE 5.4 % INTRAVENOUS PARENTERAL SOLUTION 5.4 % Drug Tier (Dextrose 20 % in Water) (Dextrose 25 % in Water) (Dextrose 40 % in Water) (Dextrose 5 % In Ringers) (Dextrose 5 % in Water) (Dextrose 50 % in Water) (Dextrose 50 % in Water) (Dextrose 70 % in Water) Requirements/Limits 2 PA BvD 2 PA BvD 2 PA BvD 2 2 2 PA BvD 2 PA BvD 2 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 72 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits NUTRILIPID INTRAVENOUS EMULSION 20 % PERIKABIVEN INTRAVENOUS EMULSION 2.36-6.8-3.5 % PREMASOL 10 % INTRAVENOUS PARENTERAL SOLUTION 10 % PREMASOL 6 % INTRAVENOUS PARENTERAL SOLUTION 6 % PROCALAMINE 3% INTRAVENOUS PARENTERAL SOLUTION 3 % PROSOL 20 % INTRAVENOUS PARENTERAL SOLUTION TRAVASOL 10 % INTRAVENOUS PARENTERAL SOLUTION 10 % TROPHAMINE 10 % INTRAVENOUS PARENTERAL SOLUTION 10 % TROPHAMINE 6% INTRAVENOUS PARENTERAL SOLUTION 6 % 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD 4 PA BvD Cardiovascular Agents Alpha-Adrenergic Agents clonidine hcl oral tablet 0.1 mg, 0.2 mg, 0.3 mg clonidine transdermal patch weekly 0.1 mg/24 hr, 0.2 mg/24 hr clonidine transdermal patch weekly 0.3 mg/24 hr clorpres oral tablet 0.1-15 mg, 0.2-15 mg, 0.3-15 mg doxazosin oral tablet 1 mg, 2 mg, 4 mg, 8 mg guanfacine oral tablet 1 mg, 2 mg midodrine oral tablet 10 mg, 2.5 mg, 5 mg (Catapres) 1 (Catapres-Tts 1) 2 QL (4 per 28 days) (Catapres-Tts 1) 2 QL (8 per 28 days) (Clonidine HCl/Chlorthalidone) (Cardura) 2 (Tenex) (Midodrine HCl) 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 73 Effective: July 01, 2016 Drug Name Drug Tier NORTHERA ORAL CAPSULE 100 MG, 200 MG, 300 MG phenylephrine hcl injection solution 10 mg/ml prazosin oral capsule 1 mg, 2 mg, 5 mg Angiotensin Ii Receptor Antagonists BENICAR HCT ORAL TABLET 20-12.5 MG, 40-12.5 MG, 40-25 MG BENICAR ORAL TABLET 20 MG, 40 MG, 5 MG candesartan oral tablet 16 mg, 32 mg, 4 mg, 8 mg candesartan-hydrochlorothiazid oral tablet 16-12.5 mg, 32-12.5 mg, 32-25 mg EDARBI ORAL TABLET 40 MG, 80 MG EDARBYCLOR ORAL TABLET 40-12.5 MG, 40-25 MG ENTRESTO ORAL TABLET 24-26 MG, 49-51 MG, 97-103 MG eprosartan oral tablet 600 mg irbesartan oral tablet 150 mg, 300 mg, 75 mg irbesartan-hydrochlorothiazide oral tablet 150-12.5 mg, 300-12.5 mg losartan oral tablet 100 mg, 25 mg, 50 mg losartan-hydrochlorothiazide oral tablet 100-12.5 mg, 100-25 mg, 50-12.5 mg telmisartan oral tablet 20 mg, 40 mg, 80 mg telmisartan-hydrochlorothiazid oral tablet 40-12.5 mg, 80-12.5 mg, 80-25 mg TEVETEN HCT ORAL TABLET 600-12.5 MG, 600-25 MG 5 (Vazculep) 2 (Minipress) 2 Requirements/Limits PA; QL (180 per 30 days) 3 3 (Atacand) 2 (Atacand HCT) 2 4 ST 4 ST 3 PA; QL (60 per 30 days) (Teveten) (Avapro) 2 2 (Avalide) 2 (Cozaar) 1 (Hyzaar) 2 (Micardis) 2 (Micardis HCT) 2 3 ST You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 74 Effective: July 01, 2016 Drug Name Drug Tier TRIBENZOR ORAL TABLET 20-5-12.5 MG, 40-10-12.5 MG, 40-10-25 MG, 40-5-12.5 MG, 40-5-25 MG valsartan oral tablet 160 mg, 320 mg, 40 mg, 80 mg valsartan-hydrochlorothiazide oral tablet 160-12.5 mg, 160-25 mg, 320-12.5 mg, 320-25 mg, 80-12.5 mg Angiotensin-Converting Enzyme Inhibitors benazepril oral tablet 10 mg, 20 mg, 40 mg, 5 mg benazepril-hydrochlorothiazide oral tablet 10-12.5 mg, 20-12.5 mg, 20-25 mg, 5-6.25 mg captopril oral tablet 100 mg, 12.5 mg, 25 mg, 50 mg captopril-hydrochlorothiazide oral tablet 25-15 mg, 25-25 mg, 50-15 mg, 50-25 mg enalapril maleate oral tablet 10 mg, 2.5 mg, 20 mg, 5 mg enalaprilat intravenous solution 1.25 mg/ml enalapril-hydrochlorothiazide oral tablet 10-25 mg, 5-12.5 mg fosinopril oral tablet 10 mg, 20 mg, 40 mg fosinopril-hydrochlorothiazide oral tablet 10-12.5 mg, 20-12.5 mg lisinopril oral tablet 10 mg, 2.5 mg, 20 mg, 30 mg, 40 mg, 5 mg lisinopril-hydrochlorothiazide oral tablet 10-12.5 mg, 20-12.5 mg, 20-25 mg moexipril oral tablet 15 mg, 7.5 mg moexipril-hydrochlorothiazide oral tablet 15-12.5 mg, 15-25 mg, 7.5-12.5 mg 3 (Diovan) 2 (Diovan HCT) 2 (Lotensin) 1 (Lotensin HCT) 2 (Captopril) 2 (Captopril/Hydrochlor othiazide) (Vasotec) 2 (Enalaprilat Dihydrate) 2 (Vaseretic) 2 (Fosinopril Sodium) 2 (Fosinopril/Hydrochlor othiazide) (Zestril) 2 (Zestoretic) 1 (Moexipril HCl) (Moexipril/Hydrochlor othiazide) 2 2 Requirements/Limits ST 1 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 75 Effective: July 01, 2016 Drug Name perindopril erbumine oral tablet 2 mg, 4 mg, 8 mg quinapril oral tablet 10 mg, 20 mg, 40 mg, 5 mg quinapril-hydrochlorothiazide oral tablet 10-12.5 mg, 20-12.5 mg, 20-25 mg ramipril oral capsule 1.25 mg, 10 mg, 2.5 mg, 5 mg trandolapril oral tablet 1 mg, 2 mg, 4 mg Antiarrhythmic Agents amiodarone intravenous solution 50 mg/ml amiodarone intravenous syringe 150 mg/3 ml amiodarone oral tablet 100 mg, 200 mg, 400 mg disopyramide phosphate oral capsule 100 mg, 150 mg flecainide oral tablet 100 mg, 150 mg, 50 mg lidocaine (pf) intravenous syringe 50 mg/5 ml (1 %) lidocaine in 5 % dextrose (pf) intravenous parenteral solution 8 mg/ml (0.8 %) mexiletine oral capsule 150 mg, 200 mg, 250 mg MULTAQ ORAL TABLET 400 MG pacerone oral tablet 100 mg, 200 mg, 400 mg procainamide injection solution 100 mg/ml, 500 mg/ml propafenone oral capsule,extended release 12 hr 225 mg, 325 mg, 425 mg propafenone oral tablet 150 mg, 225 mg, 300 mg Drug Tier (Aceon) 2 (Accupril) 2 (Accuretic) 2 (Altace) 2 (Mavik) 2 (Amiodarone HCl) 2 (Amiodarone HCl) 2 (Cordarone) 2 (Norpace) 2 (Tambocor) 2 (Lidocaine HCl/PF) 2 (Lidocaine HCl/D5w/PF) 2 (Mexiletine HCl) 2 (Cordarone) 3 2 (Procainamide HCl) 2 (Rythmol SR) 2 (Rythmol) 2 Requirements/Limits You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 76 Effective: July 01, 2016 Drug Name quinidine gluconate oral tablet extended release 324 mg quinidine sulfate oral tablet 200 mg, 300 mg quinidine sulfate oral tablet extended release 300 mg TIKOSYN ORAL CAPSULE 125 MCG, 250 MCG, 500 MCG Beta-Adrenergic Blocking Agents acebutolol oral capsule 200 mg, 400 mg atenolol oral tablet 100 mg, 25 mg, 50 mg atenolol-chlorthalidone oral tablet 100-25 mg, 50-25 mg betaxolol oral tablet 10 mg, 20 mg bisoprolol fumarate oral tablet 10 mg, 5 mg bisoprolol-hydrochlorothiazide oral tablet 10-6.25 mg, 2.5-6.25 mg, 5-6.25 mg BYSTOLIC ORAL TABLET 10 MG, 2.5 MG, 20 MG, 5 MG carvedilol oral tablet 12.5 mg, 25 mg, 3.125 mg, 6.25 mg esmolol intravenous solution 100 mg/10 ml (10 mg/ml) labetalol intravenous solution 5 mg/ml labetalol oral tablet 100 mg, 200 mg, 300 mg metoprolol succinate oral tablet extended release 24 hr 100 mg, 200 mg, 25 mg, 50 mg metoprolol ta-hydrochlorothiaz oral tablet 100-25 mg, 100-50 mg, 50-25 mg metoprolol tartrate intravenous solution 5 mg/5 ml metoprolol tartrate oral tablet 100 mg, 25 mg, 50 mg Drug Tier (Quinidine Gluconate) 2 (Quinidine Sulfate) 2 (Quinidine Sulfate) 2 Requirements/Limits 3 (Sectral) (Tenormin) (Tenoretic 50) 2 1 1 (Kerlone) (Zebeta) 2 2 (Ziac) 2 3 (Coreg) 1 (Brevibloc) 2 (Labetalol HCl) (Trandate) 2 2 (Toprol XL) 2 (Lopressor HCT) 2 (Lopressor) 2 (Lopressor) 1 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 77 Effective: July 01, 2016 Drug Name metoprolol tartrate oral tablet 37.5 mg, 75 mg nadolol oral tablet 20 mg, 40 mg, 80 mg pindolol oral tablet 10 mg, 5 mg propranolol intravenous solution 1 mg/ml propranolol oral capsule,extended release 24 hr 120 mg, 160 mg, 60 mg, 80 mg propranolol oral solution 20 mg/5 ml (4 mg/ml), 40 mg/5 ml (8 mg/ml) propranolol oral tablet 10 mg, 20 mg, 40 mg, 60 mg, 80 mg propranolol-hydrochlorothiazid oral tablet 40-25 mg, 80-25 mg sorine oral tablet 120 mg, 160 mg, 240 mg, 80 mg sotalol 120 mg tablet 120 mg sotalol af oral tablet 120 mg sotalol oral tablet 160 mg, 240 mg, 80 mg timolol maleate oral tablet 10 mg, 20 mg, 5 mg Calcium-Channel Blocking Agents cartia xt oral capsule,extended release 24hr 120 mg, 180 mg, 240 mg, 300 mg diltiazem 24hr er 180 mg cap 180 mg diltiazem 24hr er 360 mg cap once a day dosage 360 mg diltiazem hcl intravenous recon soln 100 mg diltiazem hcl intravenous solution 5 mg/ml diltiazem hcl oral capsule, extended release 180 mg, 360 mg, 420 mg diltiazem hcl oral capsule,extended release 12 hr 120 mg, 60 mg, 90 mg diltiazem hcl oral capsule,extended release 24hr 120 mg, 240 mg, 300 mg Drug Tier (Lopressor) 2 (Corgard) (Pindolol) (Propranolol HCl) (Inderal LA) 2 2 2 2 (Propranolol HCl) 2 (Propranolol HCl) 2 (Propranolol/Hydrochl orothiazid) (Betapace) 2 (Betapace) (Betapace) (Betapace) (Timolol Maleate) 2 2 2 2 (Cardizem CD) 2 (Cardizem CD) (Cardizem CD) 2 2 (Cardizem CD) 2 (Cardizem CD) 2 (Cardizem CD) 2 (Cardizem CD) 2 (Cardizem CD) 2 Requirements/Limits 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 78 Effective: July 01, 2016 Drug Name diltiazem hcl oral tablet 120 mg, 30 mg, 60 mg, 90 mg diltiazem hcl oral tablet extended release 24 hr 180 mg, 240 mg, 300 mg, 360 mg, 420 mg dilt-xr oral capsule,ext release degradable 120 mg, 180 mg, 240 mg matzim la oral tablet extended release 24 hr 180 mg, 240 mg, 300 mg, 360 mg, 420 mg taztia xt oral capsule, extended release 120 mg, 180 mg, 240 mg, 300 mg, 360 mg verapamil intravenous syringe 2.5 mg/ml verapamil oral capsule, 24 hr er pellet ct 100 mg, 200 mg, 300 mg verapamil oral capsule,ext rel. pellets 24 hr 120 mg, 180 mg, 240 mg, 360 mg verapamil oral tablet 120 mg, 40 mg, 80 mg verapamil oral tablet extended release 120 mg, 180 mg, 240 mg Cardiovascular Agents, Miscellaneous CORLANOR ORAL TABLET 5 MG, 7.5 MG DEMSER ORAL CAPSULE 250 MG digitek oral tablet 125 mcg, 250 mcg digox 125 mcg tablet 125 mcg digox 250 mcg tablet 250 mcg digoxin 0.25 mg/ml syringe 250 mcg/ml digoxin injection solution 250 mcg/ml DIGOXIN ORAL SOLUTION 50 MCG/ML digoxin oral tablet 125 mcg, 250 mcg Drug Tier (Cardizem CD) 1 (Cardizem LA) 2 (Cardizem CD) 2 (Cardizem CD) 2 (Cardizem CD) 2 (Verapamil HCl) (Verelan Pm) 2 2 (Verelan) 2 (Calan) 1 (Calan SR) 2 3 (Lanoxin) (Lanoxin) (Lanoxin) (Digoxin) (Digoxin) (Lanoxin) 5 2 2 2 2 2 3 2 Requirements/Limits ST QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) QL (300 per 30 days) QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 79 Effective: July 01, 2016 Drug Name dobutamine in d5w intravenous parenteral solution 1,000 mg/250 ml (4,000 mcg/ml), 250 mg/250 ml (1 mg/ml), 500 mg/250 ml (2,000 mcg/ml) dobutamine intravenous solution 250 mg/20 ml (12.5 mg/ml) dopamine in 5 % dextrose intravenous solution 200 mg/250 ml (800 mcg/ml), 400 mg/250 ml (1,600 mcg/ml), 800 mg/250 ml (3,200 mcg/ml) dopamine intravenous solution 200 mg/5 ml (40 mg/ml), 400 mg/5 ml (80 mg/ml), 800 mg/10 ml (80 mg/ml), 800 mg/5 ml (160 mg/ml) ephedrine sulfate injection solution 50 mg/ml epinephrine hcl (pf) intravenous solution 1 mg/ml (1 ml) epinephrine injection auto-injector 0.15 mg/0.15 ml, 0.3 mg/0.3 ml epinephrine injection solution 1 mg/ml (1 ml) epinephrine injection syringe 0.1 mg/ml EPIPEN 2-PAK INJECTION AUTO-INJECTOR 0.3 MG/0.3 ML EPIPEN JR 2-PAK INJECTION AUTO-INJECTOR 0.15 MG/0.3 ML ethamolin intravenous solution 5 % FIRAZYR SUBCUTANEOUS SYRINGE 30 MG/3 ML hydralazine injection solution 20 mg/ml hydralazine oral tablet 10 mg, 100 mg, 25 mg, 50 mg LANOXIN ORAL TABLET 187.5 MCG, 62.5 MCG milrinone in 5 % dextrose intravenous piggyback 40 mg/200 ml (200 mcg/ml) Drug Tier Requirements/Limits (Dobutamine HCl/D5W) 2 PA BvD (Dobutamine HCl) 2 PA BvD (Dopamine HCl/D5W) 2 PA BvD (Dopamine HCl) 2 PA BvD (Ephedrine Sulfate) 2 (Epinephrine HCl/PF) 2 (Adrenaclick) 2 (Epinephrine) 2 (Epinephrine) 2 3 3 (Ethanolamine Oleate) 2 5 (Hydralazine HCl) (Hydralazine HCl) 2 2 (Milrinone Lactate/D5W) 4 QL (30 per 30 days) 5 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 80 Effective: July 01, 2016 Drug Name milrinone intravenous solution 1 mg/ml norepinephrine bitartrate intravenous solution 1 mg/ml papaverine injection solution 30 mg/ml papaverine oral capsule, extended release 150 mg RANEXA ORAL TABLET EXTENDED RELEASE 12 HR 1,000 MG, 500 MG Dihydropyridines afeditab cr oral tablet extended release 30 mg, 60 mg amlodipine oral tablet 10 mg, 2.5 mg, 5 mg amlodipine-benazepril oral capsule 10-20 mg, 10-40 mg, 2.5-10 mg, 5-10 mg, 5-20 mg, 5-40 mg amlodipine-valsartan oral tablet 10-160 mg, 10-320 mg, 5-160 mg, 5-320 mg amlodipine-valsartan-hcthiazid oral tablet 10-160-12.5 mg, 10-160-25 mg, 10-320-25 mg, 5-160-12.5 mg, 5-160-25 mg AZOR ORAL TABLET 10-20 MG, 10-40 MG, 5-20 MG, 5-40 MG CLEVIPREX INTRAVENOUS EMULSION 50 MG/100 ML felodipine oral tablet extended release 24 hr 10 mg, 2.5 mg, 5 mg isradipine oral capsule 2.5 mg, 5 mg nicardipine oral capsule 20 mg, 30 mg nifedical xl oral tablet extended release 24hr 30 mg, 60 mg nifedipine er 30 mg tablet f/c 30 mg nifedipine oral tablet extended release 24hr 30 mg Drug Tier Requirements/Limits (Milrinone Lactate) (Levophed Bitartrate) 5 2 PA BvD PA BvD (Papaverine HCl) (Papaverine HCl) 2 2 PA PA 3 (Adalat CC) 2 (Norvasc) 1 (Lotrel) 2 (Exforge) 2 (Exforge HCT) 2 3 ST 4 (Felodipine) 2 (Isradipine) (Nicardipine HCl) (Procardia XL) 2 2 2 (Adalat CC) (Adalat CC) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 81 Effective: July 01, 2016 Drug Name nifedipine oral tablet extended release 24hr 60 mg, 90 mg Diuretics amiloride oral tablet 5 mg amiloride-hydrochlorothiazide oral tablet 5-50 mg bumetanide injection solution 0.25 mg/ml bumetanide oral tablet 0.5 mg, 1 mg, 2 mg chlorothiazide oral tablet 250 mg, 500 mg chlorothiazide sodium intravenous recon soln 500 mg chlorthalidone oral tablet 25 mg, 50 mg DYRENIUM ORAL CAPSULE 100 MG, 50 MG furosemide injection solution 10 mg/ml furosemide injection syringe 10 mg/ml furosemide oral solution 10 mg/ml, 40 mg/5 ml (8 mg/ml) furosemide oral tablet 20 mg, 40 mg, 80 mg hydrochlorothiazide oral capsule 12.5 mg hydrochlorothiazide oral tablet 12.5 mg, 25 mg, 50 mg indapamide oral tablet 1.25 mg, 2.5 mg methyclothiazide oral tablet 5 mg metolazone oral tablet 10 mg, 2.5 mg, 5 mg torsemide oral tablet 10 mg, 100 mg, 20 mg, 5 mg triamterene-hydrochlorothiazid oral capsule 37.5-25 mg, 50-25 mg triamterene-hydrochlorothiazid oral tablet 37.5-25 mg, 75-50 mg Drug Tier (Procardia XL) 2 (Amiloride HCl) (Amiloride/Hydrochlor othiazide) (Bumetanide) (Bumetanide) 2 2 (Chlorothiazide) (Sodium Diuril) 1 2 (Chlorthalidone) 1 4 (Furosemide) (Furosemide) (Furosemide) 2 2 2 (Lasix) 1 (Microzide) (Hydrochlorothiazide) 1 1 (Indapamide) (Methyclothiazide) (Zaroxolyn) 1 2 2 (Demadex) 2 (Dyazide) 2 (Maxzide) 2 Requirements/Limits 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 82 Effective: July 01, 2016 Drug Name Dyslipidemics ALTOPREV ORAL TABLET EXTENDED RELEASE 24 HR 20 MG, 40 MG, 60 MG amlodipine-atorvastatin oral tablet 10-10 mg, 10-20 mg, 10-40 mg, 10-80 mg, 2.5-10 mg, 2.5-20 mg, 2.5-40 mg, 5-10 mg, 5-20 mg, 5-40 mg, 5-80 mg atorvastatin oral tablet 10 mg, 20 mg, 40 mg, 80 mg cholestyramine light oral powder in packet 4 gram cholestyramine packet 4 gram colestipol hcl granules packet 5 gram colestipol oral granules 5 gram colestipol oral tablet 1 gram CRESTOR ORAL TABLET 10 MG, 20 MG, 40 MG, 5 MG fenofibrate micronized oral capsule 130 mg, 134 mg, 200 mg, 43 mg, 67 mg fenofibrate nanocrystallized oral tablet 145 mg, 48 mg fenofibrate oral tablet 120 mg, 160 mg, 40 mg, 54 mg fenofibric acid (choline) oral capsule,delayed release(dr/ec) 135 mg, 45 mg fenofibric acid oral tablet 105 mg, 35 mg fluvastatin oral capsule 20 mg, 40 mg gemfibrozil oral tablet 600 mg JUXTAPID ORAL CAPSULE 10 MG, 20 MG, 30 MG, 40 MG, 5 MG, 60 MG KYNAMRO SUBCUTANEOUS SYRINGE 200 MG/ML lovastatin oral tablet 10 mg, 20 mg, 40 mg Drug Tier Requirements/Limits 4 (Caduet) 2 (Lipitor) 1 (Questran) 2 (Questran) (Colestid) (Colestid) (Colestid) 2 2 2 2 2 (Lofibra) 2 (Tricor) 2 (Lofibra) 2 (Trilipix) 2 (Fibricor) (Lescol) (Lopid) 2 2 2 5 PA 5 PA; QL (4 per 28 days) (Mevacor) 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 83 Effective: July 01, 2016 Drug Name niacin oral tablet extended release 24 hr 1,000 mg, 500 mg, 750 mg niacor oral tablet 500 mg omega-3 acid ethyl esters oral capsule 1 gram PRALUENT PEN SUBCUTANEOUS PEN INJECTOR 150 MG/ML, 75 MG/ML PRALUENT SYRINGE SUBCUTANEOUS SYRINGE 150 MG/ML, 75 MG/ML pravastatin oral tablet 10 mg, 20 mg, 40 mg, 80 mg prevalite oral powder 4 gram prevalite packet outer 4 gram REPATHA SURECLICK SUBCUTANEOUS PEN INJECTOR 140 MG/ML REPATHA SYRINGE SUBCUTANEOUS SYRINGE 140 MG/ML simvastatin oral tablet 10 mg, 20 mg, 40 mg, 5 mg simvastatin oral tablet 80 mg VASCEPA ORAL CAPSULE 1 GRAM VYTORIN 10-10 ORAL TABLET 10-10 MG VYTORIN 10-20 ORAL TABLET 10-20 MG VYTORIN 10-40 ORAL TABLET 10-40 MG VYTORIN 10-80 ORAL TABLET 10-80 MG Drug Tier (Niaspan) 2 (Niacin) (Lovaza) 2 2 Requirements/Limits 5 PA; QL (2 per 28 days) 5 PA; QL (2 per 28 days) (Pravachol) 1 (Cholestyramine/Aspar tame) (Cholestyramine/Aspar tame) 2 2 5 PA; QL (3 per 28 days) 5 PA; QL (3 per 28 days) (Zocor) 1 (Zocor) 1 3 QL (30 per 30 days) 4 4 4 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 84 Effective: July 01, 2016 Drug Name Drug Tier WELCHOL ORAL POWDER IN PACKET 3.75 GRAM WELCHOL ORAL TABLET 625 MG ZETIA ORAL TABLET 10 MG Renin-Angiotensin-Aldosterone System Inhibitors eplerenone oral tablet 25 mg, 50 mg spironolactone oral tablet 100 mg, 25 mg, 50 mg spironolacton-hydrochlorothiaz oral tablet 25-25 mg Vasodilators BIDIL ORAL TABLET 20-37.5 MG isosorbide dinitrate oral tablet 10 mg, 20 mg, 30 mg, 5 mg isosorbide dinitrate oral tablet extended release 40 mg isosorbide dinitrate sublingual tablet 2.5 mg, 5 mg isosorbide mononitrate oral tablet 10 mg, 20 mg isosorbide mononitrate oral tablet extended release 24 hr 120 mg, 30 mg, 60 mg minitran transdermal patch 24 hour 0.1 mg/hr, 0.2 mg/hr, 0.6 mg/hr minitran transdermal patch 24 hour 0.4 mg/hr minoxidil oral tablet 10 mg, 2.5 mg NITRO-BID TRANSDERMAL OINTMENT 2 % nitroglycerin in 5 % dextrose intravenous solution 100 mg/250 ml (400 mcg/ml), 25 mg/250 ml (100 mcg/ml), 50 mg/250 ml (200 mcg/ml) nitroglycerin intravenous solution 50 mg/10 ml (5 mg/ml) 3 Requirements/Limits 3 4 (Inspra) (Aldactone) 2 2 (Aldactazide) 2 (Isochron) 3 2 (Isochron) 2 (Isosorbide Dinitrate) 1 (Isosorbide Mononitrate) (Imdur) 2 (Nitro-Dur) 2 QL (30 per 30 days) (Nitro-Dur) 2 QL (60 per 30 days) (Minoxidil) 2 2 (Nitroglycerin/D5W) 2 (Nitroglycerin) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 85 Effective: July 01, 2016 Drug Name nitroglycerin transdermal patch 24 hour 0.1 mg/hr, 0.2 mg/hr, 0.6 mg/hr nitroglycerin transdermal patch 24 hour 0.4 mg/hr NITROSTAT SUBLINGUAL TABLET 0.3 MG, 0.4 MG, 0.6 MG PROGLYCEM ORAL SUSPENSION 50 MG/ML Drug Tier Requirements/Limits (Nitro-Dur) 2 QL (30 per 30 days) (Nitro-Dur) 2 QL (60 per 30 days) 3 4 Central Nervous System Agents Central Nervous System Agents AMPYRA ORAL TABLET EXTENDED RELEASE 12 HR 10 MG caffeine citrated intravenous solution 60 mg/3 ml (20 mg/ml) caffeine citrated oral solution 60 mg/3 ml (20 mg/ml) caffeine-sodium benzoate injection solution 250 mg/ml (125 mg/ml caffeine) clonidine hcl oral tablet extended release 12 hr 0.1 mg dexmethylphenidate oral tablet 10 mg, 2.5 mg, 5 mg dextroamphetamine oral capsule, extended release 10 mg, 15 mg, 5 mg dextroamphetamine oral tablet 10 mg, 5 mg dextroamphetamine-amphetamine oral capsule,extended release 24hr 10 mg, 15 mg, 5 mg dextroamphetamine-amphetamine oral capsule,extended release 24hr 20 mg, 25 mg, 30 mg dextroamphetamine-amphetamine oral tablet 10 mg, 12.5 mg, 15 mg, 20 mg, 30 mg, 5 mg, 7.5 mg flumazenil intravenous solution 0.1 mg/ml 5 PA; QL (60 per 30 days) (Cafcit) 2 (Cafcit) 2 (Caffeine/Sodium Benzoate) (Kapvay) 2 (Focalin) 2 QL (60 per 30 days) (Dexedrine) 2 QL (120 per 30 days) (Dexedrine) 2 QL (180 per 30 days) (Adderall XR) 2 QL (30 per 30 days) (Adderall XR) 2 QL (60 per 30 days) (Adderall) 2 QL (60 per 30 days) (Romazicon) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 86 Effective: July 01, 2016 Drug Name guanfacine oral tablet extended release 24 hr 1 mg, 2 mg, 3 mg, 4 mg lithium carbonate oral capsule 150 mg, 300 mg, 600 mg lithium carbonate oral tablet 300 mg lithium carbonate oral tablet extended release 300 mg, 450 mg lithium citrate oral solution 8 meq/5 ml methylphenidate cd 20 mg cap 20 mg methylphenidate cd 40 mg cap 40 mg methylphenidate oral capsule, er biphasic 30-70 10 mg, 50 mg, 60 mg methylphenidate oral capsule, er biphasic 30-70 30 mg methylphenidate oral capsule,er biphasic 50-50 20 mg, 40 mg methylphenidate oral solution 10 mg/5 ml, 5 mg/5 ml methylphenidate oral tablet 10 mg, 20 mg, 5 mg methylphenidate oral tablet extended release 10 mg, 20 mg methylphenidate oral tablet extended release 24hr 18 mg, 27 mg, 54 mg methylphenidate oral tablet extended release 24hr 36 mg NUEDEXTA ORAL CAPSULE 20-10 MG QUILLIVANT XR ORAL SUSPENSION,EXT REL 24HR,RECON 5 MG/ML (25 MG/5 ML) riluzole oral tablet 50 mg SAVELLA ORAL TABLET 100 MG, 12.5 MG, 25 MG, 50 MG Drug Tier Requirements/Limits (Intuniv) 2 (Lithium Carbonate) 2 (Lithobid) (Lithobid) 2 2 (Lithium Citrate) (Metadate Cd) (Metadate Cd) (Metadate Cd) 2 2 2 2 QL (30 per 30 days) QL (30 per 30 days) QL (30 per 30 days) (Metadate Cd) 2 QL (60 per 30 days) (Metadate Cd) 2 QL (30 per 30 days) (Methylin) 2 QL (900 per 30 days) (Ritalin) 2 QL (90 per 30 days) (Methylphenidate HCl) 2 QL (90 per 30 days) (Concerta) 2 QL (30 per 30 days) (Concerta) 2 QL (60 per 30 days) 3 QL (60 per 30 days) 3 (Rilutek) 2 3 QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 87 Effective: July 01, 2016 Drug Name Drug Tier SAVELLA ORAL TABLETS,DOSE PACK 12.5 MG (5)-25 MG(8)-50 MG(42) STRATTERA ORAL CAPSULE 10 MG, 100 MG, 18 MG, 25 MG, 40 MG, 60 MG, 80 MG tetrabenazine oral tablet 12.5 mg, 25 mg (Xenazine) 3 Requirements/Limits QL (60 per 30 days) 3 5 PA; QL (112 per 28 days) Contraceptives Contraceptives altavera (28) oral tablet 0.15-0.03 mg alyacen 1/35 (28) oral tablet 1-35 mg-mcg alyacen 7/7/7 (28) oral tablet 0.5/0.75/1 mg- 35 mcg amethia lo oral tablets,dose pack,3 month 0.10 mg-20 mcg (84)/10 mcg (7) amethia oral tablets,dose pack,3 month 0.15 mg-30 mcg (84)/10 mcg (7) apri oral tablet 0.15-0.03 mg aranelle (28) oral tablet 0.5/1/0.5-35 mg-mcg ashlyna oral tablets,dose pack,3 month 0.15 mg-30 mcg (84)/10 mcg (7) aubra oral tablet 0.1-20 mg-mcg aviane oral tablet 0.1-20 mg-mcg azurette (28) oral tablet 0.15-0.02 mgx21 /0.01 mg x 5 balziva (28) oral tablet 0.4-35 mg-mcg bekyree (28) oral tablet 0.15-0.02 mgx21 /0.01 mg x 5 blisovi 24 fe oral tablet 1 mg-20 mcg (24)/75 mg (4) blisovi fe 1.5/30 (28) oral tablet 1.5 mg-30 mcg (21)/75 mg (7) (Amethyst) (Modicon) 2 2 (Modicon) 2 (Seasonique) 2 QL (91 per 84 days) (Seasonique) 2 QL (91 per 84 days) (Desogen) (Modicon) 2 2 (Seasonique) 2 (Amethyst) (Amethyst) (Mircette) 2 2 2 (Modicon) (Mircette) 2 2 (Loestrin Fe) 2 (Loestrin Fe) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 88 Effective: July 01, 2016 Drug Name blisovi fe 1/20 (28) oral tablet 1 mg-20 mcg (21)/75 mg (7) briellyn oral tablet 0.4-35 mg-mcg camila oral tablet 0.35 mg camrese lo oral tablets,dose pack,3 month 0.10 mg-20 mcg (84)/10 mcg (7) camrese oral tablets,dose pack,3 month 0.15 mg-30 mcg (84)/10 mcg (7) caziant (28) oral tablet 0.1/.125/.15-25 mg-mcg cryselle (28) oral tablet 0.3-30 mg-mcg cyclafem 1/35 (28) oral tablet 1-35 mg-mcg cyclafem 7/7/7 (28) oral tablet 0.5/0.75/1 mg- 35 mcg cyred oral tablet 0.15-0.03 mg dasetta 1/35 (28) oral tablet 1-35 mg-mcg dasetta 7/7/7 (28) oral tablet 0.5/0.75/1 mg- 35 mcg daysee oral tablets,dose pack,3 month 0.15 mg-30 mcg (84)/10 mcg (7) deblitane oral tablet 0.35 mg delyla (28) oral tablet 0.1-20 mg-mcg desog-e.estradiol/e.estradiol oral tablet 0.15-0.02 mgx21 /0.01 mg x 5 desogestrel-ethinyl estradiol oral tablet 0.15-0.03 mg drospirenone-ethinyl estradiol oral tablet 3-0.02 mg, 3-0.03 mg elinest oral tablet 0.3-30 mg-mcg ELLA ORAL TABLET 30 MG emoquette oral tablet 0.15-0.03 mg Drug Tier Requirements/Limits (Loestrin Fe) 2 (Modicon) (Nor-Q-D) (Seasonique) 2 2 2 QL (91 per 84 days) (Seasonique) 2 QL (91 per 84 days) (Desogen) 2 (Norgestrel-Ethinyl Estradiol) (Modicon) 2 (Modicon) 2 (Desogen) (Modicon) 2 2 (Modicon) 2 (Seasonique) 2 (Nor-Q-D) (Amethyst) (Mircette) 2 2 2 (Desogen) 2 (Yaz) 2 (Norgestrel-Ethinyl Estradiol) 2 (Desogen) 2 4 2 QL (91 per 84 days) QL (6 per 365 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 89 Effective: July 01, 2016 Drug Name enpresse oral tablet 50-30 (6)/75-40 (5)/125-30(10) enskyce oral tablet 0.15-0.03 mg errin oral tablet 0.35 mg estarylla oral tablet 0.25-35 mg-mcg falmina (28) oral tablet 0.1-20 mg-mcg gianvi (28) oral tablet 3-0.02 mg gildagia oral tablet 0.4-35 mg-mcg gildess 1.5/30 (21) oral tablet 1.5-30 mg-mcg gildess 1/20 (21) oral tablet 1-20 mg-mcg gildess 24 fe oral tablet 1 mg-20 mcg (24)/75 mg (4) gildess fe 1.5/30 (28) oral tablet 1.5 mg-30 mcg (21)/75 mg (7) gildess fe 1/20 (28) oral tablet 1 mg-20 mcg (21)/75 mg (7) heather oral tablet 0.35 mg introvale oral tablets,dose pack,3 month 0.15-30 mg-mcg jencycla oral tablet 0.35 mg jolessa oral tablets,dose pack,3 month 0.15-30 mg-mcg jolivette oral tablet 0.35 mg juleber oral tablet 0.15-0.03 mg junel 1.5/30 (21) oral tablet 1.5-30 mg-mcg junel 1/20 (21) oral tablet 1-20 mg-mcg junel fe 1.5/30 (28) oral tablet 1.5 mg-30 mcg (21)/75 mg (7) junel fe 1/20 (28) oral tablet 1 mg-20 mcg (21)/75 mg (7) junel fe 24 oral tablet 1 mg-20 mcg (24)/75 mg (4) kariva (28) oral tablet 0.15-0.02 mgx21 /0.01 mg x 5 Drug Tier Requirements/Limits (Amethyst) 2 (Desogen) (Nor-Q-D) (Ortho-Cyclen) (Amethyst) (Yaz) (Modicon) (Loestrin) 2 2 2 2 2 2 2 (Loestrin) (Loestrin Fe) 2 2 (Loestrin Fe) 2 (Loestrin Fe) 2 (Nor-Q-D) (Levonorgestrel-Ethin Estradiol) (Nor-Q-D) (Levonorgestrel-Ethin Estradiol) (Nor-Q-D) (Desogen) (Loestrin) 2 2 QL (91 per 84 days) 2 2 QL (91 per 84 days) (Loestrin) (Loestrin Fe) 2 2 (Loestrin Fe) 2 (Loestrin Fe) 2 (Mircette) 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 90 Effective: July 01, 2016 Drug Name kelnor 1/35 (28) oral tablet 1-35 mg-mcg kimidess (28) oral tablet 0.15-0.02 mgx21 /0.01 mg x 5 kurvelo oral tablet 0.15-0.03 mg l norgest/e.estradiol-e.estrad oral tablets,dose pack,3 month 0.10 mg-20 mcg (84)/10 mcg (7), 0.15 mg-30 mcg (84)/10 mcg (7) larin 1.5/30 (21) oral tablet 1.5-30 mg-mcg larin 1/20 (21) oral tablet 1-20 mg-mcg larin 24 fe oral tablet 1 mg-20 mcg (24)/75 mg (4) larin fe 1.5/30 (28) oral tablet 1.5 mg-30 mcg (21)/75 mg (7) larin fe 1/20 (28) oral tablet 1 mg-20 mcg (21)/75 mg (7) leena 28 oral tablet 0.5/1/0.5-35 mg-mcg lessina oral tablet 0.1-20 mg-mcg levonest (28) oral tablet 50-30 (6)/75-40 (5)/125-30(10) levonor-eth estrad 0.15-0.03 outer 0.15-0.03 mg levonorgestrel oral tablet 0.75 mg levonorgestrel oral tablet 1.5 mg levonorgestrel-ethinyl estrad oral tablet 0.1-20 mg-mcg levonorgestrel-ethinyl estrad oral tablets,dose pack,3 month 0.15-30 mg-mcg levonorg-eth estrad triphasic oral tablet 50-30 (6)/75-40 (5)/125-30(10) levora-28 oral tablet 0.15-0.03 mg lomedia 24 fe oral tablet 1 mg-20 mcg (24)/75 mg (4) loryna (28) oral tablet 3-0.02 mg Drug Tier Requirements/Limits (Demulen 1-50-21) (Mircette) 2 2 (Amethyst) (Seasonique) 2 2 (Loestrin) 2 (Loestrin) (Loestrin Fe) 2 2 (Loestrin Fe) 2 (Loestrin Fe) 2 (Modicon) (Amethyst) (Amethyst) 2 2 2 (Amethyst) 2 QL (91 per 84 days) (Plan B One-Step) (Plan B One-Step) (Amethyst) 2 2 2 QL (12 per 365 days) QL (6 per 365 days) (Amethyst) 2 QL (91 per 84 days) (Amethyst) 2 QL (91 per 84 days) (Amethyst) (Loestrin Fe) 2 2 (Yaz) 2 QL (91 per 84 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 91 Effective: July 01, 2016 Drug Name low-ogestrel (28) oral tablet 0.3-30 mg-mcg lutera (28) oral tablet 0.1-20 mg-mcg lyza oral tablet 0.35 mg marlissa oral tablet 0.15-0.03 mg microgestin 1.5/30 (21) oral tablet 1.5-30 mg-mcg microgestin 1/20 (21) oral tablet 1-20 mg-mcg microgestin fe 1.5/30 (28) oral tablet 1.5 mg-30 mcg (21)/75 mg (7) microgestin fe 1/20 (28) oral tablet 1 mg-20 mcg (21)/75 mg (7) mono-linyah oral tablet 0.25-35 mg-mcg mononessa (28) oral tablet 0.25-35 mg-mcg myzilra oral tablet 50-30 (6)/75-40 (5)/125-30(10) necon 0.5/35 (28) oral tablet 0.5-35 mg-mcg necon 1/35 (28) oral tablet 1-35 mg-mcg necon 1/50 (28) oral tablet 1-50 mg-mcg necon 10/11 (28) oral tablet 0.5-35/1-35 mg-mcg/mg-mcg necon 7/7/7 (28) oral tablet 0.5/0.75/1 mg- 35 mcg next choice one dose oral tablet 1.5 mg nikki (28) oral tablet 3-0.02 mg nora-be oral tablet 0.35 mg norethindrone (contraceptive) oral tablet 0.35 mg norethindrone ac-eth estradiol oral tablet 1-20 mg-mcg norethindrone-e.estradiol-iron oral tablet 1 mg-20 mcg (24)/75 mg (4) Drug Tier (Norgestrel-Ethinyl Estradiol) (Amethyst) (Nor-Q-D) (Amethyst) (Loestrin) 2 (Loestrin) 2 (Loestrin Fe) 2 (Loestrin Fe) 2 (Ortho-Cyclen) (Ortho-Cyclen) 2 2 (Amethyst) 2 (Modicon) 2 (Modicon) (Norinyl 1+50) (Modicon) 2 2 2 (Modicon) 2 (Plan B One-Step) (Yaz) (Nor-Q-D) (Nor-Q-D) 2 2 2 2 (Loestrin) 2 (Loestrin Fe) 2 Requirements/Limits 2 2 2 2 QL (6 per 365 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 92 Effective: July 01, 2016 Drug Name norg-ee 0.18-0.215-0.25/0.035 0.18/0.215/0.25 mg-35 mcg (28) norgestimate-ethinyl estradiol oral tablet 0.18/0.215/0.25 mg-25 mcg, 0.25-35 mg-mcg norlyroc oral tablet 0.35 mg nortrel 0.5/35 (28) oral tablet 0.5-35 mg-mcg nortrel 1/35 (21) oral tablet 1-35 mg-mcg nortrel 1/35 (28) oral tablet 1-35 mg-mcg nortrel 7/7/7 (28) oral tablet 0.5/0.75/1 mg- 35 mcg NUVARING VAGINAL RING 0.12-0.015 MG/24 HR ocella oral tablet 3-0.03 mg ogestrel (28) oral tablet 0.5-50 mg-mcg Drug Tier (Ortho-Cyclen) 2 (Ortho-Cyclen) 2 (Nor-Q-D) (Modicon) 2 2 (Modicon) 2 (Modicon) 2 (Modicon) 2 3 (Yaz) (Norgestrel-Ethinyl Estradiol) orsythia oral tablet 0.1-20 mg-mcg (Amethyst) philith oral tablet 0.4-35 mg-mcg (Modicon) pimtrea (28) oral tablet 0.15-0.02 mgx21 (Mircette) /0.01 mg x 5 pirmella oral tablet 0.5/0.75/1 mg- 35 (Modicon) mcg, 1-35 mg-mcg portia oral tablet 0.15-0.03 mg (Amethyst) previfem oral tablet 0.25-35 mg-mcg (Ortho-Cyclen) quasense oral tablets,dose pack,3 month (Levonorgestrel-Ethin 0.15-30 mg-mcg Estradiol) reclipsen (28) oral tablet 0.15-0.03 mg (Desogen) setlakin oral tablets,dose pack,3 month (Levonorgestrel-Ethin 0.15-30 mg-mcg Estradiol) sharobel oral tablet 0.35 mg (Nor-Q-D) sprintec (28) oral tablet 0.25-35 mg-mcg (Ortho-Cyclen) sronyx oral tablet 0.1-20 mg-mcg (Amethyst) syeda oral tablet 3-0.03 mg (Yaz) Requirements/Limits QL (1 per 28 days) 2 2 2 2 2 2 2 2 2 QL (91 per 84 days) 2 2 QL (91 per 84 days) 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 93 Effective: July 01, 2016 Drug Name tarina fe 1/20 (28) oral tablet 1 mg-20 mcg (21)/75 mg (7) tilia fe oral tablet 1-20(5)/1-30(7) /1mg-35mcg (9) tri-estarylla oral tablet 0.18/0.215/0.25 mg-35 mcg (28) tri-legest fe oral tablet 1-20(5)/1-30(7) /1mg-35mcg (9) tri-linyah oral tablet 0.18/0.215/0.25 mg-35 mcg (28) tri-lo-estarylla oral tablet 0.18/0.215/0.25 mg-25 mcg tri-lo-marzia oral tablet 0.18/0.215/0.25 mg-25 mcg tri-lo-sprintec oral tablet 0.18/0.215/0.25 mg-25 mcg trinessa (28) oral tablet 0.18/0.215/0.25 mg-35 mcg (28) tri-previfem (28) oral tablet 0.18/0.215/0.25 mg-35 mcg (28) tri-sprintec (28) oral tablet 0.18/0.215/0.25 mg-35 mcg (28) trivora (28) oral tablet 50-30 (6)/75-40 (5)/125-30(10) velivet triphasic regimen (28) oral tablet 0.1/.125/.15-25 mg-mcg vestura (28) oral tablet 3-0.02 mg vienva oral tablet 0.1-20 mg-mcg viorele (28) oral tablet 0.15-0.02 mgx21 /0.01 mg x 5 vyfemla (28) oral tablet 0.4-35 mg-mcg wera (28) oral tablet 0.5-35 mg-mcg wymzya fe oral tablet,chewable 0.4mg-35mcg(21) and 75 mg (7) xulane transdermal patch weekly 150-35 mcg/24 hr Drug Tier (Loestrin Fe) 2 (Loestrin Fe) 2 (Ortho-Cyclen) 2 (Loestrin Fe) 2 (Ortho-Cyclen) 2 (Ortho-Cyclen) 2 (Ortho-Cyclen) 2 (Ortho-Cyclen) 2 (Ortho-Cyclen) 2 (Ortho-Cyclen) 2 (Ortho-Cyclen) 2 (Amethyst) 2 (Desogen) 2 (Yaz) (Amethyst) (Mircette) 2 2 2 (Modicon) (Modicon) (Femcon Fe) 2 2 2 (Ortho Evra) 2 Requirements/Limits QL (3 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 94 Effective: July 01, 2016 Drug Name zarah oral tablet 3-0.03 mg zenchent (28) oral tablet 0.4-35 mg-mcg zenchent fe oral tablet,chewable 0.4mg-35mcg(21) and 75 mg (7) zeosa oral tablet,chewable 0.4mg-35mcg(21) and 75 mg (7) zovia 1/35e (28) oral tablet 1-35 mg-mcg zovia 1/50e (28) oral tablet 1-50 mg-mcg Drug Tier (Yaz) (Modicon) (Femcon Fe) 2 2 2 (Femcon Fe) 2 (Demulen 1-50-21) (Demulen 1-50-21) 2 2 (Evoxac) (Peridex) 2 2 (Triamcinolone Acetonide) (Peridex) 2 (Salagen) (Sodium Fluoride) 2 2 (Triamcinolone Acetonide) 2 Requirements/Limits Dental And Oral Agents Dental And Oral Agents cevimeline oral capsule 30 mg chlorhexidine gluconate mucous membrane mouthwash 0.12 % oralone dental paste 0.1 % periogard mucous membrane mouthwash 0.12 % pilocarpine hcl oral tablet 5 mg, 7.5 mg sodium fluoride oral tablet,chewable 0.25 mg fluorid (0.55 mg) triamcinolone acetonide dental paste 0.1 % 2 Dermatological Agents Dermatological Agents, Other 8-MOP ORAL CAPSULE 10 MG acitretin oral capsule 10 mg, 17.5 mg, 25 mg acyclovir topical ointment 5 % ALCOHOL PADS TOPICAL PADS, MEDICATED ALCOHOL PREP PADS ammonium lactate topical cream 12 % ammonium lactate topical lotion 12 % ANACAINE TOPICAL OINTMENT 10 % calcipotriene scalp solution 0.005 % (Soriatane) (Zovirax) 4 5 2 1 (Lac-Hydrin) (Lac-Hydrin) 1 2 2 4 (Calcipotriene) 2 QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 95 Effective: July 01, 2016 Drug Name Drug Tier calcipotriene topical cream 0.005 % calcipotriene topical ointment 0.005 % calcitrene topical ointment 0.005 % calcitriol topical ointment 3 mcg/gram CONDYLOX TOPICAL GEL 0.5 % COSENTYX (150 MG/ML) 300 MG DOSE-2 PENS 150 MG/ML COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES 150 MG/ML COSENTYX PEN SUBCUTANEOUS PEN INJECTOR 150 MG/ML COSENTYX SUBCUTANEOUS SYRINGE 150 MG/ML DENAVIR TOPICAL CREAM 1 % fluorouracil topical cream 0.5 %, 5 % fluorouracil topical solution 2 %, 5 % imiquimod topical cream in packet 5 % (Dovonex) (Calcipotriene) (Calcipotriene) (Vectical) methoxsalen rapid oral capsule 10 mg PANRETIN TOPICAL GEL 0.1 % PICATO TOPICAL GEL 0.015 % PICATO TOPICAL GEL 0.05 % podocon topical liquid 25 % podofilox topical solution 0.5 % potassium hydroxide topical solution 5 % REGRANEX TOPICAL GEL 0.01 % (Oxsoralen-Ultra) (Carac) (Fluorouracil) (Aldara) (Podophyllum Resin) (Condylox) (Potassium Hydroxide) SANTYL TOPICAL OINTMENT 250 UNIT/GRAM TALTZ AUTOINJECTOR SUBCUTANEOUS AUTO-INJECTOR 80 MG/ML TALTZ SYRINGE SUBCUTANEOUS SYRINGE 80 MG/ML TOLAK TOPICAL CREAM 4 % Requirements/Limits 2 2 2 2 4 5 PA 5 PA 5 PA 5 PA 4 2 2 2 5 5 3 3 2 2 2 4 PA NSO; QL (24 per 30 days) QL (3 per 56 days) QL (2 per 56 days) PA; QL (30 per 30 days) 4 5 PA 5 PA 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 96 Effective: July 01, 2016 Drug Name Drug Tier VALCHLOR TOPICAL GEL 0.016 % VEREGEN TOPICAL OINTMENT 15 % zenatane oral capsule 10 mg, 20 mg, 30 mg, 40 mg ZOVIRAX TOPICAL CREAM 5 % Dermatological Antibacterials clindamycin phosphate topical foam 1 % clindamycin phosphate topical gel 1 % clindamycin phosphate topical lotion 1 % clindamycin phosphate topical solution 1 % clindamycin phosphate topical swab 1 % clindamycin-benzoyl peroxide topical gel 1-5 %, 1.2 %(1 % base) -5 % ery pads topical swab 2 % 5 4 (Isotretinoin) 2 3 (Evoclin) (Cleocin T) (Cleocin T) (Cleocin T) 2 2 2 2 (Cleocin T) (Duac) 2 2 (Erythromycin Base/Ethanol) erythromycin with ethanol topical gel 2 % (Emgel) erythromycin with ethanol topical (Erythromycin solution 2 % Base/Ethanol) erythromycin with ethanol topical swab 2 (Erythromycin % Base/Ethanol) erythromycin-benzoyl peroxide topical (Benzamycin) gel 3-5 % gentamicin topical cream 0.1 % (Gentamicin Sulfate) gentamicin topical ointment 0.1 % (Gentamicin Sulfate) metronidazole topical cream 0.75 % (Metrocream) metronidazole topical gel 0.75 %, 1 % (Rosadan) metronidazole topical lotion 0.75 % (Metrolotion) mupirocin calcium topical cream 2 % (Bactroban) mupirocin topical ointment 2 % (Centany) neomycin-polymyxin b gu irrigation (Neosporin G.U. solution 40 mg-200,000 unit/ml Irrigant) neuac topical gel 1.2 %(1 % base) -5 % (Duac) rosadan topical cream 0.75 % (Metrocream) selenium sulfide topical lotion 2.5 % (Selenium Sulfide) Requirements/Limits QL (15 per 30 days) 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 97 Effective: July 01, 2016 Drug Name selenium sulfide topical shampoo 2.25 % silver nitrate topical ointment 10 % silver nitrate topical solution 0.5 %, 10 %, 25 %, 50 % silver sulfadiazine topical cream 1 % ssd topical cream 1 % sulfacetamide sodium (acne) topical suspension 10 % Dermatological Anti-Inflammatory Agents ala-cort topical cream 1 % ala-scalp topical lotion 2 % alclometasone topical cream 0.05 % Drug Tier (Selenium Sulfide) (Silver Nitrate) (Silver Nitrate) 2 2 2 (Silvadene) (Silvadene) (Klaron) 2 2 2 (Anusol-HC) (Scalacort) (Alclometasone Dipropionate) alclometasone topical ointment 0.05 % (Alclometasone Dipropionate) betamethasone dipropionate topical (Betamethasone cream 0.05 % Dipropionate) betamethasone dipropionate topical (Betamethasone lotion 0.05 % Dipropionate) betamethasone dipropionate topical (Betamethasone ointment 0.05 % Dipropionate) betamethasone valerate topical cream 0.1 (Betamethasone % Valerate) betamethasone valerate topical foam 0.12 (Luxiq) % betamethasone valerate topical lotion 0.1 (Betamethasone % Valerate) betamethasone valerate topical ointment (Betamethasone 0.1 % Valerate) betamethasone, augmented topical cream (Diprolene AF) 0.05 % betamethasone, augmented topical gel (Betamethasone 0.05 % Dipropionate) betamethasone, augmented topical lotion (Diprolene) 0.05 % Requirements/Limits 2 2 2 2 2 2 2 2 2 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 98 Effective: July 01, 2016 Drug Name betamethasone, augmented topical ointment 0.05 % clobetasol 0.05% cream 0.05 % clobetasol scalp solution 0.05 % Drug Tier (Diprolene) (Temovate) (Clobetasol Propionate) clobetasol topical foam 0.05 % (Olux) clobetasol topical gel 0.05 % (Clobetasol Propionate) clobetasol topical lotion 0.05 % (Clobex) clobetasol topical ointment 0.05 % (Temovate) clobetasol topical shampoo 0.05 % (Clobex) clobetasol-emollient topical cream 0.05 % (Temovate) clocortolone pivalate topical cream 0.1 % (Cloderm) colocort rectal enema 100 mg/60 ml (Cortenema) cormax scalp solution 0.05 % (Clobetasol Propionate) desonide topical cream 0.05 % (Desowen) desonide topical lotion 0.05 % (Desowen) desonide topical ointment 0.05 % (Desonide) desoximetasone topical cream 0.05 %, (Topicort) 0.25 % desoximetasone topical gel 0.05 % (Topicort) desoximetasone topical ointment 0.05 %, (Topicort) 0.25 % diflorasone topical cream 0.05 % (Psorcon) diflorasone topical ointment 0.05 % (Diflorasone Diacetate) ELIDEL TOPICAL CREAM 1 % fluocinonide 0.05% cream 0.05 % (Vanos) fluocinonide topical gel 0.05 % (Fluocinonide) fluocinonide topical ointment 0.05 % (Fluocinonide) fluocinonide topical solution 0.05 % (Fluocinonide) fluocinonide-e topical cream 0.05 % (Vanos) fluticasone topical cream 0.05 % (Cutivate) fluticasone topical ointment 0.005 % (Fluticasone Propionate) Requirements/Limits 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 2 2 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 99 Effective: July 01, 2016 Drug Name halobetasol propionate topical cream 0.05 % halobetasol propionate topical ointment 0.05 % hydrocortisone 1% ointment carton (otc) 1% hydrocortisone acet-aloe vera topical gel 2% hydrocortisone buty 0.1% cream 0.1 % hydrocortisone butyrate topical ointment 0.1 % hydrocortisone butyrate topical solution 0.1 % hydrocortisone butyr-emollient topical cream 0.1 % hydrocortisone rectal enema 100 mg/60 ml hydrocortisone topical cream 1 %, 2.5 % hydrocortisone topical lotion 2.5 % hydrocortisone topical ointment 1 %, 2.5 % hydrocortisone valerate topical cream 0.2 % hydrocortisone valerate topical ointment 0.2 % mometasone topical cream 0.1 % mometasone topical ointment 0.1 % mometasone topical solution 0.1 % ONFI ORAL TABLET 10 MG, 20 MG prednicarbate topical cream 0.1 % prednicarbate topical ointment 0.1 % procto-med hc rectal cream 2.5 % procto-pak rectal cream 1 % proctosol hc rectal cream 2.5 % Drug Tier (Ultravate) 2 (Ultravate) 2 (Hydrocortisone) 2 (Hydrocortisone Acetate/Aloe V) (Hydrocortisone Butyrate) (Locoid) 2 (Locoid) 2 (Hydrocortisone Butyrate) (Cortenema) 2 (Anusol-HC) (Scalacort) (Hydrocortisone) 2 2 2 (Hydrocortisone Valerate) (Westcort) 2 (Elocon) (Elocon) (Elocon) 2 2 2 4 (Dermatop) (Dermatop) (Hydrocortisone) (Anusol-HC) (Hydrocortisone) Requirements/Limits 2 2 2 2 PA NSO; QL (60 per 30 days) 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 100 Effective: July 01, 2016 Drug Name proctozone-hc rectal cream 2.5 % tacrolimus topical ointment 0.03 %, 0.1 % triamcinolone acetonide topical cream 0.025 %, 0.1 %, 0.5 % triamcinolone acetonide topical lotion 0.025 %, 0.1 % triamcinolone acetonide topical ointment 0.025 %, 0.1 %, 0.5 % trianex topical ointment 0.05 % u-cort topical cream 1-10 % Dermatological Retinoids adapalene topical cream 0.1 % adapalene topical gel 0.1 % TAZORAC TOPICAL CREAM 0.05 %, 0.1 % tretinoin gel micro 0.04% tube 0.04 % tretinoin gel micro 0.1% tube 0.1 % tretinoin microspheres topical gel with pump 0.04 %, 0.1 % tretinoin topical cream 0.025 %, 0.05 %, 0.1 % tretinoin topical gel 0.01 %, 0.025 %, 0.05 % Scabicides And Pediculicides EURAX TOPICAL CREAM 10 % EURAX TOPICAL LOTION 10 % malathion topical lotion 0.5 % permethrin topical cream 5 % spinosad topical suspension 0.9 % Drug Tier Requirements/Limits (Hydrocortisone) (Protopic) 2 2 (Triamcinolone Acetonide) (Triamcinolone Acetonide) (Triamcinolone Acetonide) (Triamcinolone Acetonide) (Hydrocortisone Acetate/Urea) 2 (Differin) (Differin) 2 2 4 (Retin-A Micro) (Retin-A Micro) (Retin-A Micro) 2 2 2 PA PA PA (Retin-A) 2 PA (Retin-A) 2 PA (Ovide) (Elimite) (Natroba) 3 3 2 2 2 2 2 2 2 Devices Devices ASSURE ID INSULIN SAFETY SYRINGE 1 ML 29 GAUGE X 1/2" 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 101 Effective: July 01, 2016 Drug Name Drug Tier BD INSULIN SYR 0.3 ML 31GX5/16 0.3 ML 31 GAUGE X 5/16 BD INSULIN SYR 0.5 ML 31GX5/16" 0.5 ML 31 GAUGE X 5/16 BD INSULIN SYR 1 ML 31GX5/16" 1 ML 31 GAUGE X 5/16 BD ULTRA-FINE PEN NDL 8MMX31G SHORT 31 GAUGE X 5/16" INSULIN SYRINGE-NEEDLE U-100 SYRINGE 0.3 ML 29, 1 ML 29 GAUGE X 1/2", 1/2 ML 28 GAUGE PEN NEEDLE, DIABETIC NEEDLE 29 GAUGE X 1/2 " VGO 40 DISPOSABLE DEVICE 2 Requirements/Limits 2 2 2 2 2 2 Enzyme Replacement/Modifiers Enzyme Replacement/Modifiers ADAGEN INTRAMUSCULAR SOLUTION 250 UNIT/ML ALDURAZYME INTRAVENOUS SOLUTION 2.9 MG/5 ML CEREZYME INTRAVENOUS RECON SOLN 400 UNIT CREON ORAL CAPSULE,DELAYED RELEASE(DR/EC) 12,000-38,000 -60,000 UNIT, 24,000-76,000 -120,000 UNIT, 3,000-9,500- 15,000 UNIT, 36,000-114,000- 180,000 UNIT, 6,000-19,000 -30,000 UNIT ELAPRASE INTRAVENOUS SOLUTION 6 MG/3 ML ELITEK INTRAVENOUS RECON SOLN 1.5 MG FABRAZYME INTRAVENOUS RECON SOLN 35 MG 5 5 5 3 5 5 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 102 Effective: July 01, 2016 Drug Name Drug Tier KANUMA INTRAVENOUS SOLUTION 2 MG/ML KRYSTEXXA INTRAVENOUS SOLUTION 8 MG/ML KUVAN ORAL TABLET,SOLUBLE 100 MG MYOZYME INTRAVENOUS RECON SOLN 50 MG NAGLAZYME INTRAVENOUS SOLUTION 5 MG/5 ML ORFADIN ORAL CAPSULE 10 MG, 2 MG, 5 MG pancrelipase 5000 oral capsule,delayed (Lipase/Protease/Amyl release(dr/ec) 5,000-17,000 -27,000 unit ase) PERTZYE ORAL CAPSULE,DELAYED RELEASE(DR/EC) 16,000-57,50060,500 UNIT, 8,000-28,750- 30,250 UNIT PULMOZYME INHALATION SOLUTION 1 MG/ML STRENSIQ SUBCUTANEOUS SOLUTION 100 MG/ML, 40 MG/ML VIMIZIM INTRAVENOUS SOLUTION 5 MG/5 ML (1 MG/ML) VPRIV INTRAVENOUS RECON SOLN 400 UNIT ZAVESCA ORAL CAPSULE 100 MG ZENPEP ORAL CAPSULE,DELAYED RELEASE(DR/EC) 10,000-34,000 -55,000 UNIT, 15,000-51,000 -82,000 UNIT, 20,000-68,000 -109,000 UNIT, 25,000-85,000- 136,000 UNIT, 3,000-10,000- 16,000 UNIT, 40,000-136,000- 218,000 UNIT, 5,000-17,000 -27,000 UNIT 5 Requirements/Limits PA 5 5 5 5 5 2 4 5 PA BvD 5 PA; LA 5 PA 5 5 3 QL (90 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 103 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits Eye, Ear, Nose, Throat Agents Eye, Ear, Nose, Throat Agents, Miscellaneous AKTEN (PF) OPHTHALMIC GEL 3.5 % alcaine ophthalmic drops 0.5 % altacaine ophthalmic drops 0.5 % apraclonidine ophthalmic drops 0.5 % atropine ophthalmic drops 1 % atropine ophthalmic ointment 1 % atropine-care ophthalmic drops 1 % azelastine nasal aerosol,spray 137 mcg (0.1 %) azelastine nasal spray,non-aerosol 0.15 % (205.5 mcg) azelastine ophthalmic drops 0.05 % BEPREVE OPHTHALMIC DROPS 1.5 % carteolol ophthalmic drops 1 % cromolyn ophthalmic drops 4 % cyclopentolate ophthalmic drops 0.5 %, 1 %, 2 % CYSTARAN OPHTHALMIC DROPS 0.44 % epinastine ophthalmic drops 0.05 % flucaine ophthalmic drops 0.25-0.5 % homatropaire ophthalmic drops 5 % homatropine hbr ophthalmic drops 5 % ipratropium bromide nasal spray,non-aerosol 0.03 % ipratropium bromide nasal spray,non-aerosol 0.06 % LACRISERT OPHTHALMIC INSERT 5 MG naphazoline ophthalmic drops 0.1 % 4 (Proparacaine HCl) (Tetravisc) (Iopidine) (Isopto Atropine) (Atropine Sulfate) (Isopto Atropine) (Astepro) 2 2 2 2 2 2 2 QL (30 per 25 days) (Astepro) 2 QL (30 per 25 days) (Azelastine HCl) 2 4 ST (Carteolol HCl) (Cromolyn Sodium) (Cyclogyl) 2 2 2 5 (Elestat) (Proparacaine/Fluoresc ein Sod) (Isopto Homatropine) (Isopto Homatropine) (Atrovent) 2 2 2 2 2 QL (30 per 28 days) (Atrovent) 2 QL (15 per 10 days) 3 (Naphazoline HCl) 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 104 Effective: July 01, 2016 Drug Name olopatadine nasal spray,non-aerosol 0.6 % olopatadine ophthalmic drops 0.1 % PATADAY OPHTHALMIC DROPS 0.2 % phenylephrine hcl ophthalmic drops 10 %, 2.5 % proparacaine ophthalmic drops 0.5 % tetracaine hcl (pf) ophthalmic drops 0.5 % TYZINE NASAL DROPS 0.1 % TYZINE NASAL SPRAY,NON-AEROSOL 0.1 % Eye, Ear, Nose, Throat Anti-Infectives Agents acetasol hc otic drops 1-2 % acetic acid otic solution 2 % bacitracin ophthalmic ointment 500 unit/gram bacitracin-polymyxin b ophthalmic ointment 500-10,000 unit/gram bleph-10 ophthalmic drops 10 % Drug Tier Requirements/Limits (Patanase) 2 QL (30.5 per 30 days) (Patanol) 2 4 ST (Mydfrin) 2 (Proparacaine HCl) (Tetracaine HCl/PF) 2 2 4 4 (Vosol HC) (Acetic Acid) (Bacitracin) 2 2 2 (Bacitracin/Polymyxin B Sulfate) (Sulfacetamide Sodium) 2 BLEPHAMIDE OPHTHALMIC DROPS,SUSPENSION 10-0.2 % BLEPHAMIDE S.O.P. OPHTHALMIC OINTMENT 10-0.2 % CILOXAN OPHTHALMIC OINTMENT 0.3 % CIPRODEX OTIC DROPS,SUSPENSION 0.3-0.1 % ciprofloxacin hcl ophthalmic drops 0.3 % (Ciloxan) ciprofloxacin hcl otic dropperette 0.2 % (Cetraxal) COLY-MYCIN S OTIC DROPS,SUSPENSION 3.3-3-10-0.5 MG/ML 2 3 2 4 3 2 2 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 105 Effective: July 01, 2016 Drug Name Drug Tier CORTISPORIN-TC OTIC DROPS,SUSPENSION 3.3-3-10-0.5 MG/ML erythromycin ophthalmic ointment 5 mg/gram (0.5 %) gatifloxacin ophthalmic drops 0.5 % gentak ophthalmic ointment 0.3 % (3 mg/gram) gentamicin ophthalmic drops 0.3 % gentamicin ophthalmic ointment 0.3 % (3 mg/gram) hydrocortisone-acetic acid otic drops 1-2 % levofloxacin ophthalmic drops 0.5 % MOXEZA OPHTHALMIC DROPS, VISCOUS 0.5 % NATACYN OPHTHALMIC DROPS,SUSPENSION 5 % neomycin-bacitracin-poly-hc ophthalmic ointment 3.5-400-10,000 mg-unit/g-1% neomycin-bacitracin-polymyxin ophthalmic ointment 3.5-400-10,000 mg-unit-unit/g neomycin-polymyxin b-dexameth ophthalmic drops,suspension 3.5mg/ml-10,000 unit/ml-0.1 % neomycin-polymyxin b-dexameth ophthalmic ointment 3.5 mg/g-10,000 unit/g-0.1 % neomycin-polymyxin-gramicidin ophthalmic drops 1.75 mg-10,000 unit-0.025mg/ml neomycin-polymyxin-hc ophthalmic drops,suspension 3.5-10,000-10 mg-unit-mg/ml 3 (Ilotycin) 2 (Zymaxid) (Garamycin) 2 2 (Garamycin) (Garamycin) 2 2 (Vosol HC) 2 (Levofloxacin) 2 3 Requirements/Limits 3 (Neomycin Su/Baci Zn/Poly/HC) (Neomycin Su/Bacitra/Polymyxin) 2 (Maxitrol) 2 (Maxitrol) 2 (Neosporin) 2 (Neomycin/Polymyxin B Sulf/HC) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 106 Effective: July 01, 2016 Drug Name neomycin-polymyxin-hc otic drops,suspension 3.5-10,000-1 mg/ml-unit/ml-% neomycin-polymyxin-hc otic solution 3.5-10,000-1 mg/ml-unit/ml-% neo-polycin hc ophthalmic ointment 3.5-400-10,000 mg-unit/g-1% neo-polycin ophthalmic ointment 3.5-400-10,000 mg-unit-unit/g ofloxacin ophthalmic drops 0.3 % ofloxacin otic drops 0.3 % polymyxin b sulf-trimethoprim ophthalmic drops 10,000 unit- 1 mg/ml sulfacetamide sodium ophthalmic drops 10 % sulfacetamide sodium ophthalmic ointment 10 % sulfacetamide-prednisolone ophthalmic drops 10 %-0.23 % (0.25 %) TOBRADEX OPHTHALMIC OINTMENT 0.3-0.1 % TOBRADEX ST OPHTHALMIC DROPS,SUSPENSION 0.3-0.05 % tobramycin ophthalmic drops 0.3 % tobramycin-dexamethasone ophthalmic drops,suspension 0.3-0.1 % trifluridine ophthalmic drops 1 % VIGAMOX OPHTHALMIC DROPS 0.5 % ZIRGAN OPHTHALMIC GEL 0.15 % ZYLET OPHTHALMIC DROPS,SUSPENSION 0.3-0.5 % Eye, Ear, Nose, Throat Anti-Inflammatory Agents ALREX OPHTHALMIC DROPS,SUSPENSION 0.2 % Drug Tier (Neomycin/Polymyxin B Sulf/HC) 2 (Cortisporin) 2 (Neomycin Su/Baci Zn/Poly/HC) (Neomycin Su/Bacitra/Polymyxin) (Ocuflox) (Ocuflox) (Polytrim) 2 (Sulfacetamide Sodium) (Sulfacetamide Sodium) (Sulfacetamide/Prednis olone Sp) 2 Requirements/Limits 2 2 2 2 2 2 4 3 (Tobrex) (Tobradex) 2 2 (Viroptic) 2 3 4 3 3 ST You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 107 Effective: July 01, 2016 Drug Name bromfenac ophthalmic drops 0.09 % dexamethasone sodium phosphate ophthalmic drops 0.1 % diclofenac sodium ophthalmic drops 0.1 % DUREZOL OPHTHALMIC DROPS 0.05 % flunisolide nasal spray,non-aerosol 25 mcg (0.025 %) fluocinolone acetonide oil otic drops 0.01 % fluorometholone ophthalmic drops,suspension 0.1 % flurbiprofen sodium ophthalmic drops 0.03 % fluticasone nasal spray,suspension 50 mcg/actuation ILEVRO OPHTHALMIC DROPS,SUSPENSION 0.3 % ketorolac ophthalmic drops 0.4 %, 0.5 % LOTEMAX OPHTHALMIC DROPS,GEL 0.5 % LOTEMAX OPHTHALMIC DROPS,SUSPENSION 0.5 % LOTEMAX OPHTHALMIC OINTMENT 0.5 % NEVANAC OPHTHALMIC DROPS,SUSPENSION 0.1 % prednisolone acetate ophthalmic drops,suspension 1 % prednisolone sodium phosphate ophthalmic drops 1 % PROLENSA OPHTHALMIC DROPS 0.07 % RESTASIS OPHTHALMIC DROPPERETTE 0.05 % Drug Tier (Bromfenac Sodium) (Dexasol) 2 2 (Diclofenac Sodium) 2 Requirements/Limits 3 (Flunisolide) 2 (Dermotic) 2 (FML) 2 (Ocufen) 2 (Fluticasone Propionate) 1 QL (50 per 25 days) 3 (Acular) 2 3 3 3 3 (Omnipred) 2 (Prednisolone Sod Phosphate) 2 3 3 QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 108 Effective: July 01, 2016 Drug Name triamcinolone acetonide nasal aerosol,spray 55 mcg Drug Tier (Triamcinolone Acetonide) 2 (Prevpac) 2 Requirements/Limits QL (16.5 per 30 days) Gastrointestinal Agents Antiulcer Agents And Acid Suppressants amoxicil-clarithromy-lansopraz oral combo pack 500-500-30 mg CARAFATE ORAL SUSPENSION 100 MG/ML cimetidine hcl oral solution 300 mg/5 ml cimetidine oral tablet 200 mg, 300 mg, 400 mg, 800 mg DEXILANT ORAL CAPSULE,BIPHASE DELAYED RELEAS 30 MG, 60 MG esomeprazole sodium intravenous recon soln 20 mg, 40 mg famotidine (pf) intravenous solution 20 mg/2 ml famotidine (pf)-nacl (iso-os) intravenous piggyback 20 mg/50 ml famotidine 40 mg/4 ml vial 25's,outer 10 mg/ml famotidine oral suspension 40 mg/5 ml (8 mg/ml) famotidine oral tablet 20 mg, 40 mg lansoprazole oral capsule,delayed release(dr/ec) 15 mg, 30 mg misoprostol oral tablet 100 mcg, 200 mcg nizatidine oral capsule 150 mg, 300 mg nizatidine oral solution 150 mg/10 ml omeprazole oral capsule,delayed release(dr/ec) 10 mg, 20 mg, 40 mg pantoprazole oral tablet,delayed release (dr/ec) 20 mg, 40 mg 3 (Cimetidine HCl) (Cimetidine) 2 2 (Rx Product Only) 3 ST (Nexium I.V.) 2 (Famotidine) 2 (Famotidine In Nacl,Iso-Osm/PF) (Famotidine) 2 (Pepcid) 2 (Rx Product Only) (Pepcid) (Prevacid) 1 2 (Rx Product Only) (Rx Product Only) (Cytotec) (Nizatidine) (Nizatidine) (Prilosec) 2 2 2 2 (Protonix) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 109 Effective: July 01, 2016 Drug Name ranitidine hcl 50 mg/2 ml vial sdv 50 mg/2 ml (25 mg/ml) ranitidine hcl injection solution 25 mg/ml ranitidine hcl oral capsule 150 mg, 300 mg ranitidine hcl oral syrup 15 mg/ml ranitidine hcl oral tablet 150 mg, 300 mg sucralfate oral suspension 100 mg/ml sucralfate oral tablet 1 gram Gastrointestinal Agents, Other AMITIZA ORAL CAPSULE 24 MCG, 8 MCG BUPHENYL ORAL TABLET 500 MG CARBAGLU ORAL TABLET, DISPERSIBLE 200 MG constulose oral solution 10 gram/15 ml cromolyn oral concentrate 100 mg/5 ml dicyclomine oral capsule 10 mg dicyclomine oral solution 10 mg/5 ml dicyclomine oral tablet 20 mg diphenoxylate-atropine oral liquid 2.5-0.025 mg/5 ml diphenoxylate-atropine oral tablet 2.5-0.025 mg enulose oral solution 10 gram/15 ml GATTEX 5 MG 30-VIAL KIT 5 MG GATTEX ONE-VIAL SUBCUTANEOUS KIT 5 MG generlac oral solution 10 gram/15 ml glycopyrrolate injection solution 0.2 mg/ml glycopyrrolate oral tablet 1 mg, 2 mg kionex 15 gm/60 ml suspension 15 gram/60 ml kionex oral powder Drug Tier Requirements/Limits (Zantac) 2 (Rx Product Only) (Zantac) (Ranitidine HCl) 2 2 (Rx Product Only) (Rx Product Only) (Ranitidine HCl) (Zantac) (Sucralfate) (Carafate) 2 1 2 2 (Rx Product Only) (Rx Product Only) 3 QL (60 per 30 days) 5 5 (Lactulose) (Gastrocrom) (Bentyl) (Dicyclomine HCl) (Bentyl) (Diphenoxylate HCl/Atropine) (Lomotil) 2 5 2 2 2 2 (Lactulose) 2 5 5 2 (Lactulose) (Robinul) 2 2 (Robinul) (Sodium Polystyrene Sulfonate) (Sodium Polystyrene Sulfonate) 2 2 PA PA 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 110 Effective: July 01, 2016 Drug Name Drug Tier lactulose oral solution 10 gram/15 ml (Lactulose) LINZESS ORAL CAPSULE 145 MCG, 290 MCG loperamide oral capsule 2 mg (Loperamide HCl) LOTRONEX ORAL TABLET 0.5 MG, 1 MG methscopolamine oral tablet 2.5 mg, 5 mg (Methscopolamine Bromide) metoclopramide hcl injection solution 5 (Metoclopramide HCl) mg/ml metoclopramide hcl oral solution 5 mg/5 (Metoclopramide HCl) ml metoclopramide hcl oral tablet 10 mg, 5 (Reglan) mg MOVANTIK ORAL TABLET 12.5 MG, 25 MG NUTRESTORE ORAL POWDER IN PACKET 5 GRAM RAVICTI ORAL LIQUID 1.1 GRAM/ML RELISTOR SUBCUTANEOUS SOLUTION 12 MG/0.6 ML RELISTOR SUBCUTANEOUS SYRINGE 12 MG/0.6 ML, 8 MG/0.4 ML sodium polystyrene (sorb free) oral (Sodium Polystyrene suspension 15 gram/60 ml Sulfonate) sodium polystyrene sulfonate rectal (Sodium Polystyrene enema 30 gram/120 ml Sulfonate) sps 15 gm/60 ml suspension 15 gram/60 (Sodium Polystyrene ml Sulfonate) ursodiol oral capsule 300 mg (Actigall) ursodiol oral tablet 250 mg, 500 mg (Urso) VELPHORO ORAL TABLET,CHEWABLE 500 MG 2 3 Requirements/Limits QL (30 per 30 days) 2 5 2 2 2 1 3 4 5 PA 4 PA; QL (28 per 28 days) PA; QL (28 per 28 days) 4 2 2 2 2 2 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 111 Effective: July 01, 2016 Drug Name VIBERZI ORAL TABLET 100 MG, 75 MG Laxatives gavilyte-c oral recon soln 240-22.72-6.72 (Golytely) -5.84 gram gavilyte-g oral recon soln 236-22.74-6.74 (Golytely) -5.86 gram gavilyte-n oral recon soln 420 gram (Nulytely with Flavor Packs) MOVIPREP ORAL POWDER IN PACKET 100-7.5-2.691 GRAM peg 3350-electrolytes oral recon soln (Golytely) 236-22.74-6.74 -5.86 gram, 240-22.72-6.72 -5.84 gram peg-electrolyte soln oral recon soln 420 (Nulytely with Flavor gram Packs) polyethylene glycol 3350 oral powder 17 (Gavilyte-N) gram/dose polyethylene glycol 3350 oral powder in (Polyethylene Glycol packet 17 gram 3350) PREPOPIK ORAL POWDER IN PACKET 10 MG-3.5 GRAM-12 GRAM trilyte with flavor packets oral recon soln (Nulytely with Flavor 420 gram Packs) Phosphate Binders AURYXIA ORAL TABLET 210 MG IRON calcium acetate oral capsule 667 mg (Phoslo) calcium acetate oral tablet 667 mg (Calcium Acetate) eliphos oral tablet 667 mg (Calcium Acetate) FOSRENOL ORAL POWDER IN PACKET 1,000 MG, 750 MG FOSRENOL ORAL TABLET,CHEWABLE 1,000 MG, 500 MG, 750 MG Drug Tier Requirements/Limits 5 ST; QL (60 per 30 days) 2 2 2 3 2 2 2 2 4 2 4 2 2 2 4 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 112 Effective: July 01, 2016 Drug Name magnebind 400 oral tablet 400-200-1 mg Drug Tier (Calcium Carbonate/Mag Carb/Fa) PHOSLYRA ORAL SOLUTION 667 MG (169 MG CALCIUM)/5 ML RENAGEL ORAL TABLET 400 MG, 800 MG RENVELA ORAL POWDER IN PACKET 0.8 GRAM, 2.4 GRAM RENVELA ORAL TABLET 800 MG Requirements/Limits 2 4 3 3 3 Genitourinary Agents Antispasmodics, Urinary flavoxate oral tablet 100 mg MYRBETRIQ ORAL TABLET EXTENDED RELEASE 24 HR 25 MG, 50 MG oxybutynin chloride oral syrup 5 mg/5 ml oxybutynin chloride oral tablet 5 mg oxybutynin chloride oral tablet extended release 24hr 10 mg, 15 mg, 5 mg tolterodine oral capsule,extended release 24hr 2 mg, 4 mg tolterodine oral tablet 1 mg, 2 mg TOVIAZ ORAL TABLET EXTENDED RELEASE 24 HR 4 MG, 8 MG trospium oral capsule,extended release 24hr 60 mg trospium oral tablet 20 mg VESICARE ORAL TABLET 10 MG, 5 MG Genitourinary Agents, Miscellaneous alfuzosin oral tablet extended release 24 hr 10 mg (Flavoxate HCl) 2 3 (Oxybutynin Chloride) (Oxybutynin Chloride) (Ditropan XL) 2 2 2 (Detrol LA) 2 (Detrol) 2 3 (Trospium Chloride) 2 (Trospium Chloride) 2 3 (Uroxatral) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 113 Effective: July 01, 2016 Drug Name Drug Tier tamsulosin oral capsule,extended release (Flomax) 24hr 0.4 mg terazosin oral capsule 1 mg, 10 mg, 2 mg, (Terazosin HCl) 5 mg Requirements/Limits 2 1 Heavy Metal Antagonists Heavy Metal Antagonists deferoxamine injection recon soln 2 gram, (Desferal) 500 mg DEPEN TITRATABS ORAL TABLET 250 MG EXJADE ORAL TABLET, DISPERSIBLE 125 MG EXJADE ORAL TABLET, DISPERSIBLE 250 MG, 500 MG FERRIPROX ORAL SOLUTION 100 MG/ML FERRIPROX ORAL TABLET 500 MG sodium thiosulfate intravenous solution 1 (Sodium Thiosulfate) gram/10 ml (100 mg/ml), 12.5 gram/50 ml (250 mg/ml) SYPRINE ORAL CAPSULE 250 MG 2 PA BvD 5 4 5 5 5 2 5 Hormonal Agents, Stimulant/Replacement/Modifying Androgens ANDRODERM TRANSDERMAL PATCH 24 HOUR 2 MG/24 HOUR, 4 MG/24 HR ANDROGEL TRANSDERMAL GEL IN METERED-DOSE PUMP 20.25 MG/1.25 GRAM (1.62 %) ANDROGEL TRANSDERMAL GEL IN PACKET 1.62 % (20.25 MG/1.25 GRAM), 1.62 % (40.5 MG/2.5 GRAM) androxy oral tablet 10 mg (Fluoxymesterone) 3 PA; QL (30 per 30 days) 3 PA; QL (150 per 30 days) 3 PA; QL (150 per 30 days) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 114 Effective: July 01, 2016 Drug Name Drug Tier AXIRON TRANSDERMAL SOLUTION IN METERED PUMP W/APP 30 MG/ACTUATION (1.5 ML) danazol oral capsule 100 mg, 200 mg, 50 mg oxandrolone oral tablet 10 mg, 2.5 mg testosterone cypionate intramuscular oil 100 mg/ml, 200 mg/ml testosterone enanthate intramuscular oil 200 mg/ml testosterone transdermal gel 50 mg/5 gram (1 %) testosterone transdermal gel in metered-dose pump 1.25 gram/ actuation (1 %) testosterone transdermal gel in packet 1 % (25 mg/2.5gram) testosterone transdermal gel in packet 1 % (50 mg/5 gram) Estrogens And Antiestrogens COMBIPATCH TRANSDERMAL PATCH SEMIWEEKLY 0.05-0.14 MG/24 HR, 0.05-0.25 MG/24 HR DUAVEE ORAL TABLET 0.45-20 MG ESTRACE VAGINAL CREAM 0.01 % (0.1 MG/GRAM) estradiol oral tablet 0.5 mg, 1 mg, 2 mg estradiol transdermal patch semiweekly 0.025 mg/24 hr, 0.0375 mg/24 hr, 0.05 mg/24 hr, 0.075 mg/24 hr, 0.1 mg/24 hr estradiol transdermal patch weekly 0.025 mg/24 hr, 0.0375 mg/24 hr, 0.05 mg/24 hr, 0.06 mg/24 hr, 0.075 mg/24 hr, 0.1 mg/24 hr 3 Requirements/Limits PA; QL (180 per 28 days) (Danazol) 2 (Oxandrin) (Depo-Testosterone) 2 2 PA (Testosterone Enanthate) (Testim) 2 PA; QL (5 per 28 days) 2 (Vogelxo) 2 PA; QL (300 per 30 days) PA; QL (300 per 30 days) (Androgel) 2 (Testim) 2 3 PA; QL (300 per 30 days) PA; QL (300 per 30 days) QL (8 per 28 days) 3 3 (Estrace) (Vivelle-Dot) 2 2 QL (8 per 28 days) (Climara) 2 QL (4 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 115 Effective: July 01, 2016 Drug Name estradiol valerate intramuscular oil 10 mg/ml, 20 mg/ml, 40 mg/ml estradiol-norethindrone acet oral tablet 0.5-0.1 mg, 1-0.5 mg ESTRING VAGINAL RING 2 MG estropipate oral tablet 0.75 mg, 1.5 mg, 3 mg FEMRING VAGINAL RING 0.05 MG/24 HR, 0.1 MG/24 HR fyavolv oral tablet 1-5 mg-mcg jinteli oral tablet 1-5 mg-mcg MENEST ORAL TABLET 0.3 MG, 0.625 MG, 1.25 MG, 2.5 MG mimvey lo oral tablet 0.5-0.1 mg mimvey oral tablet 1-0.5 mg norethindrone ac-eth estradiol oral tablet 1-5 mg-mcg PREMARIN INJECTION RECON SOLN 25 MG PREMARIN ORAL TABLET 0.3 MG, 0.45 MG, 0.625 MG, 0.9 MG, 1.25 MG PREMARIN VAGINAL CREAM 0.625 MG/GRAM PREMPHASE ORAL TABLET 0.625 MG (14)/ 0.625MG-5MG(14) PREMPRO ORAL TABLET 0.3-1.5 MG, 0.45-1.5 MG, 0.625-2.5 MG, 0.625-5 MG raloxifene oral tablet 60 mg VAGIFEM VAGINAL TABLET 10 MCG Glucocorticoids/Mineralocorticoid s a-hydrocort injection recon soln 100 mg Drug Tier Requirements/Limits (Delestrogen) 2 (Activella) 2 QL (1 per 84 days) (Estropipate) 4 2 4 QL (1 per 84 days) (Femhrt) (Femhrt) 2 2 4 (Activella) (Activella) (Femhrt) 2 2 2 3 3 3 3 3 (Evista) 2 3 (Hydrocortisone Sod Succinate) QL (18 per 28 days) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 116 Effective: July 01, 2016 Drug Name betamethasone acet,sod phos injection suspension 6 mg/ml cortisone oral tablet 25 mg dexamethasone oral elixir 0.5 mg/5 ml dexamethasone oral tablet 0.5 mg, 0.75 mg, 1 mg, 1.5 mg, 2 mg, 4 mg, 6 mg dexamethasone sodium phosphate injection solution 10 mg/ml, 4 mg/ml fludrocortisone oral tablet 0.1 mg hydrocortisone oral tablet 10 mg, 20 mg, 5 mg methylprednisolone 125 mg vial 2ml sdv, 25's,l/f 125 mg methylprednisolone acetate injection suspension 40 mg/ml, 80 mg/ml methylprednisolone oral tablet 16 mg, 32 mg, 4 mg, 8 mg methylprednisolone oral tablets,dose pack 4 mg methylprednisolone sodium succ injection recon soln 125 mg, 40 mg methylprednisolone ss 1 gm vl mdv,latex-free 1,000 mg prednisolone sodium phosphate oral solution 15 mg/5 ml (3 mg/ml), 25 mg/5 ml (5 mg/ml), 5 mg base/5 ml (6.7 mg/5 ml) PREDNISONE INTENSOL ORAL CONCENTRATE 5 MG/ML prednisone oral solution 5 mg/5 ml prednisone oral tablet 1 mg, 2.5 mg, 20 mg, 5 mg, 50 mg prednisone oral tablet 10 mg prednisone oral tablets,dose pack 10 mg, 5 mg Drug Tier Requirements/Limits (Celestone) 2 (Cortisone Acetate) (Dexamethasone) (Dexamethasone) 2 2 1 (Dexamethasone Sod Phosphate) (Fludrocortisone Acetate) (Cortef) 2 (Solu-Medrol) 2 (Depo-Medrol) 2 (Medrol) 2 PA BvD (Medrol) 2 PA BvD (Solu-Medrol) 2 (Solu-Medrol) 2 (Pediapred) 2 PA BvD 3 PA BvD (Prednisone) (Prednisone) 2 1 PA BvD PA BvD (Prednisone) (Prednisone) 1 2 PA BvD PA BvD PA BvD PA BvD PA BvD 2 2 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 117 Effective: July 01, 2016 Drug Name Drug Tier SOLU-CORTEF (PF) INJECTION RECON SOLN 100 MG/2 ML, 250 MG/2 ML triamcinolone acetonide injection suspension 10 mg/ml, 40 mg/ml Pituitary desmopressin injection solution 4 mcg/ml 4 desmopressin nasal solution 0.1 mg/ml (refrigerate) desmopressin nasal spray,non-aerosol 10 mcg/spray (0.1 ml) desmopressin oral tablet 0.1 mg, 0.2 mg GENOTROPIN MINIQUICK SUBCUTANEOUS SYRINGE 0.2 MG/0.25 ML GENOTROPIN MINIQUICK SUBCUTANEOUS SYRINGE 0.4 MG/0.25 ML, 0.6 MG/0.25 ML, 0.8 MG/0.25 ML, 1 MG/0.25 ML, 1.2 MG/0.25 ML, 1.4 MG/0.25 ML, 1.6 MG/0.25 ML, 1.8 MG/0.25 ML, 2 MG/0.25 ML GENOTROPIN SUBCUTANEOUS CARTRIDGE 12 MG/ML (36 UNIT/ML), 5 MG/ML (15 UNIT/ML) INCRELEX SUBCUTANEOUS SOLUTION 10 MG/ML LUPRON DEPOT-PED (3 MONTH) INTRAMUSCULAR SYRINGE KIT 30 MG LUPRON DEPOT-PED INTRAMUSCULAR KIT 11.25 MG, 15 MG, 7.5 MG (PED) Requirements/Limits (Triamcinolone Acetonide) 2 (Desmopressin Acetate) (DDAVP) 2 2 QL (15 per 30 days) (Desmopressin Acetate) (DDAVP) 2 QL (15 per 30 days) 2 4 PA 5 PA 5 PA 5 5 QL (1 per 84 days) 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 118 Effective: July 01, 2016 Drug Name Drug Tier NORDITROPIN FLEXPRO SUBCUTANEOUS PEN INJECTOR 10 MG/1.5 ML (6.7 MG/ML), 15 MG/1.5 ML (10 MG/ML), 30 MG/3 ML (10 MG/ML), 5 MG/1.5 ML (3.3 MG/ML) octreotide acet 50 mcg/ml syr outer,single-dose,10 50 mcg/ml (1 ml) octreotide acetate injection solution 1,000 mcg/ml octreotide acetate injection solution 100 mcg/ml, 200 mcg/ml, 500 mcg/ml octreotide acetate injection solution 50 mcg/ml SAIZEN CLICK.EASY SUBCUTANEOUS CARTRIDGE 8.8 MG/1.5 ML (FNL) SAIZEN SUBCUTANEOUS RECON SOLN 5 MG, 8.8 MG SANDOSTATIN LAR 10 MG KIT 10 MG SANDOSTATIN LAR 20 MG KIT 20 MG SANDOSTATIN LAR 30 MG KIT 30 MG SANDOSTATIN LAR DEPOT INTRAMUSCULAR SUSPENSION,EXTENDED REL RECON 10 MG, 20 MG, 30 MG SEROSTIM SUBCUTANEOUS RECON SOLN 4 MG, 5 MG, 6 MG SOMATULINE DEPOT SUBCUTANEOUS SYRINGE 120 MG/0.5 ML, 60 MG/0.2 ML, 90 MG/0.3 ML 5 (Octreotide Acetate) 2 (Sandostatin) 5 (Sandostatin) 2 (Octreotide Acetate) 2 Requirements/Limits PA 5 PA 5 PA 5 5 5 5 5 PA 5 QL (1 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 119 Effective: July 01, 2016 Drug Name Drug Tier SOMAVERT SUBCUTANEOUS RECON SOLN 10 MG, 15 MG, 20 MG, 25 MG, 30 MG STIMATE NASAL SPRAY,NON-AEROSOL 150 MCG/SPRAY (0.1 ML) SUPPRELIN LA IMPLANT KIT 50 MG (65 MCG/DAY) Progestins DEPO-PROVERA INTRAMUSCULAR SOLUTION 400 MG/ML medroxyprogesterone intramuscular suspension 150 mg/ml medroxyprogesterone intramuscular syringe 150 mg/ml medroxyprogesterone oral tablet 10 mg, 2.5 mg, 5 mg MEGACE ES ORAL SUSPENSION 625 MG/5 ML megestrol oral suspension 400 mg/10 ml (40 mg/ml), 625 mg/5 ml norethindrone acetate oral tablet 5 mg progesterone in oil intramuscular oil 50 mg/ml progesterone micronized oral capsule 100 mg, 200 mg Thyroid And Antithyroid Agents levothyroxine intravenous recon soln 100 mcg, 200 mcg, 500 mcg levothyroxine oral tablet 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg, 25 mcg, 300 mcg, 50 mcg, 75 mcg, 88 mcg liothyronine intravenous solution 10 mcg/ml 5 Requirements/Limits 4 5 QL (1 per 360 days) 4 QL (10 per 28 days) (Depo-Provera) 2 QL (1 per 84 days) (Depo-Provera) 2 QL (1 per 84 days) (Provera) 2 5 (Megace Es) 2 (Aygestin) (Progesterone) 2 2 (Prometrium) 2 (Levothyroxine Sodium) (Levoxyl) 2 (Triostat) 2 1 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 120 Effective: July 01, 2016 Drug Name Drug Tier liothyronine oral tablet 25 mcg, 5 mcg, 50 (Cytomel) mcg methimazole oral tablet 10 mg, 5 mg (Tapazole) propylthiouracil oral tablet 50 mg (Propylthiouracil) Requirements/Limits 2 2 2 Immunological Agents Immunological Agents ARCALYST SUBCUTANEOUS RECON SOLN 220 MG ASTAGRAF XL ORAL CAPSULE,EXTENDED RELEASE 24HR 0.5 MG, 1 MG, 5 MG AUBAGIO ORAL TABLET 14 MG, 7 MG azathioprine oral tablet 50 mg azathioprine sodium injection recon soln 100 mg CARIMUNE NF NANOFILTERED INTRAVENOUS RECON SOLN 6 GRAM CELLCEPT INTRAVENOUS INTRAVENOUS RECON SOLN 500 MG CIMZIA POWDER FOR RECONST SUBCUTANEOUS KIT 400 MG (200 MG X 2 VIALS) CIMZIA SUBCUTANEOUS SYRINGE KIT 400 MG/2 ML (200 MG/ML X 2) cyclosporine intravenous solution 250 mg/5 ml cyclosporine modified oral capsule 100 mg, 25 mg, 50 mg cyclosporine modified oral solution 100 mg/ml cyclosporine oral capsule 100 mg, 25 mg 5 4 PA BvD 5 2 2 PA; QL (28 per 28 days) PA BvD PA BvD 5 PA BvD 4 PA BvD 5 PA 5 PA (Sandimmune) 2 PA BvD (Neoral) 2 PA BvD (Neoral) 2 PA BvD (Sandimmune) 2 PA BvD (Imuran) (Azathioprine Sodium) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 121 Effective: July 01, 2016 Drug Name Drug Tier ENBREL SUBCUTANEOUS RECON SOLN 25 MG (1 ML) ENBREL SUBCUTANEOUS SYRINGE 25 MG/0.5ML (0.51), 50 MG/ML (0.98 ML) ENBREL SURECLICK SUBCUTANEOUS PEN INJECTOR 50 MG/ML (0.98 ML) ENVARSUS XR ORAL TABLET EXTENDED RELEASE 24 HR 0.75 MG, 1 MG, 4 MG FLEBOGAMMA DIF INTRAVENOUS SOLUTION 10 %, 5 % GAMASTAN S/D INTRAMUSCULAR SOLUTION 15-18 % RANGE GAMMAGARD LIQUID INJECTION SOLUTION 10 % GAMMAPLEX INTRAVENOUS SOLUTION 5 % GAMUNEX-C 20 GRAM/200 ML VIAL P/F,LTX-FR,SUV,OUTER 20 GRAM/200 ML (10 %) GAMUNEX-C INJECTION SOLUTION 1 GRAM/10 ML (10 %) gengraf oral capsule 100 mg, 25 mg (Neoral) gengraf oral solution 100 mg/ml (Neoral) HUMIRA PEN CROHN'S-UC-HS START SUBCUTANEOUS PEN INJECTOR KIT 40 MG/0.8 ML HUMIRA PEN SUBCUTANEOUS PEN INJECTOR KIT 40 MG/0.8 ML HUMIRA SUBCUTANEOUS SYRINGE KIT 10 MG/0.2 ML, 20 MG/0.4 ML, 40 MG/0.8 ML Requirements/Limits 5 PA 5 PA 5 PA 4 PA BvD 5 PA BvD 3 PA BvD 5 PA BvD 5 PA BvD 5 PA BvD 5 PA BvD 2 2 5 PA BvD PA BvD PA 5 PA 5 PA You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 122 Effective: July 01, 2016 Drug Name Drug Tier HYPERRAB S/D (PF) INTRAMUSCULAR SOLUTION 150 UNIT/ML, 150 UNIT/ML (10 ML) HYQVIA SUBCUTANEOUS SOLUTION 10 GRAM /100 ML (10 %), 2.5 GRAM /25 ML (10 %), 20 GRAM /200 ML (10 %), 30 GRAM /300 ML (10 %), 5 GRAM /50 ML (10 %) ILARIS (PF) SUBCUTANEOUS RECON SOLN 180 MG/1.2 ML (150 MG/ML) IMOGAM RABIES-HT (PF) INTRAMUSCULAR SOLUTION 150 UNIT/ML KINERET SUBCUTANEOUS SYRINGE 100 MG/0.67 ML leflunomide oral tablet 10 mg, 20 mg mycophenolate mofetil oral capsule 250 mg mycophenolate mofetil oral suspension for reconstitution 200 mg/ml mycophenolate mofetil oral tablet 500 mg mycophenolate sodium oral tablet,delayed release (dr/ec) 180 mg, 360 mg NULOJIX INTRAVENOUS RECON SOLN 250 MG OCTAGAM INTRAVENOUS SOLUTION 10 %, 5 % ORENCIA (WITH MALTOSE) INTRAVENOUS RECON SOLN 250 MG ORENCIA SUBCUTANEOUS SYRINGE 125 MG/ML PRIVIGEN INTRAVENOUS SOLUTION 10 % 4 Requirements/Limits 5 PA BvD 5 PA 4 5 PA; QL (18.76 per 28 days) (Arava) (Cellcept) 2 2 PA BvD (Cellcept) 5 PA BvD (Cellcept) (Myfortic) 2 2 PA BvD PA BvD 5 PA BvD 5 PA BvD 5 PA 5 PA 5 PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 123 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits PROGRAF INTRAVENOUS SOLUTION 5 MG/ML RAPAMUNE ORAL SOLUTION 1 MG/ML RIDAURA ORAL CAPSULE 3 MG sirolimus oral tablet 0.5 mg, 1 mg (Rapamune) sirolimus oral tablet 2 mg (Rapamune) tacrolimus oral capsule 0.5 mg, 1 mg, 5 (Hecoria) mg TYSABRI INTRAVENOUS SOLUTION 300 MG/15 ML ZORTRESS ORAL TABLET 0.25 MG 4 PA BvD 5 PA BvD 5 2 5 2 PA BvD PA BvD PA BvD ZORTRESS ORAL TABLET 0.5 MG, 0.75 MG Vaccines ACTHIB (PF) INTRAMUSCULAR RECON SOLN 10 MCG/0.5 ML ADACEL(TDAP ADOLESN/ADULT)(PF) INTRAMUSCULAR SUSPENSION 2 LF-(2.5-5-3-5 MCG)-5LF/0.5 ML ADACEL(TDAP ADOLESN/ADULT)(PF) INTRAMUSCULAR SYRINGE 2 LF-(2.5-5-3-5 MCG)-5LF/0.5 ML BCG (TICE STRAIN) VIAL 50 MG BCG VACCINE, LIVE (PF) PERCUTANEOUS SUSPENSION FOR RECONSTITUTION 50 MG BEXSERO (PF) INTRAMUSCULAR SYRINGE 50-50-50-25 MCG/0.5 ML BOOSTRIX TDAP INTRAMUSCULAR SUSPENSION 2.5-8-5 LF-MCG-LF/0.5ML 5 5 4 PA; LA; QL (15 per 28 days) PA BvD; QL (120 per 30 days) PA BvD; QL (120 per 30 days) 3 3 3 3 3 PA BvD PA BvD 3 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 124 Effective: July 01, 2016 Drug Name Drug Tier BOOSTRIX TDAP INTRAMUSCULAR SYRINGE 2.5-8-5 LF-MCG-LF/0.5ML CERVARIX VACCINE (PF) INTRAMUSCULAR SYRINGE 20-20 MCG/0.5 ML COMVAX (PF) INTRAMUSCULAR SUSPENSION 5-7.5-125 MCG/0.5 ML DAPTACEL (DTAP PEDIATRIC) (PF) INTRAMUSCULAR SUSPENSION 15-10-5 LF-MCG-LF/0.5ML ENGERIX-B (PF) INTRAMUSCULAR SYRINGE 20 MCG/ML ENGERIX-B 20 MCG/ML VIAL 10'S,ADULT,P/F,OUTER 20 MCG/ML ENGERIX-B PEDIATRIC (PF) INTRAMUSCULAR SUSPENSION 10 MCG/0.5 ML ENGERIX-B PEDIATRIC (PF) INTRAMUSCULAR SYRINGE 10 MCG/0.5 ML GARDASIL (PF) INTRAMUSCULAR SUSPENSION 20-40-40-20 MCG/0.5 ML GARDASIL (PF) INTRAMUSCULAR SYRINGE 20-40-40-20 MCG/0.5 ML GARDASIL 9 (PF) INTRAMUSCULAR SUSPENSION 0.5 ML GARDASIL 9 (PF) INTRAMUSCULAR SYRINGE 0.5 ML 3 Requirements/Limits 3 3 3 3 PA BvD; QL (3 per 365 days) 3 PA BvD; QL (3 per 365 days) 3 PA BvD; QL (3 per 365 days) 3 PA BvD; QL (3 per 365 days) 3 QL (1.5 per 365 days) 3 QL (1.5 per 365 days) 3 QL (1.5 per 365 days) 3 QL (1.5 per 365 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 125 Effective: July 01, 2016 Drug Name Drug Tier HAVRIX (PF) INTRAMUSCULAR SUSPENSION 1,440 ELISA UNIT/ML HAVRIX (PF) INTRAMUSCULAR SYRINGE 1,440 ELISA UNIT/ML, 720 ELISA UNIT/0.5 ML IMOVAX RABIES VACCINE (PF) INTRAMUSCULAR RECON SOLN 2.5 UNIT INFANRIX (DTAP) (PF) INTRAMUSCULAR SUSPENSION 25-58-10 LF-MCG-LF/0.5ML IPOL INJECTION SUSPENSION 40-8-32 UNIT/0.5 ML IPOL INJECTION SYRINGE 40-8-32 UNIT/0.5 ML IXIARO (PF) INTRAMUSCULAR SYRINGE 6 MCG/0.5 ML KINRIX (PF) INTRAMUSCULAR SUSPENSION 25 LF-58 MCG-10 LF/0.5 ML KINRIX (PF) INTRAMUSCULAR SYRINGE 25 LF-58 MCG-10 LF/0.5 ML MENACTRA (PF) INTRAMUSCULAR SOLUTION 4 MCG/0.5 ML MENHIBRIX (PF) INTRAMUSCULAR RECON SOLN 5-2.5 MCG/0.5 ML MENOMUNE - A/C/Y/W-135 (PF) SUBCUTANEOUS RECON SOLN 50 MCG MENVEO A-C-Y-W-135-DIP (PF) INTRAMUSCULAR KIT 10-5 MCG/0.5 ML 3 Requirements/Limits 3 3 PA BvD 3 3 3 3 3 3 3 3 3 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 126 Effective: July 01, 2016 Drug Name Drug Tier MENVEO MENA COMPONENT (PF) INTRAMUSCULAR RECON SOLN 10 MCG /0.5 ML (FINAL) MENVEO MENCYW-135 COMPNT (PF) INTRAMUSCULAR RECON SOLN 5 MCG X 3/ 0.5 ML (FINAL) M-M-R II (PF) SUBCUTANEOUS RECON SOLN 1,000-12,500 TCID50/0.5 ML PEDIARIX (PF) INTRAMUSCULAR SYRINGE 10 MCG-25LF-25 MCG-10LF/0.5 ML PEDVAX HIB (PF) INTRAMUSCULAR SOLUTION 7.5 MCG/0.5 ML PENTACEL (PF) INTRAMUSCULAR KIT 15 LF UNIT-20 MCG-5 LF/0.5 ML PENTACEL ACTHIB COMPONENT (PF) INTRAMUSCULAR RECON SOLN 10 MCG/0.5 ML PROQUAD (PF) SUBCUTANEOUS SUSPENSION FOR RECONSTITUTION 10EXP3-4.3-33.99 TCID50/0.5 QUADRACEL (PF) INTRAMUSCULAR SUSPENSION 15 LF-48 MCG- 5 LF UNIT/0.5ML RABAVERT (PF) INTRAMUSCULAR SUSPENSION FOR RECONSTITUTION 2.5 UNIT RECOMBIVAX HB (PF) INTRAMUSCULAR SUSPENSION 10 MCG/ML, 40 MCG/ML RECOMBIVAX HB (PF) INTRAMUSCULAR SYRINGE 10 MCG/ML, 5 MCG/0.5 ML 3 Requirements/Limits 3 3 QL (2 per 365 days) 3 3 3 3 3 QL (2 per 365 days) 3 3 PA BvD 3 PA BvD; QL (3 per 365 days) 3 PA BvD; QL (3 per 365 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 127 Effective: July 01, 2016 Drug Name Drug Tier ROTARIX ORAL SUSPENSION FOR RECONSTITUTION 10EXP6 CCID50/ML ROTATEQ VACCINE ORAL SUSPENSION 2 ML TENIVAC (PF) INTRAMUSCULAR SYRINGE 5-2 LF UNIT/0.5 ML TETANUS TOXOID,ADSORBED (PF) INTRAMUSCULAR SUSPENSION 5 LF UNIT/0.5 ML TETANUS,DIPHTHERIA TOX PED(PF) INTRAMUSCULAR SUSPENSION 5-25 LF UNIT/0.5 ML tetanus-diphtheria toxoids-td intramuscular suspension 2-2 lf unit/0.5 ml TRUMENBA INTRAMUSCULAR SYRINGE 120 MCG/0.5 ML TWINRIX (PF) INTRAMUSCULAR SUSPENSION 720 ELISA UNIT -20 MCG/ML TWINRIX (PF) INTRAMUSCULAR SYRINGE 720 ELISA UNIT -20 MCG/ML TYPHIM VI INTRAMUSCULAR SOLUTION 25 MCG/0.5 ML TYPHIM VI INTRAMUSCULAR SYRINGE 25 MCG/0.5 ML VAQTA (PF) INTRAMUSCULAR SUSPENSION 50 UNIT/ML VAQTA (PF) INTRAMUSCULAR SYRINGE 25 UNIT/0.5 ML, 50 UNIT/ML VAQTA 25 UNITS/0.5 ML VIAL SDV, OUTER 25 UNIT/0.5 ML 3 Requirements/Limits 3 3 3 PA BvD 3 (Tetanus, Diphtheria Tox,Adult) 3 3 3 3 3 3 3 3 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 128 Effective: July 01, 2016 Drug Name Drug Tier VARIVAX (PF) SUBCUTANEOUS SUSPENSION FOR RECONSTITUTION 1,350 UNIT/0.5 ML YF-VAX (PF) SUBCUTANEOUS SUSPENSION FOR RECONSTITUTION 10 EXP4.74 UNIT/0.5 ML ZOSTAVAX (PF) SUBCUTANEOUS SUSPENSION FOR RECONSTITUTION 19,400 UNIT/0.65 ML 3 Requirements/Limits QL (2 per 365 days) 3 3 QL (1 per 365 days) Inflammatory Bowel Disease Agents Inflammatory Bowel Disease Agents alosetron oral tablet 0.5 mg, 1 mg APRISO ORAL CAPSULE,EXTENDED RELEASE 24HR 0.375 GRAM ASACOL HD ORAL TABLET,DELAYED RELEASE (DR/EC) 800 MG balsalazide oral capsule 750 mg budesonide oral capsule,delayed,extend.release 3 mg DELZICOL ORAL CAPSULE,DELAYED RELEASE(DR/EC) 400 MG DIPENTUM ORAL CAPSULE 250 MG (Alosetron HCl) 5 3 3 (Colazal) (Entocort EC) 2 5 3 4 ST Irrigating Solutions Irrigating Solutions acetic acid irrigation solution 0.25 % LACTATED RINGERS IRRIGATION SOLUTION ringers irrigation solution (Acetic Acid) 2 3 (Tis-U-Sol) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 129 Effective: July 01, 2016 Drug Name sodium chloride irrigation solution 0.9 % sorbitol irrigation solution 3 %, 3.3 % sorbitol-mannitol urethral solution 2.7-0.54 g/100 ml water for irrigation, sterile irrigation solution Drug Tier Requirements/Limits (Sodium Chloride Irrig Solution) (Sorbitol Solution) (Mannitol/Sorbitol Solution) (Water For Irrigation,Sterile) 2 (Alendronate Sodium) (Fosamax) 2 1 QL (300 per 28 days) (Fosamax) (Miacalcin) 1 2 QL (4 per 28 days) QL (3.7 per 28 days) (Calcitriol) (Rocaltrol) (Rocaltrol) (Doxercalciferol) 2 2 2 2 (Hectorol) 2 (Etidronate Disodium) 2 2 2 2 Metabolic Bone Disease Agents Metabolic Bone Disease Agents alendronate oral solution 70 mg/75 ml alendronate oral tablet 10 mg, 40 mg, 5 mg alendronate oral tablet 35 mg, 70 mg calcitonin (salmon) nasal spray,non-aerosol 200 unit/actuation calcitriol intravenous solution 1 mcg/ml calcitriol oral capsule 0.25 mcg, 0.5 mcg calcitriol oral solution 1 mcg/ml doxercalciferol intravenous solution 4 mcg/2 ml doxercalciferol oral capsule 0.5 mcg, 1 mcg, 2.5 mcg etidronate disodium oral tablet 200 mg, 400 mg FORTEO SUBCUTANEOUS PEN INJECTOR 20 MCG/DOSE - 600 MCG/2.4 ML FORTICAL NASAL SPRAY,NON-AEROSOL 200 UNIT/ACTUATION ibandronate intravenous solution 3 mg/3 ml ibandronate intravenous syringe 3 mg/3 ml ibandronate oral tablet 150 mg 4 QL (2.4 per 28 days) 4 QL (3.7 per 28 days) (Ibandronate Sodium) 2 QL (3 per 84 days) (Boniva) 2 QL (3 per 84 days) (Boniva) 2 QL (1 per 28 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 130 Effective: July 01, 2016 Drug Name Drug Tier MIACALCIN INJECTION SOLUTION 200 UNIT/ML NATPARA SUBCUTANEOUS CARTRIDGE 100 MCG/DOSE, 25 MCG/DOSE, 50 MCG/DOSE, 75 MCG/DOSE pamidronate intravenous solution 30 mg/10 ml (3 mg/ml), 60 mg/10 ml (6 mg/ml), 90 mg/10 ml (9 mg/ml) paricalcitol oral capsule 1 mcg, 2 mcg, 4 mcg PROLIA SUBCUTANEOUS SYRINGE 60 MG/ML risedronate oral tablet 150 mg risedronate oral tablet 30 mg, 5 mg risedronate oral tablet 35 mg (12 pack), 35 mg (4 pack) risedronate sodium 35 mg tab f/c, once-a-week 35 mg XGEVA SUBCUTANEOUS SOLUTION 120 MG/1.7 ML (70 MG/ML) ZEMPLAR INTRAVENOUS SOLUTION 2 MCG/ML, 5 MCG/ML zoledronic acid intravenous solution 4 mg/5 ml zoledronic acid-mannitol-water intravenous piggyback 4 mg/100 ml 3 zoledronic acid-mannitol-water intravenous solution 5 mg/100 ml ZOMETA INTRAVENOUS SOLUTION 4 MG/100 ML 5 (Pamidronate Disodium) 2 (Zemplar) 2 Requirements/Limits PA; QL (2 per 28 days) 3 QL (1 per 180 days) (Actonel) (Actonel) (Actonel) 2 2 2 QL (1 per 28 days) QL (30 per 28 days) QL (4 per 28 days) (Actonel) 2 QL (4 per 28 days) 5 PA 3 (Zometa) 2 (Zoledronic Acid/Mannitol and Water) (Reclast) 2 2 QL (100 per 300 days) 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 131 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits Miscellaneous Therapeutic Agents Miscellaneous Therapeutic Agents ACTEMRA INTRAVENOUS SOLUTION 200 MG/10 ML (20 MG/ML), 400 MG/20 ML (20 MG/ML), 80 MG/4 ML (20 MG/ML) ACTEMRA SUBCUTANEOUS SYRINGE 162 MG/0.9 ML ACTIMMUNE SUBCUTANEOUS SOLUTION 100 MCG/0.5 ML allopurinol oral tablet 100 mg, 300 mg allopurinol sodium intravenous recon soln 500 mg amifostine crystalline intravenous recon soln 500 mg ammonium chloride intravenous solution 5 meq/ml anticoag citrate phos dextrose solution 2.63-222 gram-mg/100ml AVONEX (WITH ALBUMIN) INTRAMUSCULAR KIT 30 MCG AVONEX INTRAMUSCULAR PEN INJECTOR KIT 30 MCG/0.5 ML AVONEX INTRAMUSCULAR SYRINGE KIT 30 MCG/0.5 ML BENLYSTA INTRAVENOUS RECON SOLN 120 MG, 400 MG BETASERON SUBCUTANEOUS KIT 0.3 MG bethanechol chloride oral tablet 10 mg, 25 mg, 5 mg, 50 mg BOTOX INJECTION RECON SOLN 100 UNIT BOTOX INJECTION RECON SOLN 200 UNIT 5 PA 5 PA 5 (Zyloprim) (Allopurinol Sodium) 2 2 (Amifostine Crystalline) (Ammonium Chloride) 2 (Citrate Phosphate Dextros Soln) 2 (Urecholine) 2 5 ST 5 ST 5 ST 5 PA 5 ST 2 3 PA; QL (4 per 90 days) 3 PA; QL (1 per 90 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 132 Effective: July 01, 2016 Drug Name buspirone oral tablet 10 mg, 15 mg, 30 mg, 5 mg, 7.5 mg CERDELGA ORAL CAPSULE 84 MG colchicine oral tablet 0.6 mg colchicine-probenecid oral tablet 0.5-500 mg COPAXONE SUBCUTANEOUS SYRINGE 20 MG/ML, 40 MG/ML CYSTADANE ORAL POWDER 1 GRAM/1.7 ML dexrazoxane hcl intravenous recon soln 250 mg droperidol injection solution 2.5 mg/ml dutasteride oral capsule 0.5 mg dutasteride-tamsulosin oral capsule, er multiphase 24 hr 0.5-0.4 mg ELMIRON ORAL CAPSULE 100 MG ergoloid oral tablet 1 mg EXTAVIA SUBCUTANEOUS KIT 0.3 MG finasteride oral tablet 5 mg fomepizole intravenous solution 1 gram/ml FUSILEV INTRAVENOUS RECON SOLN 50 MG GAUZE PAD TOPICAL BANDAGE 2X2" GILENYA ORAL CAPSULE 0.5 MG GLUCAGEN HYPOKIT INJECTION RECON SOLN 1 MG GLUCAGON EMERGENCY KIT (HUMAN) INJECTION KIT 1 MG guanidine oral tablet 125 mg hydroxyzine hcl intramuscular solution 25 mg/ml, 50 mg/ml Drug Tier (Buspirone HCl) 2 5 (Colcrys) (Colchicine/Probenecid ) Requirements/Limits PA 2 2 5 5 (Totect) 2 (Droperidol) (Avodart) (Jalyn) 2 2 2 QL (30 per 30 days) (Ergoloid Mesylates) 4 2 5 ST (Proscar) (Fomepizole) 2 5 5 1 5 3 QL (28 per 28 days) 4 (Guanidine HCl) (Hydroxyzine HCl) 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 133 Effective: July 01, 2016 Drug Name Drug Tier hydroxyzine hcl oral solution 10 mg/5 ml (Hydroxyzine HCl) hydroxyzine hcl oral tablet 10 mg, 25 mg, (Hydroxyzine HCl) 50 mg hydroxyzine pamoate oral capsule 100 (Vistaril) mg, 25 mg, 50 mg KEVEYIS ORAL TABLET 50 MG 2 2 LEMTRADA INTRAVENOUS SOLUTION 12 MG/1.2 ML leucovorin calcium 200 mg vial sdv, p/f, latex-free 200 mg leucovorin calcium injection recon soln 100 mg, 350 mg leucovorin calcium oral tablet 10 mg, 15 mg, 25 mg, 5 mg levocarnitine (with sugar) oral solution 100 mg/ml levocarnitine intravenous solution 200 mg/ml levocarnitine oral tablet 330 mg mesna intravenous solution 100 mg/ml MESNEX ORAL TABLET 400 MG MESTINON ORAL SYRUP 60 MG/5 ML MESTINON TIMESPAN ORAL TABLET EXTENDED RELEASE 180 MG methylergonovine injection solution 0.2 mg/ml (1 ml) methylergonovine oral tablet 0.2 mg morrhuate sodium intravenous solution 5 % MYOBLOC INTRAMUSCULAR SOLUTION 10,000 UNIT/2 ML, 2,500 UNIT/0.5 ML, 5,000 UNIT/ML 5 Requirements/Limits 2 5 (Leucovorin Calcium) 2 (Leucovorin Calcium) 2 (Leucovorin Calcium) 2 (Levocarnitine (With Sugar)) (Carnitor) 2 (Carnitor) (Mesnex) 2 2 5 4 PA NSO; QL (120 per 30 days) PA 2 4 (Methylergonovine Maleate) (Methergine) (Sodium Morrhuate) 2 2 2 4 QL (1 per 90 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 134 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits NPLATE SUBCUTANEOUS RECON SOLN 250 MCG, 500 MCG OTEZLA ORAL TABLET 30 MG 5 PA; QL (8 per 28 days) 5 OTEZLA STARTER ORAL TABLETS,DOSE PACK 10 MG (4)-20 MG (4)-30 MG (47), 10 MG (4)-20 MG (4)-30 MG(19) OTREXUP (PF) SUBCUTANEOUS AUTO-INJECTOR 10 MG/0.4 ML, 15 MG/0.4 ML, 17.5 MG/0.4 ML, 20 MG/0.4 ML, 22.5 MG/0.4 ML, 25 MG/0.4 ML, 7.5 MG/0.4 ML PLEGRIDY SUBCUTANEOUS PEN INJECTOR 125 MCG/0.5 ML, 63 MCG/0.5 ML- 94 MCG/0.5 ML PLEGRIDY SUBCUTANEOUS SYRINGE 125 MCG/0.5 ML, 63 MCG/0.5 ML- 94 MCG/0.5 ML probenecid oral tablet 500 mg (Probenecid) PROCYSBI ORAL CAPSULE, DELAYED REL SPRINKLE 25 MG, 75 MG pyridostigmine bromide oral tablet 60 mg (Mestinon) pyridostigmine bromide oral tablet (Mestinon) extended release 180 mg RASUVO (PF) SUBCUTANEOUS AUTO-INJECTOR 10 MG/0.2 ML, 12.5 MG/0.25 ML, 15 MG/0.3 ML, 17.5 MG/0.35 ML, 20 MG/0.4 ML, 22.5 MG/0.45 ML, 25 MG/0.5 ML, 27.5 MG/0.55 ML, 30 MG/0.6 ML, 7.5 MG/0.15 ML REBIF (WITH ALBUMIN) SUBCUTANEOUS SYRINGE 22 MCG/0.5 ML, 44 MCG/0.5 ML 5 PA; QL (60 per 30 days) PA; QL (60 per 30 days) 3 5 ST 5 ST 2 5 2 2 3 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 135 Effective: July 01, 2016 Drug Name Drug Tier REBIF REBIDOSE SUBCUTANEOUS PEN INJECTOR 22 MCG/0.5 ML, 44 MCG/0.5 ML, 8.8MCG/0.2ML-22 MCG/0.5ML (6) REBIF TITRATION PACK SUBCUTANEOUS SYRINGE 8.8MCG/0.2ML-22 MCG/0.5ML (6) REMICADE INTRAVENOUS RECON SOLN 100 MG SENSIPAR ORAL TABLET 30 MG SENSIPAR ORAL TABLET 60 MG, 90 MG SIGNIFOR SUBCUTANEOUS SOLUTION 0.3 MG/ML (1 ML), 0.6 MG/ML (1 ML), 0.9 MG/ML (1 ML) SIMPONI ARIA INTRAVENOUS SOLUTION 12.5 MG/ML SIMPONI SUBCUTANEOUS PEN INJECTOR 100 MG/ML, 50 MG/0.5 ML SIMPONI SUBCUTANEOUS SYRINGE 100 MG/ML, 50 MG/0.5 ML STELARA SUBCUTANEOUS SYRINGE 45 MG/0.5 ML, 90 MG/ML STERILE PADS 2" X 2" 2 X 2 " SYNAREL NASAL SPRAY,NON-AEROSOL 2 MG/ML TECFIDERA ORAL CAPSULE,DELAYED RELEASE(DR/EC) 120 MG TECFIDERA ORAL CAPSULE,DELAYED RELEASE(DR/EC) 120 MG (14)- 240 MG (46), 240 MG THALOMID ORAL CAPSULE 100 MG, 150 MG, 200 MG, 50 MG 5 Requirements/Limits 5 5 PA 3 5 5 QL (60 per 30 days) 5 PA 5 PA 5 PA 5 PA 1 5 5 QL (14 per 30 days) 5 QL (60 per 30 days) 5 PA NSO; QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 136 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits TYBOST ORAL TABLET 150 MG ULORIC ORAL TABLET 40 MG, 80 MG XELJANZ ORAL TABLET 5 MG 4 3 QL (30 per 30 days) QL (30 per 30 days) 5 XELJANZ XR ORAL TABLET EXTENDED RELEASE 24 HR 11 MG 5 PA; QL (60 per 30 days) PA; QL (30 per 30 days) Ophthalmic Agents Antiglaucoma Agents acetazolamide oral capsule, extended release 500 mg acetazolamide oral tablet 125 mg, 250 mg acetazolamide sodium injection recon soln 500 mg ALPHAGAN P OPHTHALMIC DROPS 0.1 % AZOPT OPHTHALMIC DROPS,SUSPENSION 1 % betaxolol ophthalmic drops 0.5 % BETOPTIC S OPHTHALMIC DROPS,SUSPENSION 0.25 % bimatoprost ophthalmic drops 0.03 % brimonidine ophthalmic drops 0.15 %, 0.2 % COMBIGAN OPHTHALMIC DROPS 0.2-0.5 % dorzolamide ophthalmic drops 2 % dorzolamide-timolol ophthalmic drops 22.3-6.8 mg/ml latanoprost ophthalmic drops 0.005 % levobunolol ophthalmic drops 0.25 %, 0.5 % LUMIGAN OPHTHALMIC DROPS 0.01 % methazolamide oral tablet 25 mg, 50 mg (Diamox Sequels) 2 (Acetazolamide) (Acetazolamide Sodium) 2 2 3 3 (Betaxolol HCl) 2 4 (Bimatoprost) (Alphagan P) 2 2 (drops: 0.15%, 0.20%) 3 (Trusopt) (Cosopt) 2 2 (Xalatan) (Betagan) 2 2 3 (Neptazane) QL (2.5 per 25 days) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 137 Effective: July 01, 2016 Drug Name metipranolol ophthalmic drops 0.3 % PHOSPHOLINE IODIDE OPHTHALMIC DROPS 0.125 % pilocarpine hcl ophthalmic drops 1 %, 2 %, 4 % SIMBRINZA OPHTHALMIC DROPS,SUSPENSION 1-0.2 % timolol maleate ophthalmic drops 0.25 %, 0.5 % timolol maleate ophthalmic gel forming solution 0.25 %, 0.5 % TRAVATAN Z OPHTHALMIC DROPS 0.004 % travoprost (benzalkonium) ophthalmic drops 0.004 % ZIOPTAN (PF) OPHTHALMIC DROPPERETTE 0.0015 % Drug Tier (Metipranolol) 2 3 (Isopto Carpine) 2 Requirements/Limits 3 (Timoptic) 2 (Timoptic-Xe) 2 (Travoprost (Benzalkonium)) 3 QL (2.5 per 25 days) 2 QL (2.5 per 25 days) 4 QL (30 per 30 days) Replacement Preparations Replacement Preparations calcium chloride intravenous solution 100 mg/ml (10 %) calcium chloride intravenous syringe 100 mg/ml (10 %) calcium gluconate intravenous solution 100 mg/ml (10%) d10 %-0.45 % sodium chloride intravenous parenteral solution d2.5 %-0.45 % sodium chloride intravenous parenteral solution d5 % and 0.9 % sodium chloride intravenous parenteral solution d5 %-0.45 % sodium chloride intravenous parenteral solution dextrose 10 % and 0.2 % nacl intravenous parenteral solution (Calcium Chloride) 2 (Calcium Chloride) 2 (Calcium Gluconate) 2 (Dextrose 10 % and 0.45 % NaCl) (Dextrose 2.5 % and 0.45 % NaCl) (Dextrose 5 % and 0.9 % NaCl) (Dextrose 5 %-0.45 % NaCl) (Dextrose 10 % and 0.2 % NaCl) 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 138 Effective: July 01, 2016 Drug Name dextrose 5 %-lactated ringers intravenous parenteral solution dextrose 5%-0.2 % sod chloride intravenous parenteral solution dextrose 5%-0.3 % sod.chloride intravenous parenteral solution dextrose with sodium chloride intravenous parenteral solution 5-0.2 % effer-k oral tablet, effervescent 25 meq electrolyte-48 in d5w intravenous parenteral solution HYPERLYTE CR INTRAVENOUS SOLUTION 25-20-5-5-30-30 MEQ/20 ML IONOSOL-B IN D5W INTRAVENOUS PARENTERAL SOLUTION 5 % IONOSOL-MB IN D5W INTRAVENOUS PARENTERAL SOLUTION 5 % ISOLYTE M IN 5 % DEXTROSE INTRAVENOUS PARENTERAL SOLUTION ISOLYTE-H IN 5 % DEXTROSE INTRAVENOUS PARENTERAL SOLUTION 5 % ISOLYTE-P IN 5 % DEXTROSE INTRAVENOUS PARENTERAL SOLUTION 5 % ISOLYTE-S INTRAVENOUS PARENTERAL SOLUTION k-effervescent oral tablet, effervescent 25 meq klor-con 10 oral tablet extended release 10 meq klor-con m10 tablet 10 meq Drug Tier (Dextrose 5%-Lactated Ringers) (Dextrose 5 %-0.2 % NaCl) (Dextrose 5 % and 0.3 % NaCl) (Dextrose 5 %-0.2 % NaCl) (Klor-Con-Ef) (Electrolyte-48 Solution/D5W) Requirements/Limits 2 2 2 2 2 2 4 4 4 4 4 4 4 (Klor-Con-Ef) 2 (Potassium Chloride) 2 (Potassium Chloride) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 139 Effective: July 01, 2016 Drug Name klor-con m15 oral tablet,er particles/crystals 15 meq klor-con m20 oral tablet,er particles/crystals 20 meq klor-con sprinkle oral capsule, extended release 10 meq, 8 meq magnesium chloride injection solution 200 mg/ml (20 %) magnesium sulf in 0.45% nacl intravenous solution 20 gram/500 ml (40 mg/ml) magnesium sulfate in d5w intravenous piggyback 1 gram/100 ml, 4 gram/100 ml magnesium sulfate in water intravenous parenteral solution 20 gram/500 ml (4 %), 40 gram/1,000 ml (4 %) magnesium sulfate in water intravenous piggyback 2 gram/50 ml (4 %), 4 gram/100 ml (4 %), 4 gram/50 ml (8 %) magnesium sulfate injection solution 4 meq/ml (50 %) magnesium sulfate injection syringe 4 meq/ml NORMOSOL-M IN 5 % DEXTROSE INTRAVENOUS PARENTERAL SOLUTION NORMOSOL-R PH 7.4 INTRAVENOUS PARENTERAL SOLUTION NUTRILYTE II INTRAVENOUS SOLUTION 35-20-5 MEQ/20 ML NUTRILYTE INTRAVENOUS SOLUTION 25-40.6-5 MEQ/20 ML phospha 250 neutral oral tablet 250 mg PLASMA-LYTE 148 INTRAVENOUS PARENTERAL SOLUTION PLASMA-LYTE A INTRAVENOUS PARENTERAL SOLUTION Drug Tier (Potassium Chloride) 2 (Potassium Chloride) 2 (Potassium Chloride) 2 (Magnesium Chloride) 2 (Magnesium Sulf In 0.45% NaCl) (Magnesium Sulfate/D5W) (Magnesium Sulfate in Water) 2 (Magnesium Sulfate in Water) 2 (Magnesium Sulfate) 2 (Magnesium Sulfate) 2 Requirements/Limits 2 2 4 4 4 4 (K-Phos Neutral) 2 4 4 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 140 Effective: July 01, 2016 Drug Name Drug Tier PLASMA-LYTE-56 IN 5 % DEXTROSE INTRAVENOUS PARENTERAL SOLUTION 5 % potassium acetate intravenous solution 2 meq/ml, 4 meq/ml potassium bicarb and chloride oral tablet, effervescent 25 meq potassium bicarb-citric acid oral tablet, effervescent 25 meq potassium chlorid-d5-0.45%nacl intravenous parenteral solution 10 meq/l, 20 meq/l, 30 meq/l, 40 meq/l potassium chloride in 0.9%nacl intravenous parenteral solution 20 meq/l, 40 meq/l potassium chloride in 5 % dex intravenous parenteral solution 20 meq/l, 30 meq/l, 40 meq/l potassium chloride in lr-d5 intravenous parenteral solution 20 meq/l potassium chloride intravenous piggyback 10 meq/100 ml, 20 meq/100 ml, 30 meq/100 ml, 40 meq/100 ml potassium chloride intravenous solution 2 meq/ml potassium chloride oral capsule, extended release 10 meq, 8 meq potassium chloride oral liquid 20 meq/15 ml, 40 meq/15 ml potassium chloride oral packet 20 meq potassium chloride oral tablet extended release 8 meq potassium chloride oral tablet,er particles/crystals 10 meq potassium chloride oral tablet,er particles/crystals 20 meq 4 (Potassium Acetate) 2 (Pot Chloride/Pot Bicarb/Cit Ac) (Klor-Con-Ef) 2 (Potassium Chloride/D5-0.45nacl) 2 (Potassium Chloride In 0.9%NaCl) 2 (Potassium Chloride In D5w) 2 (Potassium Chloride In Lr-D5) (Potassium Chloride) 2 (Potassium Chloride) 2 (Potassium Chloride) 2 (Potassium Chloride) 2 (Klor-Con) (K-Tab ER) 2 2 (K-Tab ER) 2 (Potassium Chloride) 2 Requirements/Limits 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 141 Effective: July 01, 2016 Drug Name potassium chloride-0.45 % nacl intravenous parenteral solution 20 meq/l potassium chloride-d5-0.2%nacl intravenous parenteral solution 10 meq/l, 20 meq/l, 30 meq/l, 40 meq/l potassium chloride-d5-0.3%nacl intravenous parenteral solution 20 meq/l potassium chloride-d5-0.9%nacl intravenous parenteral solution 20 meq/l, 40 meq/l potassium citrate oral tablet extended release 10 meq (1,080 mg), 15 meq, 5 meq (540 mg) potassium citrate-citric acid oral packet 3,300-1,002 mg potassium cl 10 meq/50 ml sol 10 meq/50 ml potassium cl 20 meq/50 ml sol 20 meq/50 ml potassium cl er 10 meq tablet f/c 10 meq potassium phosphate m-/d-basic intravenous solution 3 mmol/ml ringers intravenous parenteral solution sodium acetate intravenous solution 2 meq/ml, 4 meq/ml sodium bicarbonate intravenous solution 1 meq/ml (8.4 %) sodium bicarbonate intravenous syringe 10 meq/10 ml (8.4 %), 4.2 % (0.5 meq/ml), 7.5 % (0.9 meq/ml), 8.4 % (1 meq/ml) sodium chloride 0.45 % intravenous parenteral solution 0.45 % sodium chloride 0.9 % intravenous parenteral solution 0.9 % Drug Tier (Potassium Chloride-0.45% NaCl) (Potassium Chloride/D5-0.2%NaC l) (Potassium Chloride/D5-0.3%NaC l) (Potassium Chloride/D5-0.9%NaC l) (Urocit-K) 2 (Potassium Citrate/Citric Acid) (Potassium Chloride) 2 (Potassium Chloride) 2 (K-Tab ER) (Potassium Phos,M-Basic-D-Basic) (Ringers Solution) (Sodium Acetate) 2 2 (Sodium Bicarbonate) 2 (Sodium Bicarbonate) 2 (Sodium Chloride 0.45 %) (0.9 % Sodium Chloride) 2 Requirements/Limits 2 2 2 2 2 2 2 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 142 Effective: July 01, 2016 Drug Name sodium chloride 3 % intravenous parenteral solution 3 % sodium chloride 5 % intravenous parenteral solution 5 % sodium chloride intravenous parenteral solution 2.5 meq/ml, 4 meq/ml sodium lactate intravenous parenteral solution 167 meq/l sodium lactate intravenous solution 5 meq/ml sodium phosphate intravenous solution 3 mmol/ml TPN ELECTROLYTES II IV SOLN 25'S,20ML/50ML FTV 18-18-5-4.5-35 MEQ/20 ML TPN ELECTROLYTES INTRAVENOUS SOLUTION 35-20-5 MEQ/20 ML virt-phos 250 neutral oral tablet 250 mg Drug Tier (Sodium Chloride 3 %) 2 (Sodium Chloride 5 %) 2 (Sodium Chloride) 2 (Sodium Lactate) 2 (Sodium Lactate) 2 (Sodium Phos,M-Basic-D-Basic) 2 Requirements/Limits 4 4 (K-Phos Neutral) 2 Respiratory Tract Agents Anti-Inflammatories, Inhaled Corticosteroids ADVAIR DISKUS INHALATION BLISTER WITH DEVICE 100-50 MCG/DOSE, 250-50 MCG/DOSE, 500-50 MCG/DOSE ADVAIR HFA INHALATION HFA AEROSOL INHALER 115-21 MCG/ACTUATION, 230-21 MCG/ACTUATION, 45-21 MCG/ACTUATION BREO ELLIPTA INHALATION BLISTER WITH DEVICE 100-25 MCG/DOSE, 200-25 MCG/DOSE 3 QL (60 per 30 days) 3 QL (12 per 28 days) 3 QL (60 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 143 Effective: July 01, 2016 Drug Name Drug Tier DULERA INHALATION HFA AEROSOL INHALER 100-5 MCG/ACTUATION, 200-5 MCG/ACTUATION FLOVENT DISKUS INHALATION BLISTER WITH DEVICE 100 MCG/ACTUATION, 50 MCG/ACTUATION FLOVENT DISKUS INHALATION BLISTER WITH DEVICE 250 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 110 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 220 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 44 MCG/ACTUATION QVAR INHALATION AEROSOL 40 MCG/ACTUATION, 80 MCG/ACTUATION Antileukotrienes montelukast oral granules in packet 4 mg montelukast oral tablet 10 mg montelukast oral tablet,chewable 4 mg, 5 mg zafirlukast oral tablet 10 mg, 20 mg Bronchodilators albuterol sulfate inhalation solution for nebulization 0.63 mg/3 ml, 1.25 mg/3 ml, 2.5 mg /3 ml (0.083 %), 5 mg/ml albuterol sulfate oral syrup 2 mg/5 ml albuterol sulfate oral tablet 2 mg, 4 mg albuterol sulfate oral tablet extended release 12 hr 4 mg, 8 mg 3 QL (13 per 28 days) 3 QL (60 per 30 days) 3 QL (120 per 30 days) 3 QL (12 per 28 days) 3 QL (24 per 28 days) 3 QL (21.2 per 28 days) 3 QL (17.4 per 25 days) (Singulair) (Singulair) (Singulair) 2 2 2 (Accolate) 2 (Albuterol Sulfate) 2 (Albuterol Sulfate) (Albuterol Sulfate) (Vospire ER) 2 2 2 Requirements/Limits PA BvD You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 144 Effective: July 01, 2016 Drug Name ATROVENT HFA INHALATION HFA AEROSOL INHALER 17 MCG/ACTUATION COMBIVENT RESPIMAT INHALATION MIST 20-100 MCG/ACTUATION elixophyllin oral elixir 80 mg/15 ml FORADIL AEROLIZER INHALATION CAPSULE, W/INHALATION DEVICE 12 MCG ipratropium bromide inhalation solution 0.02 % ipratropium-albuterol inhalation solution for nebulization 0.5 mg-3 mg(2.5 mg base)/3 ml metaproterenol oral syrup 10 mg/5 ml metaproterenol oral tablet 10 mg, 20 mg Drug Tier (Theophylline Anhydrous) Requirements/Limits 3 QL (25.8 per 28 days) 3 QL (8 per 30 days) 2 3 (Ipratropium Bromide) 2 (Ipratropium/Albuterol Sulfate) 2 (Metaproterenol Sulfate) (Metaproterenol Sulfate) 2 PROAIR HFA INHALATION HFA AEROSOL INHALER 90 MCG/ACTUATION PROAIR RESPICLICK INHALATION AEROSOL POWDR BREATH ACTIVATED 90 MCG/ACTUATION SEREVENT DISKUS INHALATION BLISTER WITH DEVICE 50 MCG/DOSE SPIRIVA RESPIMAT INHALATION MIST 1.25 MCG/ACTUATION, 2.5 MCG/ACTUATION SPIRIVA WITH HANDIHALER INHALATION CAPSULE, W/INHALATION DEVICE 18 MCG 2 3 3 3 3 3 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 145 Effective: July 01, 2016 Drug Name Drug Tier STRIVERDI RESPIMAT INHALATION MIST 2.5 MCG/ACTUATION terbutaline oral tablet 2.5 mg, 5 mg terbutaline subcutaneous solution 1 mg/ml theochron oral tablet extended release 12 hr 100 mg, 200 mg, 300 mg theophylline in dextrose 5 % intravenous parenteral solution 200 mg/100 ml, 200 mg/50 ml, 400 mg/250 ml, 400 mg/500 ml, 800 mg/250 ml theophylline oral solution 80 mg/15 ml 3 theophylline oral tablet extended release 12 hr 100 mg, 200 mg, 300 mg, 450 mg theophylline oral tablet extended release 400 mg, 600 mg TUDORZA PRESSAIR INHALATION AEROSOL POWDR BREATH ACTIVATED 400 MCG/ACTUATION, 400 MCG/ACTUATION (30 ACTUAT) VENTOLIN HFA INHALATION HFA AEROSOL INHALER 90 MCG/ACTUATION Respiratory Tract Agents, Other acetylcysteine intravenous solution 200 mg/ml (20 %) acetylcysteine solution 100 mg/ml (10 %), 200 mg/ml (20 %) CINQAIR INTRAVENOUS SOLUTION 10 MG/ML cromolyn inhalation solution for nebulization 20 mg/2 ml DALIRESP ORAL TABLET 500 MCG (Terbutaline Sulfate) (Terbutaline Sulfate) 2 2 (Theophylline Anhydrous) (Theophylline/D5W) 2 (Theophylline Anhydrous) (Theophylline Anhydrous) (Theophylline Anhydrous) 2 Requirements/Limits 2 2 2 3 QL (2 per 28 days) 3 (Acetadote) 2 PA BvD (Acetadote) 2 PA BvD 5 PA 2 PA BvD 3 QL (30 per 30 days) (Cromolyn Sodium) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 146 Effective: July 01, 2016 Drug Name Drug Tier ESBRIET ORAL CAPSULE 267 MG 5 KALYDECO ORAL GRANULES IN PACKET 50 MG, 75 MG KALYDECO ORAL TABLET 150 MG NUCALA SUBCUTANEOUS RECON SOLN 100 MG OFEV ORAL CAPSULE 100 MG, 150 MG ORKAMBI ORAL TABLET 200-125 MG PROLASTIN-C INTRAVENOUS RECON SOLN 1,000 MG XOLAIR SUBCUTANEOUS RECON SOLN 150 MG 5 5 5 5 5 Requirements/Limits PA; QL (270 per 30 days) PA; QL (60 per 30 days) PA; QL (60 per 30 days) PA; LA; QL (1 per 28 days) PA PA; QL (120 per 30 days) 5 5 PA Skeletal Muscle Relaxants Skeletal Muscle Relaxants baclofen oral tablet 10 mg, 20 mg carisoprodol oral tablet 250 mg, 350 mg chlorzoxazone oral tablet 500 mg cyclobenzaprine oral tablet 10 mg, 5 mg, 7.5 mg dantrolene oral capsule 100 mg, 25 mg, 50 mg metaxall oral tablet 800 mg metaxalone oral tablet 400 mg, 800 mg methocarbamol oral tablet 500 mg, 750 mg revonto intravenous recon soln 20 mg tizanidine oral capsule 2 mg, 4 mg, 6 mg tizanidine oral tablet 2 mg, 4 mg (Baclofen) (Soma) (Parafon Forte DSC) (Fexmid) 2 2 2 2 (Dantrium) 2 (Skelaxin) (Skelaxin) (Robaxin) 2 2 2 (Zanaflex) (Zanaflex) 2 2 2 QL (120 per 30 days) Sleep Disorder Agents Sleep Disorder Agents BELSOMRA ORAL TABLET 10 MG, 15 MG, 20 MG, 5 MG 3 QL (30 per 30 days) You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 147 Effective: July 01, 2016 Drug Name eszopiclone oral tablet 1 mg, 2 mg, 3 mg HETLIOZ ORAL CAPSULE 20 MG NUVIGIL ORAL TABLET 150 MG, 200 MG, 250 MG, 50 MG ROZEREM ORAL TABLET 8 MG XYREM ORAL SOLUTION 500 MG/ML zaleplon oral capsule 10 mg, 5 mg zolpidem oral tablet 10 mg, 5 mg zolpidem oral tablet,ext release multiphase 12.5 mg, 6.25 mg Drug Tier (Lunesta) (Sonata) (Ambien) (Ambien CR) Requirements/Limits 2 5 3 QL (30 per 30 days) PA PA 3 5 LA 2 2 2 QL (60 per 30 days) QL (30 per 30 days) QL (30 per 30 days) 5 2 PA; QL (60 per 30 days) PA; QL (90 per 30 days) PA; QL (30 per 30 days) PA BvD 5 PA BvD 5 Vasodilating Agents Vasodilating Agents ADCIRCA ORAL TABLET 20 MG ADEMPAS ORAL TABLET 0.5 MG, 1 MG, 1.5 MG, 2 MG, 2.5 MG CIALIS ORAL TABLET 2.5 MG, 5 MG epoprostenol (glycine) intravenous recon (Flolan) soln 0.5 mg epoprostenol (glycine) intravenous recon (Flolan) soln 1.5 mg LETAIRIS ORAL TABLET 10 MG, 5 MG OPSUMIT ORAL TABLET 10 MG 5 ORENITRAM ORAL TABLET EXTENDED RELEASE 0.125 MG ORENITRAM ORAL TABLET EXTENDED RELEASE 0.25 MG, 1 MG, 2.5 MG REMODULIN INJECTION SOLUTION 1 MG/ML, 10 MG/ML, 2.5 MG/ML, 5 MG/ML 3 PA; QL (30 per 30 days) PA; QL (30 per 30 days) PA 5 PA 5 PA BvD 3 5 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 148 Effective: July 01, 2016 Drug Name Drug Tier Requirements/Limits sildenafil intravenous solution 10 mg/12.5 (Revatio) ml sildenafil oral tablet 20 mg (Revatio) 5 PA; QL (37.5 per 1 day) 2 TRACLEER ORAL TABLET 125 MG, 62.5 MG TYVASO INHALATION SOLUTION FOR NEBULIZATION 1.74 MG/2.9 ML (0.6 MG/ML) TYVASO REFILL KIT INHALATION SOLUTION FOR NEBULIZATION 1.74 MG/2.9 ML (0.6 MG/ML) TYVASO STARTER KIT INHALATION SOLUTION FOR NEBULIZATION 1.74 MG/2.9 ML UPTRAVI ORAL TABLET 1,000 MCG, 1,200 MCG, 1,400 MCG, 1,600 MCG, 400 MCG, 600 MCG, 800 MCG UPTRAVI ORAL TABLET 200 MCG 5 5 PA; QL (90 per 30 days) PA; LA; QL (60 per 30 days) PA BvD 5 PA BvD 5 PA BvD 5 PA; QL (60 per 30 days) 5 UPTRAVI ORAL TABLETS,DOSE PACK 200 MCG (140)- 800 MCG (60) 5 PA; QL (240 per 30 days) PA; QL (200 per 365 days) Vitamins And Minerals Vitamins And Minerals multivit-fluor 0.5 mg tab chew chewable, d/f, s/f 0.5 mg pnv prenatal plus multivit tab s/f, gluten-free 27 mg iron- 1 mg prenatal vitamin plus low iron oral tablet 27 mg iron- 1 mg sodium fluoride 1 mg (2.2 mg) 1 mg fluoride (2.2 mg) sodium fluoride oral tablet 1 mg fluoride (2.2 mg) (Pedi M.Vit No.17 with Fluoride) (Pnv with Ca,No.72/Iron/Fa) (Pnv with Ca,No.72/Iron/Fa) (Sodium Fluoride) 2 (Pedi M.Vit No.17 with Fluoride) 2 3 3 (All Rx Prenatal Vitamins Covered) (All Rx Prenatal Vitamins Covered) 2 You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 149 Effective: July 01, 2016 Drug Name Drug Tier VITAFOL FE+ (WITH DOCUSATE) ORAL CAPSULE 90 MG IRON-1 MG -50 MG-200 MG 3 Requirements/Limits You can find information on what the symbols and abbreviations in this table mean by going to the introduction pages of this document Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 150 Effective: July 01, 2016 INDEX Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-1 AMINOSYN 7 % WITH ELECTROLYTES ................................. 69 AMINOSYN 8.5 % ............................... 69 AMINOSYN 8.5 %-ELECTROLYTES ........................ 69 AMINOSYN II 10 % .......................... 69 AMINOSYN II 15 % .......................... 69 AMINOSYN II 7 % ............................. 69 AMINOSYN II 8.5 % ........................ 69 AMINOSYN II 8.5 %-ELECTROLYTES ........................ 70 AMINOSYN M 3.5 % ...................... 70 AMINOSYN-HBC 7% .................... 70 AMINOSYN-PF 10 % ..................... 70 AMINOSYN-PF 7 % (SULFITE-FREE) ................................. 70 AMINOSYN-RF 5.2 % .................. 70 amiodarone .......................................................... 76 AMITIZA ........................................................ 110 amitriptyline ...................................................... 39 amlodipine ............................................................. 81 amlodipine-atorvastatin ..................... 83 amlodipine-benazepril ........................... 81 amlodipine-valsartan .............................. 81 amlodipine-valsartan-hcthiazid ............................................................................................... 81 ammonium chloride .............................. 132 ammonium lactate ..................................... 95 amoxapine ............................................................ 39 amoxicil-clarithromy-lansopraz ........................................................................................... 109 amoxicillin ............................................................ 19 amoxicillin-pot clavulanate ........... 19 amphotericin b ................................................ 47 ampicillin ................................................................ 19 ampicillin sodium ........................................ 19 ampicillin-sulbactam ................... 19, 20 AMPYRA ........................................................... 86 ANACAINE .................................................... 95 anagrelide .............................................................. 68 anastrozole ........................................................... 24 ANDRODERM ..................................... 114 Index ala-scalp ................................................................... 98 ALBENZA ......................................................... 53 albuterol sulfate ......................................... 144 alcaine ..................................................................... 104 alclometasone ................................................... 98 ALCOHOL PADS ................................. 95 ALCOHOL PREP PADS ............ 95 ALDURAZYME ................................. 102 ALECENSA .................................................... 23 alendronate ...................................................... 130 alfuzosin ............................................................... 113 ALIMTA ............................................................... 23 ALINIA .................................................................. 53 allopurinol ......................................................... 132 allopurinol sodium .................................. 132 ALLZITAL ........................................................... 3 almotriptan malate ................................... 50 alogliptin ................................................................. 42 alogliptin-metformin ............................... 43 alogliptin-pioglitazone ......................... 43 alosetron .............................................................. 129 ALPHAGAN P ....................................... 137 alprazolam ............................................................ 12 ALREX ............................................................... 107 altacaine ............................................................... 104 altavera (28) .................................................... 88 ALTOPREV .................................................... 83 alyacen 1/35 (28) ....................................... 88 alyacen 7/7/7 (28) ..................................... 88 amantadine hcl ................................................ 54 AMBISOME ................................................... 47 amethia ..................................................................... 88 amethia lo .............................................................. 88 amifostine crystalline ......................... 132 amiloride ................................................................. 82 amiloride-hydrochlorothiazide ............................................................................................... 82 AMINO ACIDS 15 % ....................... 69 aminocaproic acid ...................................... 68 AMINOSYN 10 % ................................. 69 AMINOSYN 3.5 % ............................... 69 AMINOSYN 7 % ..................................... 69 Index Index 8-MOP ...................................................................... 95 abacavir .................................................................... 59 abacavir-lamivudine-zidovudine ............................................................................................... 59 ABELCET .......................................................... 47 ABILIFY MAINTENA ..... 55, 56 ABRAXANE .................................................. 23 acamprosate ....................................................... 11 acarbose ................................................................... 42 acebutolol ............................................................... 77 acetaminophen-codeine ........................... 3 acetasol hc ......................................................... 105 acetazolamide ............................................... 137 acetazolamide sodium ....................... 137 acetic acid ........................................... 105, 129 acetylcysteine ................................................ 146 acitretin .................................................................... 95 ACTEMRA ................................................... 132 ACTHIB (PF) ............................................ 124 ACTIMMUNE ........................................ 132 ACTOPLUS MET XR ..................... 42 acyclovir ....................................................... 64, 95 acyclovir sodium ........................................... 64 ADACEL(TDAP ADOLESN/ADULT)(PF) ...... 124 ADAGEN ........................................................ 102 adapalene ............................................................ 101 ADCETRIS ...................................................... 23 ADCIRCA ...................................................... 148 adefovir ..................................................................... 64 ADEMPAS .................................................... 148 adriamycin ............................................................ 23 adrucil ......................................................................... 23 ADVAIR DISKUS ............................ 143 ADVAIR HFA ........................................ 143 afeditab cr ............................................................. 81 AFINITOR ....................................................... 23 AFINITOR DISPERZ .................... 23 a-hydrocort ...................................................... 116 AKTEN (PF) .............................................. 104 AKYNZEO ....................................................... 52 ala-cort ...................................................................... 98 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-2 bicalutamide ....................................................... 24 BICILLIN C-R ............................................ 20 BICILLIN L-A ............................................ 20 BIDIL ........................................................................ 85 bimatoprost ..................................................... 137 bisoprolol fumarate .................................. 77 bisoprolol-hydrochlorothiazide ............................................................................................... 77 bleomycin ............................................................... 24 bleph-10 ................................................................ 105 BLEPHAMIDE ...................................... 105 BLEPHAMIDE S.O.P. ................ 105 BLINCYTO ...................................................... 24 blisovi 24 fe .......................................................... 88 blisovi fe 1.5/30 (28) .............................. 88 blisovi fe 1/20 (28) ................................... 89 BOOSTRIX TDAP ............. 124, 125 BOSULIF ............................................................ 24 BOTOX ............................................................... 132 BREO ELLIPTA .................................. 143 briellyn ....................................................................... 89 BRILINTA ........................................................ 68 brimonidine ...................................................... 137 BRINTELLIX .............................................. 39 BRIVIACT ........................................................ 34 bromfenac .......................................................... 108 bromocriptine ................................................... 54 budesonide ......................................................... 129 bumetanide ........................................................... 82 BUPHENYL ............................................... 110 buprenorphine hcl ................................ 3, 11 buprenorphine-naloxone .................... 11 buproban ................................................................. 39 bupropion hcl ......................................... 11, 39 buspirone ............................................................. 133 butalbital compound w/codeine .... 3 butalbital-acetaminop-caf-cod ...... 3 butalbital-acetaminophen .................... 3 butalbital-acetaminophen-caff ...... 3 butalbital-aspirin-caffeine ................... 3 butorphanol tartrate ................................... 3 BUTRANS ............................................................ 4 BYSTOLIC ........................................................ 77 cabergoline ........................................................... 54 CABOMETYX ............................................ 24 Index azithromycin ........................................... 17, 18 AZOPT ................................................................. 137 AZOR ........................................................................ 81 aztreonam .............................................................. 18 azurette (28) .................................................... 88 baciim .......................................................................... 13 bacitracin ................................................ 14, 105 bacitracin-polymyxin b ................... 105 baclofen ................................................................. 147 balsalazide ........................................................ 129 balziva (28) ........................................................ 88 BANZEL .............................................................. 34 BARACLUDE ............................................. 64 BCG VACCINE, LIVE (PF) ........................................................................................... 124 BD INSULIN PEN NEEDLE UF SHORT ................................................... 102 BD INSULIN SYRINGE ULTRA-FINE .......................................... 102 bekyree (28) ..................................................... 88 BELBUCA ............................................................. 3 BELEODAQ ................................................... 24 BELSOMRA ............................................... 147 benazepril ............................................................... 75 benazepril-hydrochlorothiazide ............................................................................................... 75 BENDEKA ....................................................... 24 BENICAR .......................................................... 74 BENICAR HCT ........................................ 74 BENLYSTA ................................................. 132 benztropine .......................................................... 54 BEPREVE ....................................................... 104 betamethasone acet,sod phos ........................................................................................... 117 betamethasone dipropionate ........ 98 betamethasone valerate ...................... 98 betamethasone, augmented .................................................................................... 98, 99 BETASERON ........................................... 132 betaxolol .................................................. 77, 137 bethanechol chloride ............................ 132 BETHKIS ............................................................ 13 BETOPTIC S .............................................. 137 bexarotene ............................................................ 24 BEXSERO (PF) ...................................... 124 Index Index ANDROGEL ............................................. 114 androxy ................................................................. 114 anticoag citrate phos dextrose ........................................................................................... 132 APOKYN ............................................................ 54 apraclonidine ................................................. 104 apri .................................................................................. 88 APRISO .............................................................. 129 APTIOM ............................................................... 34 APTIVUS ............................................................. 59 aranelle (28) ..................................................... 88 ARCALYST ................................................ 121 aripiprazole ......................................................... 56 ARISTADA ..................................................... 56 ASACOL HD ............................................. 129 ascomp with codeine ................................... 3 ashlyna ....................................................................... 88 aspirin-dipyridamole ............................... 68 ASSURE ID INSULIN SAFETY ............................................................ 101 ASTAGRAF XL ................................... 121 atenolol ..................................................................... 77 atenolol-chlorthalidone ....................... 77 atorvastatin ......................................................... 83 atovaquone ........................................................... 53 atovaquone-proguanil ............................ 53 ATRIPLA ............................................................ 60 atropine ...................................................... 33, 104 atropine-care ................................................. 104 ATROVENT HFA ............................ 145 AUBAGIO ..................................................... 121 aubra ............................................................................ 88 AURYXIA ..................................................... 112 AVASTIN ........................................................... 24 AVC VAGINAL ....................................... 50 aviane .......................................................................... 88 AVONEX ......................................................... 132 AVONEX (WITH ALBUMIN) ........................................................................................... 132 AXIRON ........................................................... 115 azacitidine ............................................................. 24 azathioprine .................................................... 121 azathioprine sodium ............................. 121 azelastine ............................................................ 104 AZILECT ............................................................ 54 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-3 chlorzoxazone .............................................. 147 cholestyramine (with sugar) ....... 83 cholestyramine light ................................ 83 choline,magnesium salicylate ......... 8 CIALIS ................................................................. 148 ciclopirox ............................................................... 48 ciclopirox-ure-camph-menth-euc ............................................................................................... 48 cidofovir ................................................................... 64 cilostazol ................................................................. 68 CILOXAN ...................................................... 105 cimetidine ........................................................... 109 cimetidine hcl ................................................ 109 CIMZIA ............................................................. 121 CIMZIA POWDER FOR RECONST ...................................................... 121 CINQAIR ........................................................ 146 CINRYZE .......................................................... 67 CIPRODEX .................................................. 105 ciprofloxacin ...................................................... 21 ciprofloxacin (mixture) .................... 21 ciprofloxacin hcl ............................ 21, 105 ciprofloxacin in 5 % dextrose ..... 21 ciprofloxacin lactate ............................... 21 citalopram ............................................................. 39 cladribine ................................................................ 24 clarithromycin ................................................. 18 clemastine .............................................................. 50 CLEVIPREX .................................................. 81 clindamycin hcl ............................................... 14 clindamycin in 5 % dextrose ........ 14 clindamycin palmitate hcl ................ 14 clindamycin pediatric ............................. 14 clindamycin phosphate ........................................................................ 14, 50, 97 clindamycin-benzoyl peroxide ... 97 CLINIMIX 5%/D15W SULFITE FREE ....................................... 70 CLINIMIX 5%/D25W SULFITE-FREE ...................................... 70 CLINIMIX 2.75%/D5W SULFIT FREE ............................................ 70 CLINIMIX 4.25%/D10W SULF FREE ......................................................................... 70 Index cefdinir ....................................................................... 16 cefditoren pivoxil ......................................... 16 cefepime ................................................................... 16 CEFEPIME IN DEXTROSE 5 % ........................................................................................ 16 CEFEPIME IN DEXTROSE,ISO-OSM .................. 16 cefixime .................................................................... 16 cefotaxime ............................................................ 16 cefoxitin ................................................................... 16 cefoxitin in dextrose, iso-osm ..... 16 cefpodoxime ....................................................... 16 cefprozil .................................................................... 16 ceftazidime ........................................................... 16 ceftibuten ................................................................ 16 ceftriaxone ................................................ 16, 17 ceftriaxone in dextrose,iso-os .................................................................................... 16, 17 cefuroxime axetil ........................................ 17 cefuroxime sodium .................................... 17 celecoxib ..................................................................... 8 CELLCEPT INTRAVENOUS ........................................................................................... 121 CELONTIN ..................................................... 34 cephalexin ............................................................. 17 CEPROTIN (BLUE BAR) ........ 65 CERDELGA ............................................... 133 CEREZYME ............................................... 102 CERVARIX VACCINE (PF) ........................................................................................... 125 cevimeline .............................................................. 95 CHANTIX ......................................................... 11 CHANTIX CONTINUING MONTH BOX .............................................. 11 CHANTIX STARTING MONTH BOX .............................................. 11 chloramphenicol sod succinate ............................................................................................... 14 chlordiazepoxide hcl ............................... 12 chlorhexidine gluconate ...................... 95 chloroquine phosphate .......................... 53 chlorothiazide ................................................... 82 chlorothiazide sodium ........................... 82 chlorpromazine ............................................... 56 chlorthalidone .................................................. 82 Index Index caffeine citrated ............................................ 86 caffeine-sodium benzoate ................. 86 calcipotriene ............................................ 95, 96 calcitonin (salmon) .............................. 130 calcitrene ................................................................ 96 calcitriol .................................................... 96, 130 calcium acetate ........................................... 112 calcium chloride ........................................ 138 calcium gluconate ................................... 138 CALDOLOR ...................................................... 8 camila .......................................................................... 89 camrese ..................................................................... 89 camrese lo .............................................................. 89 CANCIDAS ..................................................... 48 candesartan ......................................................... 74 candesartan-hydrochlorothiazid ............................................................................................... 74 capacet .......................................................................... 4 CAPASTAT ..................................................... 51 CAPRELSA ..................................................... 24 captopril ................................................................... 75 captopril-hydrochlorothiazide ... 75 CARAFATE ............................................... 109 CARBAGLU .............................................. 110 carbamazepine ................................................ 34 carbidopa ................................................................ 54 carbidopa-levodopa ....................... 54, 55 carbidopa-levodopa-entacapone ............................................................................................... 55 carbinoxamine maleate ....................... 50 carboplatin ........................................................... 24 CARIMUNE NF NANOFILTERED ........................... 121 carisoprodol .................................................... 147 carteolol ............................................................... 104 cartia xt .................................................................... 78 carvedilol ................................................................ 77 CAYSTON ........................................................ 18 caziant (28) ....................................................... 89 cefaclor ...................................................................... 15 cefadroxil ............................................................... 15 cefazolin ................................................................... 15 CEFAZOLIN IN DEXTROSE (ISO-OS) ................................................................ 15 cefazolin in dextrose (iso-os) .... 15 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-4 d10 %-0.45 % sodium chloride Index colocort ..................................................................... 99 COLY-MYCIN S ................................. 105 COMBIGAN .............................................. 137 COMBIPATCH ...................................... 115 COMBIVENT RESPIMAT ........................................................................................... 145 COMETRIQ .................................................... 24 COMPLERA .................................................. 60 compro ....................................................................... 52 COMVAX (PF) ....................................... 125 CONDYLOX ................................................. 96 constulose ........................................................... 110 COPAXONE ............................................... 133 CORLANOR ................................................. 79 cormax ....................................................................... 99 cortisone ............................................................... 117 CORTISPORIN-TC ........................ 106 COSENTYX .................................................... 96 COSENTYX (2 SYRINGES) ............................................................................................... 96 COSENTYX PEN .................................. 96 COSENTYX PEN (2 PENS) ............................................................................................... 96 COTELLIC ....................................................... 25 CREON ............................................................... 102 CRESTOR .......................................................... 83 CRIXIVAN ...................................................... 60 cromolyn ................................ 104, 110, 146 cryselle (28) ...................................................... 89 CUBICIN ............................................................. 14 cyclafem 1/35 (28) ................................... 89 cyclafem 7/7/7 (28) ................................. 89 cyclobenzaprine ......................................... 147 cyclopentolate .............................................. 104 cyclophosphamide ...................................... 25 CYCLOPHOSPHAMIDE ......... 25 CYCLOSET ..................................................... 43 cyclosporine .................................................... 121 cyclosporine modified ........................ 121 cyproheptadine ............................................... 50 CYRAMZA ...................................................... 25 cyred ............................................................................. 89 CYSTADANE .......................................... 133 CYSTARAN ............................................... 104 cysteine (l-cysteine) ............................... 71 Index Index CLINIMIX 4.25%/D5W SULFIT FREE ............................................ 70 CLINIMIX 4.25%-D20W SULF-FREE ................................................... 70 CLINIMIX 4.25%-D25W SULF-FREE ................................................... 71 CLINIMIX 5%-D20W(SULFITE-FREE) ............................................................................................... 71 CLINIMIX E 2.75%/D10W SUL FREE ......................................................... 71 CLINIMIX E 2.75%/D5W SULF FREE .................................................... 71 CLINIMIX E 4.25%/D10W SUL FREE ......................................................... 71 CLINIMIX E 4.25%/D25W SUL FREE ......................................................... 71 CLINIMIX E 4.25%/D5W SULF FREE .................................................... 71 CLINIMIX E 5%/D15W SULFIT FREE ............................................ 71 CLINIMIX E 5%/D20W SULFIT FREE ............................................ 71 CLINIMIX E 5%/D25W SULFIT FREE ............................................ 71 CLINISOL SF 15 % ............................. 71 clobetasol ............................................................... 99 clobetasol-emollient ................................. 99 clocortolone pivalate ............................... 99 clomipramine .................................................... 39 clonazepam .......................................................... 12 clonidine ................................................................... 73 clonidine hcl ............................................. 73, 86 clopidogrel ............................................................ 68 clorazepate dipotassium ..................... 12 clorpres ...................................................................... 73 clotrimazole ........................................................ 48 clotrimazole-betamethasone ........ 48 clozapine ................................................................. 56 COARTEM ...................................................... 54 codeine sulfate ..................................................... 4 colchicine ............................................................ 133 colchicine-probenecid ......................... 133 colestipol ................................................................. 83 colistin (colistimethate na) ........... 14 138 d2.5 %-0.45 % sodium chloride ........................................................................................... 138 d5 % and 0.9 % sodium chloride ........................................................................................... 138 d5 %-0.45 % sodium chloride ........................................................................................... 138 dactinomycin ..................................................... 25 DAKLINZA .................................................... 63 DALIRESP .................................................... 146 danazol ................................................................... 115 dantrolene .......................................................... 147 dapsone ..................................................................... 51 DAPTACEL (DTAP PEDIATRIC) (PF) ............................. 125 DARAPRIM .................................................. 54 DARZALEX .................................................. 25 dasetta 1/35 (28) ........................................ 89 dasetta 7/7/7 (28) ...................................... 89 DAUNOXOME ......................................... 25 daysee .......................................................................... 89 deblitane .................................................................. 89 decitabine ............................................................... 25 deferoxamine ................................................. 114 delyla (28) ........................................................... 89 DELZICOL ................................................... 129 demeclocycline ................................................ 22 DEMSER ............................................................. 79 DENAVIR ......................................................... 96 DEPEN TITRATABS .................. 114 DEPO-PROVERA ............................. 120 DESCOVY ......................................................... 60 desipramine ......................................................... 39 desmopressin .................................................. 118 desog-e.estradiol/e.estradiol ......... 89 desogestrel-ethinyl estradiol ......... 89 desonide .................................................................... 99 desoximetasone .............................................. 99 DESVENLAFAXINE FUMARATE ................................................. 40 dexamethasone ........................................... 117 dexamethasone sodium phosphate ............................................................................ 108, 117 DEXILANT ................................................. 109 ........................................................................................... Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-5 ELAPRASE .................................................. 102 electrolyte-48 in d5w ........................... 139 ELIDEL ................................................................. 99 ELIGARD .......................................................... 25 elinest .......................................................................... 89 eliphos ..................................................................... 112 ELIQUIS ............................................................... 65 ELITEK .............................................................. 102 elixophyllin ...................................................... 145 ELLA ......................................................................... 89 ELMIRON ..................................................... 133 EMBEDA ................................................................ 4 EMCYT .................................................................. 25 EMEND ................................................................. 52 emoquette ............................................................... 89 EMPLICITI ...................................................... 26 EMSAM ................................................................. 40 EMTRIVA ......................................................... 60 EMVERM .......................................................... 54 enalapril maleate ......................................... 75 enalaprilat ............................................................. 75 enalapril-hydrochlorothiazide .... 75 ENBREL ........................................................... 122 ENBREL SURECLICK ............ 122 endocet .......................................................................... 4 endodan ........................................................................ 4 ENGERIX-B (PF) .............................. 125 ENGERIX-B PEDIATRIC (PF) ........................................................................................... 125 enoxaparin ............................................................ 65 enpresse .................................................................... 90 enskyce ...................................................................... 90 entacapone ............................................................ 55 entecavir .................................................................. 64 ENTRESTO ..................................................... 74 enulose .................................................................... 110 ENVARSUS XR ................................... 122 ephedrine sulfate .......................................... 80 epinastine ............................................................ 104 epinephrine ........................................................... 80 epinephrine hcl (pf) ................................. 80 EPIPEN 2-PAK .......................................... 80 EPIPEN JR 2-PAK ............................... 80 epitol ............................................................................. 34 EPIVIR HBV .................................................. 60 Index DILANTIN ...................................................... 34 diltiazem hcl ............................................ 78, 79 dilt-xr .......................................................................... 79 dimenhydrinate ............................................... 52 DIPENTUM ................................................ 129 diphenhydramine hcl ............................... 50 diphenoxylate-atropine .................... 110 dipyridamole ...................................................... 68 disopyramide phosphate ..................... 76 disulfiram ............................................................... 11 divalproex .............................................................. 34 dobutamine .......................................................... 80 dobutamine in d5w ..................................... 80 docetaxel ................................................................. 25 donepezil ................................................................. 38 dopamine ................................................................. 80 dopamine in 5 % dextrose ................ 80 dorzolamide ..................................................... 137 dorzolamide-timolol ............................. 137 doxazosin ............................................................... 73 doxepin ...................................................................... 40 doxercalciferol ............................................ 130 doxorubicin, peg-liposomal ........... 25 doxy-100 ................................................................. 22 doxycycline hyclate .................................. 22 doxycycline monohydrate ................ 22 dronabinol ............................................................. 52 droperidol ........................................................... 133 drospirenone-ethinyl estradiol ... 89 DROXIA .............................................................. 25 DUAVEE ......................................................... 115 DULERA ......................................................... 144 duloxetine .............................................................. 40 DUREZOL .................................................... 108 dutasteride ........................................................ 133 dutasteride-tamsulosin ..................... 133 DYRENIUM ................................................. 82 e.e.s. 400 .................................................................. 18 e.e.s. granules ................................................... 18 econazole ................................................................ 48 EDARBI ................................................................ 74 EDARBYCLOR ....................................... 74 EDURANT ...................................................... 60 effer-k ...................................................................... 139 EFFIENT ............................................................ 69 Index Index dexmethylphenidate ................................. 86 dexrazoxane hcl ........................................ 133 dextroamphetamine ................................. 86 dextroamphetamine-amphetamine ............................................................................................... 86 dextrose 10 % and 0.2 % nacl ........................................................................................... 138 dextrose 10 % in water (d10w) ............................................................................................... 71 dextrose 20 % in water (d20w) ............................................................................................... 72 dextrose 25 % in water (d25w) ............................................................................................... 72 dextrose 40 % in water (d40w) ............................................................................................... 72 dextrose 5 % in ringers ........................ 72 dextrose 5 % in water (d5w) ...... 72 dextrose 5 %-lactated ringers ........................................................................................... 139 dextrose 5%-0.2 % sod chloride ........................................................................................... 139 dextrose 5%-0.3 % sod.chloride ........................................................................................... 139 dextrose 50 % in water (d50w) ............................................................................................... 72 dextrose 70 % in water (d70w) ............................................................................................... 72 dextrose with sodium chloride ........................................................................................... 139 diazepam ................................................................. 12 diazepam intensol ........................................ 12 diclofenac potassium .................................. 8 diclofenac sodium ............................ 8, 108 diclofenac-misoprostol ............................. 8 dicloxacillin ......................................................... 20 dicyclomine ...................................................... 110 didanosine .............................................................. 60 DIFICID ............................................................... 18 diflorasone ............................................................ 99 diflunisal ...................................................................... 9 digitek ......................................................................... 79 digox ............................................................................. 79 digoxin ....................................................................... 79 DIGOXIN ........................................................... 79 dihydroergotamine .................................... 50 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-6 fluorometholone ........................................ 108 fluorouracil ............................................... 26, 96 fluoxetine ............................................................... 40 FLUOXETINE ........................................... 40 fluphenazine decanoate ....................... 57 fluphenazine hcl ............................................. 57 flurazepam ............................................................ 12 flurbiprofen ............................................................. 9 flurbiprofen sodium .............................. 108 flutamide ................................................................. 26 fluticasone .............................................. 99, 108 fluvastatin .............................................................. 83 fluvoxamine ............................................. 40, 41 fomepizole ......................................................... 133 fondaparinux .......................................... 65, 66 FORADIL AEROLIZER ....... 145 FORTEO .......................................................... 130 FORTICAL .................................................. 130 foscarnet .................................................................. 63 fosinopril ................................................................. 75 fosinopril-hydrochlorothiazide ............................................................................................... 75 fosphenytoin ....................................................... 35 FOSRENOL ................................................ 112 FREAMINE HBC 6.9 % .............. 72 FREAMINE III 10 % ........................ 72 furosemide ............................................................. 82 FUSILEV ......................................................... 133 FUZEON ............................................................. 60 fyavolv .................................................................... 116 FYCOMPA ....................................................... 35 gabapentin ............................................................ 35 GABITRIL ........................................................ 35 galantamine ........................................................ 38 GAMASTAN S/D ............................... 122 GAMMAGARD LIQUID .... 122 GAMMAPLEX ...................................... 122 GAMUNEX-C ......................................... 122 ganciclovir sodium ..................................... 65 GARDASIL (PF) ................................. 125 GARDASIL 9 (PF) ........................... 125 gatifloxacin ...................................................... 106 GATTEX 30-VIAL ............................ 110 GATTEX ONE-VIAL .................. 110 GAUZE PAD ............................................ 133 Index FABRAZYME ........................................ 102 falmina (28) ...................................................... 90 famciclovir ............................................................ 64 famotidine .......................................................... 109 famotidine (pf) .......................................... 109 famotidine (pf)-nacl (iso-os) ........................................................................................... 109 FANAPT .............................................................. 56 FARESTON .................................................... 26 FARYDAK ...................................................... 26 FASLODEX .................................................... 26 felbamate ................................................................ 34 felodipine ................................................................ 81 FEMRING .................................................... 116 fenofibrate ............................................................ 83 fenofibrate micronized ......................... 83 fenofibrate nanocrystallized ......... 83 fenofibric acid .................................................. 83 fenofibric acid (choline) ................... 83 fenoprofen ................................................................. 9 fentanyl ......................................................................... 4 fentanyl citrate ................................................... 4 FERRIPROX ............................................. 114 FETZIMA .......................................................... 40 finasteride .......................................................... 133 FIRAZYR .......................................................... 80 flavoxate .............................................................. 113 FLEBOGAMMA DIF ................. 122 flecainide ................................................................. 76 FLECTOR ............................................................. 9 FLOVENT DISKUS ...................... 144 FLOVENT HFA ................................... 144 floxuridine ............................................................. 26 flucaine .................................................................. 104 fluconazole ........................................................... 48 fluconazole in dextrose(iso-o) ............................................................................................... 48 fluconazole in nacl (iso-osm) ..... 48 flucytosine ............................................................. 48 fludrocortisone ............................................ 117 flumazenil .............................................................. 86 flunisolide ........................................................... 108 fluocinolone acetonide oil ............. 108 fluocinonide ......................................................... 99 fluocinonide-e ................................................... 99 Index Index eplerenone ............................................................. 85 EPOGEN .............................................................. 67 epoprostenol (glycine) ..................... 148 eprosartan ............................................................. 74 EPZICOM .......................................................... 60 ergoloid ................................................................. 133 ERGOMAR ..................................................... 51 ERIVEDGE ..................................................... 26 errin ............................................................................... 90 ery pads .................................................................... 97 ery-tab ........................................................................ 18 ERY-TAB ............................................................ 18 ERYTHROCIN ......................................... 18 erythrocin (as stearate) .................... 18 erythromycin ...................................... 18, 106 erythromycin ethylsuccinate ........ 18 erythromycin with ethanol .............. 97 erythromycin-benzoyl peroxide ............................................................................................... 97 ESBRIET .......................................................... 147 escitalopram oxalate .............................. 40 esmolol ....................................................................... 77 esomeprazole sodium .......................... 109 estarylla ................................................................... 90 estazolam ............................................................... 12 ESTRACE ....................................................... 115 estradiol ................................................................ 115 estradiol valerate ...................................... 116 estradiol-norethindrone acet .... 116 ESTRING ........................................................ 116 estropipate ........................................................ 116 eszopiclone ........................................................ 148 ethambutol ............................................................ 51 ethamolin ................................................................ 80 ethosuximide ...................................................... 34 etidronate disodium .............................. 130 etodolac ........................................................................ 9 ETOPOPHOS ................................................ 26 etoposide ................................................................. 26 EURAX .............................................................. 101 EVOTAZ .............................................................. 60 EXELDERM ................................................. 48 exemestane ........................................................... 26 EXJADE ............................................................ 114 EXTAVIA ....................................................... 133 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-7 HUMULIN N ............................................... 45 HUMULIN N KWIKPEN ....... 45 HUMULIN R ............................................... 46 HUMULIN R U-500 (CONC) KWIKPEN ........................................................ 46 HUMULIN R U-500 (CONCENTRATED) ....................... 46 hydralazine .......................................................... 80 hydrochlorothiazide ................................. 82 hydrocodone-acetaminophen ........... 4 hydrocodone-ibuprofen ........................... 4 hydrocortisone .............................. 100, 117 hydrocortisone acet-aloe vera ........................................................................................... 100 hydrocortisone butyrate ................. 100 hydrocortisone butyr-emollient ........................................................................................... 100 hydrocortisone valerate ................... 100 hydrocortisone-acetic acid .......... 106 hydromorphone .................................................. 5 hydromorphone (pf) .................................. 4 hydroxychloroquine ................................. 54 hydroxyurea ....................................................... 26 hydroxyzine hcl ........................... 133, 134 hydroxyzine pamoate ......................... 134 HYPERLYTE CR .............................. 139 HYPERRAB S/D (PF) ................. 123 HYQVIA ........................................................... 123 HYSINGLA ER ............................................ 5 ibandronate ...................................................... 130 IBRANCE .......................................................... 27 ibuprofen ..................................................................... 9 ICLUSIG .............................................................. 27 ifosfamide .............................................................. 27 ifosfamide-mesna ......................................... 27 ILARIS (PF) ................................................ 123 ILEVRO ............................................................. 108 IMBRUVICA ................................................ 27 imipenem-cilastatin .................................. 18 imipramine hcl ................................................. 41 imipramine pamoate ............................... 41 imiquimod .............................................................. 96 IMLYGIC ........................................................... 27 IMOGAM RABIES-HT (PF) ........................................................................................... 123 Index granisetron (pf) ............................................ 52 granisetron hcl ................................................ 52 granisol ..................................................................... 52 GRANIX .............................................................. 67 griseofulvin microsize ............................ 48 griseofulvin ultramicrosize ............. 49 guanfacine .................................................. 73, 87 guanidine ............................................................. 133 halobetasol propionate ..................... 100 haloperidol ............................................................ 57 haloperidol decanoate ........................... 57 haloperidol lactate ..................................... 57 HARVONI ......................................................... 63 HAVRIX (PF) ........................................... 126 heather ....................................................................... 90 heparin (porcine) ....................................... 66 heparin (porcine) in 5 % dex ...... 66 heparin (porcine) in nacl (pf) ............................................................................................... 66 heparin(porcine) in 0.45% nacl ............................................................................................... 66 heparin, porcine (pf) ............................. 66 HEPATAMINE 8% ............................. 72 HEPATASOL 8 % .................................. 72 HERCEPTIN ................................................. 26 HETLIOZ ........................................................ 148 HEXALEN ........................................................ 26 homatropaire ................................................. 104 homatropine hbr ........................................ 104 HUMALOG .................................................... 45 HUMALOG KWIKPEN ............ 45 HUMALOG MIX 50-50 ............... 45 HUMALOG MIX 50-50 KWIKPEN ........................................................ 45 HUMALOG MIX 75-25 ............... 45 HUMALOG MIX 75-25 KWIKPEN ........................................................ 45 HUMIRA ......................................................... 122 HUMIRA PEN ....................................... 122 HUMIRA PEN CROHN'S-UC-HS START ........................................................................................... 122 HUMULIN 70/30 .................................... 45 HUMULIN 70/30 KWIKPEN ............................................................................................... 45 Index Index gavilyte-c ............................................................. 112 gavilyte-g ............................................................ 112 gavilyte-n ............................................................ 112 GAZYVA ............................................................. 26 gemcitabine ......................................................... 26 gemfibrozil ........................................................... 83 generlac ................................................................. 110 gengraf ................................................................... 122 GENOTROPIN ...................................... 118 GENOTROPIN MINIQUICK ........................................................................................... 118 gentak ...................................................................... 106 gentamicin .................................. 13, 97, 106 gentamicin in nacl (iso-osm) ...... 13 gentamicin sulfate (ped) (pf) ... 13 gentamicin sulfate (pf) ....................... 13 GENVOYA ...................................................... 60 GEODON ........................................................... 57 gianvi (28) ........................................................... 90 gildagia ..................................................................... 90 gildess 1.5/30 (21) .................................... 90 gildess 1/20 (21) .......................................... 90 gildess 24 fe ......................................................... 90 gildess fe 1.5/30 (28) ............................. 90 gildess fe 1/20 (28) .................................. 90 GILENYA ...................................................... 133 GILOTRIF ........................................................ 26 GLEEVEC .......................................................... 26 GLEOSTINE ................................................. 26 glimepiride ............................................................ 47 glipizide .................................................................... 47 glipizide-metformin .................................. 47 GLUCAGEN HYPOKIT ....... 133 GLUCAGON EMERGENCY KIT (HUMAN) ...................................... 133 glyburide ................................................................. 47 glyburide micronized .............................. 47 glyburide-metformin ............................... 47 glycopyrrolate .............................................. 110 glydo ............................................................................. 10 GLYSET ............................................................... 43 GLYXAMBI ................................................... 43 GRALISE ............................................................ 35 GRALISE 30-DAY STARTER PACK ........................................................................ 35 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-8 KUVAN ............................................................. 103 KYNAMRO .................................................... 83 KYPROLIS ...................................................... 28 l norgest/e.estradiol-e.estrad ....... 91 labetalol ................................................................... 77 LACRISERT .............................................. 104 LACTATED RINGERS ........... 129 lactulose ............................................................... 111 LAMICTAL .................................................... 35 LAMICTAL ODT STARTER (BLUE) .................................................................... 35 LAMICTAL ODT STARTER (GREEN) ............................................................. 35 LAMICTAL ODT STARTER (ORANGE) ....................................................... 35 lamivudine ............................................................. 61 lamivudine-zidovudine .......................... 61 lamotrigine ................................................ 35, 36 LANOXIN ......................................................... 80 lansoprazole .................................................... 109 LANTUS .............................................................. 46 LANTUS SOLOSTAR .................... 46 larin 1.5/30 (21) .......................................... 91 larin 1/20 (21) ................................................ 91 larin 24 fe ............................................................... 91 larin fe 1.5/30 (28) ................................... 91 larin fe 1/20 (28) ......................................... 91 latanoprost ....................................................... 137 LATUDA ............................................................. 57 LAZANDA ........................................................... 5 leena 28 ..................................................................... 91 leflunomide ....................................................... 123 LEMTRADA ............................................. 134 LENVIMA ......................................................... 28 lessina .......................................................................... 91 LETAIRIS ...................................................... 148 letrozole .................................................................... 28 leucovorin calcium .................................. 134 LEUKERAN .................................................. 28 LEUKINE .......................................................... 67 leuprolide ................................................................ 28 levetiracetam ..................................................... 36 levetiracetam in nacl (iso-os) .... 36 levobunolol ........................................................ 137 levocarnitine ................................................... 134 Index IXEMPRA ......................................................... 27 IXIARO (PF) .............................................. 126 JAKAFI ................................................................. 27 jantoven .................................................................... 66 JANUMET ........................................................ 43 JANUMET XR .......................................... 43 JANUVIA ........................................................... 43 JARDIANCE ................................................ 43 jencycla ..................................................................... 90 JENTADUETO ......................................... 43 jinteli ......................................................................... 116 jolessa .......................................................................... 90 jolivette ...................................................................... 90 juleber ......................................................................... 90 junel 1.5/30 (21) .......................................... 90 junel 1/20 (21) ................................................ 90 junel fe 1.5/30 (28) .................................. 90 junel fe 1/20 (28) ........................................ 90 junel fe 24 ............................................................... 90 JUXTAPID ....................................................... 83 KABIVEN .......................................................... 72 KALETRA ........................................................ 61 KALYDECO .............................................. 147 KANUMA ..................................................... 103 kariva (28) .......................................................... 90 KAZANO ............................................................ 43 k-effervescent ................................................ 139 kelnor 1/35 (28) ........................................... 91 ketoconazole ...................................................... 49 ketoprofen ................................................................. 9 ketorolac ...................................................... 9, 108 KEVEYIS ........................................................ 134 KEYTRUDA ...................................... 27, 28 kimidess (28) ................................................... 91 KINERET ....................................................... 123 KINRIX (PF) ............................................. 126 kionex ...................................................................... 110 klor-con 10 ....................................................... 139 klor-con m10 .................................................. 139 klor-con m15 .................................................. 140 klor-con m20 .................................................. 140 klor-con sprinkle ....................................... 140 KORLYM ........................................................... 43 KRYSTEXXA .......................................... 103 kurvelo ....................................................................... 91 Index Index IMOVAX RABIES VACCINE (PF) ............................................................................ 126 INCRELEX .................................................. 118 indapamide ........................................................... 82 indomethacin ......................................................... 9 indomethacin sodium ................................. 9 INFANRIX (DTAP) (PF) ...... 126 INLYTA ................................................................ 27 INSULIN SYRINGE-NEEDLE U-100 ....................................................................... 102 INTELENCE ................................................. 60 INTRALIPID ................................................ 72 INTRON A ....................................................... 64 introvale ................................................................... 90 INVANZ ............................................................... 19 INVEGA SUSTENNA ................... 57 INVEGA TRINZA ............................... 57 INVIRASE ........................................................ 60 INVOKAMET ............................................. 43 INVOKANA .................................................. 43 IONOSOL-B IN D5W .................. 139 IONOSOL-MB IN D5W ........... 139 IPOL ........................................................................ 126 ipratropium bromide ............ 104, 145 ipratropium-albuterol ........................ 145 IPRIVASK ......................................................... 66 irbesartan ............................................................... 74 irbesartan-hydrochlorothiazide ............................................................................................... 74 IRESSA ................................................................... 27 irinotecan ............................................................... 27 ISENTRESS .................................................... 60 ISOLYTE M IN 5 % DEXTROSE ................................................ 139 ISOLYTE-H IN 5 % DEXTROSE ................................................ 139 ISOLYTE-P IN 5 % DEXTROSE ................................................ 139 ISOLYTE-S ................................................... 139 isoniazid ................................................................... 51 isosorbide dinitrate ................................... 85 isosorbide mononitrate ........................ 85 isradipine ................................................................ 81 itraconazole ........................................................ 49 ivermectin .............................................................. 54 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-9 MENHIBRIX (PF) ............................ 126 MENOMUNE - A/C/Y/W-135 (PF) ............................................................................ 126 MENVEO A-C-Y-W-135-DIP (PF) ............................................................................ 126 MENVEO MENA COMPONENT (PF) ........................ 127 MENVEO MENCYW-135 COMPNT (PF) ........................................ 127 mercaptopurine .............................................. 29 meropenem ........................................................... 19 mesna ....................................................................... 134 MESNEX ......................................................... 134 MESTINON ................................................ 134 MESTINON TIMESPAN ...... 134 metaproterenol ............................................ 145 metaxall ............................................................... 147 metaxalone ....................................................... 147 metformin ................................................... 43, 44 methadone ................................................................. 5 methadose ................................................................. 5 methazolamide ............................................ 137 methenamine hippurate ....................... 14 methimazole .................................................... 121 methocarbamol ........................................... 147 methotrexate sodium .............................. 29 methotrexate sodium (pf) .............. 29 methoxsalen rapid ...................................... 96 methscopolamine ...................................... 111 methyclothiazide .......................................... 82 methylergonovine .................................... 134 methylphenidate ............................................ 87 methylprednisolone ............................... 117 methylprednisolone acetate ....... 117 methylprednisolone sodium succ ........................................................................................... 117 metipranolol .................................................... 138 metoclopramide hcl ............................... 111 metolazone ........................................................... 82 metoprolol succinate ............................... 77 metoprolol ta-hydrochlorothiaz ............................................................................................... 77 metoprolol tartrate ........................ 77, 78 metronidazole ............................ 14, 50, 97 Index LUMIGAN ................................................... 137 LUPRON DEPOT ................................. 28 LUPRON DEPOT (3 MONTH) ............................................................................................... 28 LUPRON DEPOT (4 MONTH) ............................................................................................... 28 LUPRON DEPOT (6 MONTH) ............................................................................................... 28 LUPRON DEPOT-PED ........... 118 LUPRON DEPOT-PED (3 MONTH) .......................................................... 118 lutera (28) ........................................................... 92 LYNPARZA ................................................... 28 LYRICA ................................................................ 36 LYSODREN ................................................... 28 lyza ................................................................................. 92 magnebind 400 ............................................ 113 magnesium chloride .............................. 140 magnesium sulf in 0.45% nacl ........................................................................................... 140 magnesium sulfate .................................. 140 magnesium sulfate in d5w ............ 140 magnesium sulfate in water ....... 140 malathion ............................................................ 101 maprotiline ........................................................... 41 margesic ...................................................................... 5 marlissa .................................................................... 92 MARPLAN ...................................................... 41 MARQIBO ........................................................ 28 MATULANE ................................................ 29 matzim la ................................................................ 79 meclizine .................................................................. 52 medroxyprogesterone ........................ 120 mefenamic acid .................................................. 9 mefloquine ............................................................. 54 MEFOXIN IN DEXTROSE (ISO-OSM) ......................................................... 17 MEGACE ES ............................................. 120 megestrol ................................................. 29, 120 MEKINIST ....................................................... 29 meloxicam ............................................................. 10 melphalan hcl .................................................... 29 memantine ............................................................. 38 MENACTRA (PF) ............................ 126 MENEST .......................................................... 116 Index Index levocarnitine (with sugar) .......... 134 levocetirizine ...................................................... 50 levofloxacin .......................................... 21, 106 levofloxacin in d5w ................................... 21 levonest (28) ..................................................... 91 levonorgestrel ................................................... 91 levonorgestrel-ethinyl estrad ....... 91 levonorg-eth estrad triphasic ....... 91 levora-28 ................................................................. 91 levothyroxine ................................................. 120 LEXIVA ................................................................. 61 lidocaine ................................................................... 11 lidocaine (pf) ........................................ 10, 76 lidocaine hcl ........................................................ 10 lidocaine in 5 % dextrose (pf) ............................................................................................... 76 lidocaine viscous ........................................... 10 lidocaine-prilocaine .................................. 11 linezolid .................................................................... 14 LINZESS .......................................................... 111 liothyronine ....................................... 120, 121 lipodox ....................................................................... 28 LIPOSYN II ..................................................... 72 LIPOSYN III .................................................. 72 lisinopril ................................................................... 75 lisinopril-hydrochlorothiazide .... 75 lithium carbonate ........................................ 87 lithium citrate ................................................... 87 lomedia 24 fe ..................................................... 91 lomustine ................................................................. 28 LONSURF ........................................................ 28 loperamide ........................................................ 111 lorazepam .............................................................. 12 lorazepam intensol ..................................... 12 lorcet (hydrocodone) ................................ 5 lorcet hd ....................................................................... 5 lorcet plus .................................................................. 5 loryna (28) .......................................................... 91 losartan ..................................................................... 74 losartan-hydrochlorothiazide ...... 74 LOTEMAX ................................................... 108 LOTRONEX ............................................... 111 lovastatin ................................................................ 83 low-ogestrel (28) ........................................ 92 loxapine succinate ...................................... 57 Effective: July 01, 2016 14 mexiletine .............................................................. 76 MIACALCIN ............................................ 131 miconazole-3 ...................................................... 49 microgestin 1.5/30 (21) ..................... 92 microgestin 1/20 (21) ........................... 92 microgestin fe 1.5/30 (28) .............. 92 microgestin fe 1/20 (28) ................... 92 midazolam ............................................................. 12 midodrine ............................................................... 73 miglitol ...................................................................... 44 milrinone ................................................................. 81 milrinone in 5 % dextrose ................ 80 mimvey ................................................................... 116 mimvey lo ........................................................... 116 minitran .................................................................... 85 MINOCIN .......................................................... 23 minocycline .......................................................... 23 minoxidil ................................................................. 85 MIRCERA ........................................................ 67 mirtazapine .......................................................... 41 misoprostol ....................................................... 109 mitoxantrone ..................................................... 29 M-M-R II (PF) ......................................... 127 moexipril ................................................................. 75 moexipril-hydrochlorothiazide ............................................................................................... 75 molindone ................................................... 57, 58 mometasone .................................................... 100 mono-linyah ........................................................ 92 mononessa (28) ............................................ 92 montelukast ..................................................... 144 morphine .............................................................. 5, 6 MORPHINE ....................................................... 6 morphine (pf) in 0.9 % nacl ............. 5 morphine concentrate ................................ 5 morphine in dextrose 5 % .................... 6 morrhuate sodium ................................... 134 MOVANTIK .............................................. 111 MOVIPREP .................................................. 112 MOXEZA ........................................................ 106 moxifloxacin ...................................................... 21 MOZOBIL .......................................................... 67 MULTAQ ........................................................... 76 ............................................................................................... Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-10 NEPHRAMINE 5.4 % ..................... 72 NESINA ................................................................ 44 neuac ............................................................................ 97 NEULASTA .................................................... 67 NEUMEGA ..................................................... 67 NEUPOGEN ...................................... 67, 68 NEUPRO ............................................................. 55 NEVANAC ................................................... 108 nevirapine ............................................................... 61 NEXAVAR ....................................................... 29 next choice one dose ................................ 92 niacin ............................................................................ 84 niacor ........................................................................... 84 nicardipine ............................................................ 81 NICOTROL ..................................................... 11 nifedical xl ............................................................ 81 nifedipine ..................................................... 81, 82 nikki (28) .............................................................. 92 NILANDRON ............................................. 29 NINLARO ......................................................... 29 NITRO-BID .................................................... 85 nitrofurantoin ................................................... 15 nitrofurantoin macrocrystal ......... 14 nitrofurantoin monohyd/m-cryst .................................................................................... 14, 15 nitroglycerin ............................................ 85, 86 nitroglycerin in 5 % dextrose ...... 85 NITROSTAT ................................................. 86 nizatidine ............................................................. 109 nora-be ....................................................................... 92 NORDITROPIN FLEXPRO ........................................................................................... 119 norepinephrine bitartrate ................. 81 norethindrone (contraceptive) ............................................................................................... 92 norethindrone acetate ........................ 120 norethindrone ac-eth estradiol ................................................................................ 92, 116 norethindrone-e.estradiol-iron ... 92 norgestimate-ethinyl estradiol ... 93 norlyroc .................................................................... 93 NORMOSOL-M IN 5 % DEXTROSE ................................................ 140 NORMOSOL-R PH 7.4 ............. 140 NORTHERA ................................................. 74 Index multivitamin with fluoride ........... 149 mupirocin ............................................................... 97 mupirocin calcium ...................................... 97 mycophenolate mofetil ..................... 123 mycophenolate sodium ..................... 123 MYOBLOC ................................................... 134 MYOZYME ................................................. 103 MYRBETRIQ ........................................... 113 myzilra ....................................................................... 92 nabumetone ......................................................... 10 nadolol ....................................................................... 78 nafcillin ..................................................................... 20 NAGLAZYME ....................................... 103 naloxone .................................................................. 11 naltrexone ............................................................. 11 NAMENDA XR ....................................... 39 NAMZARIC .................................................. 39 naphazoline ...................................................... 104 naproxen ................................................................. 10 naproxen sodium .......................................... 10 naratriptan ........................................................... 51 NARCAN ........................................................... 11 NATACYN ................................................... 106 nateglinide ............................................................. 44 NATPARA .................................................... 131 NEBUPENT .................................................... 54 necon 0.5/35 (28) ....................................... 92 necon 1/35 (28) ............................................. 92 necon 1/50 (28) ............................................. 92 necon 10/11 (28) ......................................... 92 necon 7/7/7 (28) ........................................... 92 nefazodone ............................................................ 41 neomycin ................................................................. 13 neomycin-bacitracin-poly-hc ... 106 neomycin-bacitracin-polymyxin ........................................................................................... 106 neomycin-polymyxin b gu ................ 97 neomycin-polymyxin b-dexameth ........................................................................................... 106 neomycin-polymyxin-gramicidin ........................................................................................... 106 neomycin-polymyxin-hc ............................................................................ 106, 107 neo-polycin ....................................................... 107 neo-polycin hc .............................................. 107 Index Index metronidazole in nacl (iso-os) Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-11 paroxetine hcl ................................................... 41 PASER ..................................................................... 51 PATADAY .................................................... 105 PAXIL ...................................................................... 41 PEDIARIX (PF) .................................... 127 PEDVAX HIB (PF) .......................... 127 peg 3350-electrolytes .......................... 112 PEGANONE .................................................. 36 PEGASYS ........................................................... 64 PEGASYS PROCLICK ................. 64 peg-electrolyte soln ............................... 112 PEGINTRON ............................................... 64 PEN NEEDLE, DIABETIC ........................................................................................... 102 penicillin g pot in dextrose .............. 20 penicillin g potassium ............................ 20 penicillin g procaine ................................. 20 penicillin v potassium ............................. 20 PENTACEL (PF) ................................. 127 PENTACEL ACTHIB COMPONENT (PF) ........................ 127 PENTAM ............................................................. 54 pentoxifylline .................................................... 69 PERIKABIVEN ........................................ 73 perindopril erbumine ............................... 76 periogard ................................................................. 95 PERJETA ............................................................ 30 permethrin ......................................................... 101 perphenazine ...................................................... 58 perphenazine-amitriptyline ............ 41 PERTZYE ....................................................... 103 pfizerpen-g ............................................................ 21 phenadoz ................................................................. 53 phenelzine .............................................................. 41 phenobarbital .................................................... 37 phenobarbital sodium ............................ 37 phenylephrine hcl .......................... 74, 105 phenytoin ................................................................ 37 phenytoin sodium ......................................... 37 phenytoin sodium extended ........... 37 philith .......................................................................... 93 PHOSLYRA ................................................ 113 phospha 250 neutral ............................. 140 PHOSPHOLINE IODIDE ..... 138 PICATO ................................................................. 96 Index omega-3 acid ethyl esters ................. 84 omeprazole ....................................................... 109 ONCASPAR ................................................... 29 ondansetron ......................................................... 53 ondansetron hcl .............................................. 53 ondansetron hcl (pf) ................... 52, 53 ONFI ........................................................... 13, 100 onxol ............................................................................. 29 OPDIVO ................................................................ 29 OPSUMIT ....................................................... 148 oralone ....................................................................... 95 ORENCIA ...................................................... 123 ORENCIA (WITH MALTOSE) ........................................................................................... 123 ORENITRAM ......................................... 148 ORFADIN ..................................................... 103 ORKAMBI .................................................... 147 orsythia ..................................................................... 93 OSENI ...................................................................... 44 OTEZLA ........................................................... 135 OTEZLA STARTER ..................... 135 OTREXUP (PF) ..................................... 135 oxacillin .................................................................... 20 oxacillin in dextrose(iso-osm) ............................................................................................... 20 oxaliplatin ............................................................. 29 oxandrolone .................................................... 115 oxcarbazepine .................................................. 36 OXTELLAR XR ...................................... 36 oxybutynin chloride .............................. 113 oxycodone ......................................................... 6, 7 oxycodone-acetaminophen ................. 7 oxycodone-aspirin .......................................... 7 OXYCONTIN .................................................. 7 oxymorphone ........................................................ 7 pacerone ................................................................... 76 paclitaxel ................................................................ 29 paliperidone ........................................................ 58 pamidronate .................................................... 131 pancrelipase 5000 .................................... 103 PANRETIN ..................................................... 96 pantoprazole ................................................... 109 papaverine ............................................................. 81 paricalcitol ........................................................ 131 paromomycin .................................................... 54 Index Index nortrel 0.5/35 (28) .................................... 93 nortrel 1/35 (21) .......................................... 93 nortrel 1/35 (28) .......................................... 93 nortrel 7/7/7 (28) ....................................... 93 nortriptyline ........................................................ 41 NORVIR ............................................................... 61 NOVOLIN 70/30 ....................................... 46 NOVOLIN N ................................................. 46 NOVOLIN R .................................................. 46 NOVOLOG ...................................................... 46 NOVOLOG FLEXPEN ................. 46 NOVOLOG MIX 70-30 .................. 46 NOVOLOG MIX 70-30 FLEXPEN .......................................................... 46 NOVOLOG PENFILL .................... 46 NOXAFIL .......................................................... 49 NPLATE ........................................................... 135 NUCALA ........................................................ 147 NUCYNTA .......................................................... 6 NUCYNTA ER ............................................. 6 NUEDEXTA .................................................. 87 NULOJIX ........................................................ 123 NUPLAZID ..................................................... 58 NUTRESTORE ..................................... 111 NUTRILIPID ............................................... 73 NUTRILYTE ............................................ 140 NUTRILYTE II ..................................... 140 NUVARING .................................................. 93 NUVIGIL ........................................................ 148 nyamyc ...................................................................... 49 nystatin ..................................................................... 49 nystatin-triamcinolone ......................... 49 nystop .......................................................................... 49 ocella ............................................................................ 93 OCTAGAM .................................................. 123 octreotide acetate .................................... 119 ODEFSEY .......................................................... 61 ODOMZO ........................................................... 29 OFEV ..................................................................... 147 ofloxacin .................................................. 21, 107 ogestrel (28) ..................................................... 93 olanzapine ............................................................. 58 olanzapine-fluoxetine ............................ 41 olopatadine ....................................................... 105 OLYSIO ................................................................. 63 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-12 procto-med hc ............................................... 100 procto-pak ......................................................... 100 proctosol hc ..................................................... 100 proctozone-hc ............................................... 101 PROCYSBI .................................................... 135 progesterone in oil .................................. 120 progesterone micronized ................ 120 PROGLYCEM ............................................ 86 PROGRAF .................................................... 124 PROLASTIN-C ...................................... 147 PROLENSA ................................................. 108 PROLEUKIN ............................................... 30 PROLIA ............................................................. 131 PROMACTA ................................................. 68 promethazine .......................................... 50, 53 promethegan ...................................................... 53 propafenone ........................................................ 76 propantheline .................................................... 33 proparacaine .................................................. 105 propranolol .......................................................... 78 propranolol-hydrochlorothiazid ............................................................................................... 78 propylthiouracil ......................................... 121 PROQUAD (PF) ................................... 127 PROSOL 20 % .............................................. 73 protamine ............................................................... 68 protriptyline ........................................................ 41 PULMOZYME ....................................... 103 PURIXAN ......................................................... 30 pyrazinamide ..................................................... 52 pyridostigmine bromide .................. 135 QUADRACEL (PF) ........................ 127 quasense ................................................................... 93 quetiapine ............................................................... 58 QUILLIVANT XR ............................... 87 quinapril ................................................................... 76 quinapril-hydrochlorothiazide ... 76 quinidine gluconate ................................... 77 quinidine sulfate ............................................ 77 quinine sulfate .................................................. 54 QVAR .................................................................... 144 RABAVERT (PF) ............................... 127 raloxifene ........................................................... 116 ramipril ..................................................................... 76 RANEXA ............................................................ 81 Index potassium citrate-citric acid ..... 142 potassium hydroxide ............................... 96 potassium phosphate m-/d-basic ........................................................................................... 142 POTIGA ................................................................ 37 PRADAXA ....................................................... 66 PRALUENT PEN .................................. 84 PRALUENT SYRINGE .............. 84 pramipexole ........................................................ 55 pravastatin ............................................................ 84 prazosin .................................................................... 74 prednicarbate ................................................ 100 prednisolone acetate ............................ 108 prednisolone sodium phosphate ............................................................................ 108, 117 prednisone .......................................................... 117 PREDNISONE INTENSOL ........................................................................................... 117 PREMARIN ................................................ 116 PREMASOL 10 % .................................. 73 PREMASOL 6 % ...................................... 73 PREMPHASE ........................................... 116 PREMPRO .................................................... 116 prenatal plus (calcium carb) ... 149 prenatal vitamin plus low iron ........................................................................................... 149 PREPOPIK .................................................... 112 prevalite .................................................................... 84 previfem .................................................................... 93 PREZCOBIX ................................................. 61 PREZISTA ........................................................ 61 PRIFTIN .............................................................. 52 PRIMAQUINE .......................................... 54 primidone ............................................................... 37 PRISTIQ ............................................................... 41 PRIVIGEN .................................................... 123 PROAIR HFA .......................................... 145 PROAIR RESPICLICK ............ 145 probenecid ......................................................... 135 procainamide ..................................................... 76 PROCALAMINE 3% ........................ 73 prochlorperazine ........................................... 53 prochlorperazine edisylate .............. 53 prochlorperazine maleate ................. 53 PROCRIT ........................................................... 68 Index Index pilocarpine hcl .................................. 95, 138 pimozide ................................................................... 58 pimtrea (28) ...................................................... 93 pindolol ..................................................................... 78 pioglitazone ......................................................... 44 pioglitazone-glimepiride .................... 44 pioglitazone-metformin ....................... 44 piperacillin-tazobactam ...................... 21 pirmella ..................................................................... 93 piroxicam ............................................................... 10 PLASMA-LYTE 148 ...................... 140 PLASMA-LYTE A ............................ 140 PLASMA-LYTE-56 IN 5 % DEXTROSE ................................................ 141 PLEGRIDY .................................................. 135 podocon ..................................................................... 96 podofilox ................................................................. 96 polyethylene glycol 3350 ............... 112 polymyxin b sulfate .................................. 15 polymyxin b sulf-trimethoprim ........................................................................................... 107 POMALYST ................................................... 30 portia ............................................................................ 93 PORTRAZZA .............................................. 30 potassium acetate .................................... 141 potassium bicarb and chloride ........................................................................................... 141 potassium bicarb-citric acid ...... 141 potassium chlorid-d5-0.45%nacl ........................................................................................... 141 potassium chloride .................. 141, 142 potassium chloride in 0.9%nacl ........................................................................................... 141 potassium chloride in 5 % dex ........................................................................................... 141 potassium chloride in lr-d5 ......... 141 potassium chloride-0.45 % nacl ........................................................................................... 142 potassium chloride-d5-0.2%nacl ........................................................................................... 142 potassium chloride-d5-0.3%nacl ........................................................................................... 142 potassium chloride-d5-0.9%nacl ........................................................................................... 142 potassium citrate ...................................... 142 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-13 sodium chloride 5 % ............................. 143 sodium fluoride ................................ 95, 149 sodium lactate .............................................. 143 sodium phosphate .................................... 143 sodium polystyrene (sorb free) ........................................................................................... 111 sodium polystyrene sulfonate ........................................................................................... 111 sodium thiosulfate ................................... 114 SOLTAMOX .................................................. 30 SOLU-CORTEF (PF) ................... 118 SOMATULINE DEPOT .......... 119 SOMAVERT ............................................... 120 sorbitol ................................................................... 130 sorbitol-mannitol ...................................... 130 sorine ............................................................................ 78 sotalol .......................................................................... 78 sotalol af .................................................................. 78 SOVALDI ........................................................... 63 spinosad ................................................................ 101 SPIRIVA RESPIMAT .................. 145 SPIRIVA WITH HANDIHALER .................................... 145 spironolactone ................................................. 85 spironolacton-hydrochlorothiaz ............................................................................................... 85 SPORANOX ................................................... 49 sprintec (28) ..................................................... 93 SPRITAM ........................................................... 37 SPRYCEL ........................................................... 30 sps ................................................................................. 111 sronyx ......................................................................... 93 ssd ..................................................................................... 98 stavudine ................................................................. 62 STELARA ...................................................... 136 STERILE PADS .................................... 136 STIMATE ........................................................ 120 STIOLTO RESPIMAT ................... 33 STIVARGA ...................................................... 30 STRATTERA ............................................... 88 STRENSIQ .................................................... 103 streptomycin ...................................................... 13 STRIBILD .......................................................... 62 STRIVERDI RESPIMAT ...... 146 sucralfate ............................................................ 110 Index rivastigmine tartrate ............................... 39 rizatriptan ............................................................. 51 ropinirole ................................................................ 55 rosadan ...................................................................... 97 ROTARIX ...................................................... 128 ROTATEQ VACCINE ............... 128 roxicet ............................................................................ 7 ROZEREM ................................................... 148 SABRIL .................................................................. 37 SAIZEN .............................................................. 119 SAIZEN CLICK.EASY ............. 119 SANDOSTATIN LAR DEPOT ........................................................................................... 119 SANTYL ............................................................... 96 SAPHRIS (BLACK CHERRY) ............................................................................................... 59 SAVAYSA .......................................................... 66 SAVELLA ............................................... 87, 88 selegiline hcl ....................................................... 55 selenium sulfide ................................... 97, 98 SELZENTRY ................................................ 62 SENSIPAR .................................................... 136 SEREVENT DISKUS .................. 145 SEROQUEL XR ....................................... 59 SEROSTIM ................................................... 119 sertraline ...................................................... 41, 42 setlakin ...................................................................... 93 sharobel .................................................................... 93 SIGNIFOR .................................................... 136 sildenafil ............................................................... 149 SILENOR ............................................................ 42 silver nitrate ........................................................ 98 silver sulfadiazine ........................................ 98 SIMBRINZA .............................................. 138 SIMPONI ......................................................... 136 SIMPONI ARIA ................................... 136 simvastatin ........................................................... 84 sirolimus ............................................................... 124 SIRTURO ........................................................... 52 sodium acetate ............................................. 142 sodium bicarbonate ............................... 142 sodium chloride ........................... 130, 143 sodium chloride 0.45 % .................... 142 sodium chloride 0.9 % ....................... 142 sodium chloride 3 % ............................. 143 Index Index ranitidine hcl .................................................. 110 RAPAMUNE ............................................ 124 RASUVO (PF) .......................................... 135 RAVICTI .......................................................... 111 REBIF (WITH ALBUMIN) ........................................................................................... 135 REBIF REBIDOSE .......................... 136 REBIF TITRATION PACK ........................................................................................... 136 reclipsen (28) ................................................... 93 RECOMBIVAX HB (PF) ........ 127 REGRANEX ................................................. 96 RELENZA DISKHALER ......... 63 RELISTOR ................................................... 111 REMICADE ............................................... 136 REMODULIN ......................................... 148 RENAGEL .................................................... 113 RENVELA ..................................................... 113 repaglinide ............................................................ 44 repaglinide-metformin .......................... 44 REPATHA SURECLICK ......... 84 REPATHA SYRINGE ................... 84 reprexain .................................................................... 7 RESCRIPTOR ............................................. 61 RESTASIS ...................................................... 108 RETROVIR ..................................................... 62 REVLIMID ...................................................... 30 revonto ................................................................... 147 REXULTI ........................................................... 58 REYATAZ ........................................................ 62 ribasphere .............................................................. 65 ribasphere ribapak ..................................... 65 ribavirin .................................................................... 65 RIDAURA .................................................... 124 rifabutin ................................................................... 52 rifampin .................................................................... 52 RIFATER ........................................................... 52 riluzole ....................................................................... 87 rimantadine ......................................................... 63 ringers ...................................................... 129, 142 risedronate ........................................................ 131 RISPERDAL CONSTA ................ 58 risperidone ............................................................ 58 RITUXAN ......................................................... 30 rivastigmine ......................................................... 39 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-14 TOBRADEX ............................................... 107 TOBRADEX ST .................................... 107 tobramycin ........................................................ 107 tobramycin in 0.225 % nacl ........... 13 tobramycin in 0.9 % nacl .................. 13 tobramycin sulfate ..................................... 13 tobramycin-dexamethasone ...... 107 TOLAK ................................................................... 96 tolazamide ............................................................. 47 tolbutamide .......................................................... 47 tolmetin ..................................................................... 10 tolterodine ......................................................... 113 topiragen ................................................................. 37 topiramate ................................................. 37, 38 toposar ....................................................................... 31 topotecan ................................................................ 31 TORISEL ............................................................. 31 torsemide ................................................................ 82 TOUJEO SOLOSTAR ..................... 46 TOVIAZ ............................................................. 113 TPN ELECTROLYTES ............ 143 TPN ELECTROLYTES II .... 143 TRACLEER ................................................ 149 TRADJENTA ............................................... 44 tramadol ...................................................................... 7 tramadol-acetaminophen ...................... 7 trandolapril .......................................................... 76 tranexamic acid ............................................. 68 TRANSDERM-SCOP ..................... 53 tranylcypromine ............................................ 42 TRAVASOL 10 % ................................... 73 TRAVATAN Z ....................................... 138 travoprost (benzalkonium) ....... 138 trazodone ................................................................ 42 TREANDA ....................................................... 31 TRECATOR ................................................... 52 TRELSTAR .......................................... 31, 32 tretinoin ................................................................ 101 tretinoin (chemotherapy) ................ 32 tretinoin microspheres ...................... 101 TREXALL ......................................................... 32 triamcinolone acetonide .................................................. 95, 101, 109, 118 triamterene-hydrochlorothiazid ............................................................................................... 82 Index TECHNIVIE ................................................... 63 TEFLARO ......................................................... 17 TEGRETOL XR ....................................... 37 telmisartan ........................................................... 74 telmisartan-hydrochlorothiazid ............................................................................................... 74 temazepam ........................................................... 13 TEMODAR ...................................................... 31 tencon .............................................................................. 7 teniposide ............................................................... 31 TENIVAC (PF) ....................................... 128 terazosin ............................................................... 114 terbinafine hcl .................................................. 49 terbutaline ......................................................... 146 terconazole ........................................................... 50 testosterone ...................................................... 115 testosterone cypionate ...................... 115 testosterone enanthate ...................... 115 TETANUS TOXOID,ADSORBED (PF) ........................................................................................... 128 TETANUS,DIPHTHERIA TOX PED(PF) .......................................... 128 tetanus-diphtheria toxoids-td ........................................................................................... 128 tetrabenazine ..................................................... 88 tetracaine hcl (pf) .................................. 105 tetracycline .......................................................... 23 TEVETEN HCT ........................................ 74 THALOMID ............................................... 136 theochron ............................................................ 146 theophylline ..................................................... 146 theophylline in dextrose 5 % .... 146 thioridazine .......................................................... 59 thiotepa ..................................................................... 31 thiothixene ............................................................ 59 tiagabine .................................................................. 37 TICE BCG ...................................................... 124 TIKOSYN ........................................................... 77 tilia fe .......................................................................... 94 timolol maleate ................................ 78, 138 tinidazole ................................................................ 54 TIVICAY ............................................................. 62 tizanidine ............................................................. 147 TOBI PODHALER .............................. 13 Index Index sulfacetamide sodium ......................... 107 sulfacetamide sodium (acne) ..... 98 sulfacetamide-prednisolone ........ 107 sulfadiazine .......................................................... 21 sulfamethoxazole-trimethoprim .................................................................................... 21, 22 sulfasalazine ....................................................... 22 sulfatrim .................................................................. 22 sulindac ..................................................................... 10 sumatriptan ......................................................... 51 sumatriptan succinate ........................... 51 SUPPRELIN LA .................................. 120 SUPRAX .............................................................. 17 SURMONTIL .............................................. 42 SUSTIVA ............................................................. 62 SUTENT ............................................................... 30 syeda ............................................................................. 93 SYLATRON ................................................... 64 SYLVANT ......................................................... 30 SYMLINPEN 120 ................................... 44 SYMLINPEN 60 ...................................... 44 SYNAGIS ........................................................... 63 SYNAREL ..................................................... 136 SYNERCID ..................................................... 15 SYNJARDY .................................................... 44 SYNRIBO ........................................................... 30 SYPRINE ........................................................ 114 TABLOID ........................................................... 30 tacrolimus ........................................... 101, 124 TAFINLAR ..................................................... 30 TAGRISSO ....................................................... 30 TALTZ AUTOINJECTOR ...... 96 TALTZ SYRINGE ............................... 96 TAMIFLU ......................................................... 63 tamoxifen ............................................................... 30 tamsulosin .......................................................... 114 TARCEVA ........................................................ 31 TARGRETIN ............................................... 31 tarina fe 1/20 (28) .................................... 94 TASIGNA ........................................................... 31 tazicef .......................................................................... 17 TAZORAC .................................................... 101 taztia xt .................................................................... 79 TECENTRIQ ................................................. 31 TECFIDERA ............................................. 136 Effective: July 01, 2016 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-15 VIMPAT ............................................................... 38 vinblastine ............................................................. 32 vincasar pfs .......................................................... 32 vincristine ............................................................... 32 vinorelbine ............................................................. 32 viorele (28) ......................................................... 94 VIRACEPT ....................................................... 62 VIRAMUNE XR ..................................... 62 VIRAZOLE ...................................................... 65 VIREAD ............................................................... 62 virt-phos 250 neutral ........................... 143 VITAFOL FE+ (WITH DOCUSATE) ............................................. 150 VITEKTA ........................................................... 62 VOLTAREN ................................................... 10 voriconazole ........................................................ 49 VOTRIENT ...................................................... 32 VPRIV ................................................................... 103 VRAYLAR ....................................................... 59 vyfemla (28) ..................................................... 94 VYTORIN 10-10 ....................................... 84 VYTORIN 10-20 ....................................... 84 VYTORIN 10-40 ....................................... 84 VYTORIN 10-80 ....................................... 84 warfarin .................................................................... 67 water for irrigation, sterile ......... 130 WELCHOL ....................................................... 85 wera (28) ............................................................... 94 wymzya fe ............................................................. 94 XALKORI ......................................................... 33 XARELTO ........................................................ 67 XARTEMIS XR ........................................... 8 XELJANZ ....................................................... 137 XELJANZ XR .......................................... 137 XGEVA ............................................................... 131 XIFAXAN ......................................................... 15 XOLAIR ............................................................ 147 XTANDI ............................................................... 33 xulane .......................................................................... 94 xylon 10 ....................................................................... 8 XYREM ............................................................. 148 YERVOY ............................................................. 33 YF-VAX (PF) ............................................ 129 YONDELIS ...................................................... 33 zafirlukast ......................................................... 144 Index VAGIFEM ..................................................... 116 valacyclovir ......................................................... 65 VALCHLOR .................................................. 97 VALCYTE ......................................................... 65 valganciclovir .................................................... 65 valproate sodium .......................................... 38 valproic acid ....................................................... 38 valproic acid (as sodium salt) ... 38 valsartan .................................................................. 75 valsartan-hydrochlorothiazide ... 75 VALSTAR .......................................................... 32 vancomycin .......................................................... 15 vancomycin in dextrose 5 % ......... 15 VAQTA (PF) ............................................... 128 VARIVAX (PF) ...................................... 129 VASCEPA .......................................................... 84 VECTIBIX ......................................................... 32 VELCADE ......................................................... 32 velivet triphasic regimen (28) ... 94 VELPHORO ............................................... 111 VENCLEXTA .............................................. 32 VENCLEXTA STARTING PACK ........................................................................ 32 venlafaxine ........................................................... 42 VENTOLIN HFA ............................... 146 verapamil ................................................................ 79 VEREGEN ........................................................ 97 VERSACLOZ ............................................... 59 VESICARE ................................................... 113 vestura (28) ....................................................... 94 VGO 40 ................................................................ 102 VIBERZI ........................................................... 112 vicodin ............................................................................ 8 vicodin es .................................................................... 8 vicodin hp ................................................................... 8 VICTOZA 3-PAK ................................... 44 VIDEX 2 GRAM PEDIATRIC ............................................................................................... 62 VIDEX 4 GRAM PEDIATRIC ............................................................................................... 62 VIEKIRA PAK .......................................... 63 vienva ........................................................................... 94 VIGAMOX .................................................... 107 VIIBRYD ............................................................. 42 VIMIZIM ......................................................... 103 Index Index trianex .................................................................... 101 triazolam ................................................................. 13 TRIBENZOR ................................................ 75 tri-estarylla .......................................................... 94 trifluoperazine ................................................. 59 trifluridine ......................................................... 107 trihexyphenidyl .............................................. 55 tri-legest fe ........................................................... 94 tri-linyah ................................................................. 94 tri-lo-estarylla .................................................. 94 tri-lo-marzia ....................................................... 94 tri-lo-sprintec .................................................... 94 trilyte with flavor packets ............ 112 trimethoprim ...................................................... 15 trimipramine ...................................................... 42 trinessa (28) ...................................................... 94 TRINTELLIX .............................................. 42 tri-previfem (28) ......................................... 94 tri-sprintec (28) ............................................ 94 TRIUMEQ ........................................................ 62 trivora (28) ......................................................... 94 TROKENDI XR ...................................... 38 TROPHAMINE 10 % ....................... 73 TROPHAMINE 6% ............................. 73 trospium ............................................................... 113 TRULICITY ................................................... 44 TRUMENBA ............................................. 128 TRUVADA ...................................................... 62 TUDORZA PRESSAIR ............ 146 TWINRIX (PF) ....................................... 128 TYBOST ............................................................ 137 TYGACIL .......................................................... 23 TYKERB .............................................................. 32 TYPHIM VI ................................................. 128 TYSABRI ........................................................ 124 TYVASO ........................................................... 149 TYVASO REFILL KIT ............. 149 TYVASO STARTER KIT ..... 149 TYZEKA .............................................................. 65 TYZINE ............................................................. 105 u-cort ........................................................................ 101 ULORIC ............................................................ 137 UNITUXIN ..................................................... 32 UPTRAVI ....................................................... 149 ursodiol .................................................................. 111 Effective: July 01, 2016 Index zaleplon ................................................................. 148 ZALTRAP .......................................................... 33 zarah ............................................................................. 95 ZARXIO ............................................................... 68 ZAVESCA ...................................................... 103 zebutal ............................................................................ 8 ZELBORAF .................................................... 33 ZEMPLAR .................................................... 131 zenatane ................................................................... 97 zenchent (28) ................................................... 95 zenchent fe ............................................................ 95 ZENPEP ............................................................ 103 zeosa ............................................................................. 95 ZEPATIER ........................................................ 63 ZETIA ....................................................................... 85 ZIAGEN ............................................................... 63 zidovudine .............................................................. 63 ZIOPTAN (PF) ....................................... 138 ziprasidone hcl ................................................. 59 ZIRGAN ........................................................... 107 ZOHYDRO ER ............................................. 8 ZOLADEX ........................................................ 33 zoledronic acid ............................................ 131 zoledronic acid-mannitol-water ........................................................................................... 131 ZOLINZA ........................................................... 33 zolmitriptan ........................................................ 51 zolpidem ............................................................... 148 ZOMETA ......................................................... 131 zonisamide ............................................................ 38 ZORTRESS .................................................. 124 ZOSTAVAX (PF) ................................ 129 zovia 1/35e (28) ........................................... 95 zovia 1/50e (28) ........................................... 95 ZOVIRAX .......................................................... 97 ZUBSOLV .......................................................... 11 ZYDELIG .......................................................... 33 ZYKADIA ......................................................... 33 ZYLET ................................................................. 107 ZYPREXA RELPREVV .............. 59 ZYTIGA ................................................................ 33 ZYVOX ................................................................... 15 Sharp Advantage 2016 Part D Formulary Formulary ID: 16490.001, Version: 15 I-16 Effective: July 01, 2016 This formulary was updated on 06/27/2016. For more recent information or other questions, please contact Sharp Advantage Customer Care at 1-855-820-2112 or visit www.sharphealthplan.com/sharpadvantage for additional information. (TTY users should call 711.) Hours are 8:00 a.m. to 6:00 p.m. Pacific Time, Monday to Friday. Sharp Advantage is offered by Sharp Health Plan. Sharp Advantage is an HMO plan with a Medicare contract. Enrollment in Sharp Advantage depends on contract renewal. This information is available for free in other languages. Please call our Customer Care number at 1-855-820-2112 for additional information. (TTY users should call 711.) Hours are 8:00 a.m. to 6:00 p.m., Monday to Friday. Customer Care also has free language interpreter services available for non-English speakers. Please contact Sharp Advantage if you need information in another format. Esta información puede obtenerse sin cargo en otros idiomas. Si desea más información, llame a nuestro servicio de atención a los miembros al 1-855-820-2112. (Los usuarios de TTY deben llamar al 711.) El horario es de 8:00 de la mañana a 6:00 de la tarde de lunes a viernes. Alguien que hable español le podrá ayudar. Este es un servicio gratuito. Por favor, póngase en contacto con Sharp Advantage si usted necesita información en otro forma. The formulary, pharmacy network, and/or provider network may change at any time. You will receive notice when necessary.
Similar documents
Printable Formulary for 2016 (effective 9/1/16)
For members who experience a level of care change such as changing from one treatment setting to another (e.g. hospital to long-term care facility), being admitted to or discharged from a long-term...
More informationHealthPartners EnhancedRx
need to meet the HealthPartners prior authorization criteria in order for the medicine to be covered by your pharmacy benefits. Your doctor will get the approval for you. The approval decision is u...
More information2015 Prescription Drug Formular and Network Pharmacies
along with the date we last updated the formulary, appears on the front and back cover pages. You must generally use network pharmacies to use your prescription drug benefit. Benefits, formulary, p...
More informationList of Covered Drugs - Inland Empire Health Plan
11-84. You can also get more information by visiting our web site at www.iehp.org. We have posted online documents that explain our prior authorization restrictions. You may also ask us to send you...
More information(PDP) 2016 Formulary - Blue Cross and Blue Shield of Illinois
Note to existing members: This formulary has changed since last year. Please review this document to make sure it still contains the drugs you take. When this drug list (formulary) refers to “we,” ...
More information